International consensus statement on allergy and rhinology: Olfaction.
anosmia
evidence-based medicine
hyposmia
loss of smell
olfaction
olfactory dysfunction
olfactory loss
parosmia
phantosmia
systematic review
Journal
International forum of allergy & rhinology
ISSN: 2042-6984
Titre abrégé: Int Forum Allergy Rhinol
Pays: United States
ID NLM: 101550261
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
revised:
01
01
2021
received:
18
11
2021
accepted:
19
11
2021
entrez:
4
4
2022
pubmed:
5
4
2022
medline:
6
4
2022
Statut:
ppublish
Résumé
The literature regarding clinical olfaction, olfactory loss, and olfactory dysfunction has expanded rapidly over the past two decades, with an exponential rise in the past year. There is substantial variability in the quality of this literature and a need to consolidate and critically review the evidence. It is with that aim that we have gathered experts from around the world to produce this International Consensus on Allergy and Rhinology: Olfaction (ICAR:O). Using previously described methodology, specific topics were developed relating to olfaction. Each topic was assigned a literature review, evidence-based review, or evidence-based review with recommendations format as dictated by available evidence and scope within the ICAR:O document. Following iterative reviews of each topic, the ICAR:O document was integrated and reviewed by all authors for final consensus. The ICAR:O document reviews nearly 100 separate topics within the realm of olfaction, including diagnosis, epidemiology, disease burden, diagnosis, testing, etiology, treatment, and associated pathologies. This critical review of the existing clinical olfaction literature provides much needed insight and clarity into the evaluation, diagnosis, and treatment of patients with olfactory dysfunction, while also clearly delineating gaps in our knowledge and evidence base that we should investigate further.
Sections du résumé
BACKGROUND
The literature regarding clinical olfaction, olfactory loss, and olfactory dysfunction has expanded rapidly over the past two decades, with an exponential rise in the past year. There is substantial variability in the quality of this literature and a need to consolidate and critically review the evidence. It is with that aim that we have gathered experts from around the world to produce this International Consensus on Allergy and Rhinology: Olfaction (ICAR:O).
METHODS
Using previously described methodology, specific topics were developed relating to olfaction. Each topic was assigned a literature review, evidence-based review, or evidence-based review with recommendations format as dictated by available evidence and scope within the ICAR:O document. Following iterative reviews of each topic, the ICAR:O document was integrated and reviewed by all authors for final consensus.
RESULTS
The ICAR:O document reviews nearly 100 separate topics within the realm of olfaction, including diagnosis, epidemiology, disease burden, diagnosis, testing, etiology, treatment, and associated pathologies.
CONCLUSION
This critical review of the existing clinical olfaction literature provides much needed insight and clarity into the evaluation, diagnosis, and treatment of patients with olfactory dysfunction, while also clearly delineating gaps in our knowledge and evidence base that we should investigate further.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
327-680Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022 ARS-AAOA, LLC.
Références
Buck L, Axel R. A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell. 1991;65:175-187.
Patel ZM, Fernandez-Miranda J, Hwang PH, et al. Letter: precautions for endoscopic transnasal skull base surgery during the COVID-19 pandemic. Neurosurgery. 2020;87:E66-E67.
Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020;10:806-813.
Orlandi RR, Kingdom TT, Hwang PH, et al. International consensus statement on allergy and rhinology: rhinosinusitis. Int Forum Allergy Rhinol. 2016;6(1):S22-S209.
Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11:213-739.
Wise SK, Lin SY, Toskala E, et al. International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol. 2018;8:108-352.
Rudmik L, Smith TL. Development of an evidence-based review with recommendations using an online iterative process. Int Forum Allergy Rhinol. 2011;1:431-437.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1-e34.
Oxford Centre for Evidence-based Medicine (CEBM). Levels of Evidence. 2009. Accessed January 1, 2020. http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009
American Academy of Pediatrics Steering Committee on Quality Improvement and Management (AAP SCQIM): classifying recommendations for clinical practice guidelines. Pediatrics. 2004;114:874-877.
Boesveldt S, Postma EM, Boak D, et al. Anosmia-A clinical review. Chem Senses. 2017;42:513-523.
Kobal G, Klimek L, Wolfensberger M, et al. Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Otorhinolaryngol. 2000;257:205-211.
Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav. 1984;32:489-502.
Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54:1-30.
Croy I, Olgun S, Mueller L, et al. Peripheral adaptive filtering in human olfaction? Three studies on prevalence and effects of olfactory training in specific anosmia in more than 1600 participants. Cortex. 2015;73:180-187.
Hummel T, Kobal G, Gudziol H, Mackay-Sim A. Normative data for the “Sniffin’ Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol. 2007;264:237-243.
Cain WS, Gent J, Catalanotto FA, Goodspeed RB. Clinical evaluation of olfaction. Am J Otolaryngol. 1983;4:252-256.
Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54:1-30.
Leopold DA, Loehrl TA, Schwob JE. Long-term follow-up of surgically treated phantosmia. Arch Otolaryngol Head Neck Surg. 2002;128:642-647.
Leopold D. Distortion of olfactory perception: diagnosis and treatment. Chem Senses. 2002;27:611-615.
Keller A, Malaspina D. Hidden consequences of olfactory dysfunction: a patient report series. BMC Ear Nose Throat Disord. 2013;13:8.
Nordin S, Murphy C, Davidson TM, Quiñonez C, Jalowayski AA, Ellison DW. Prevalence and assessment of qualitative olfactory dysfunction in different age groups. Laryngoscope. 1996;106:739-744.
Hong SC, Holbrook EH, Leopold DA, Hummel T. Distorted olfactory perception: a systematic review. Acta Otolaryngol. 2012;132 suppl 1: S27-S31.
Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54:1-30.
Nordin S, Murphy C, Davidson TM, Quiñonez C, Jalowayski AA, Ellison DW. Prevalence and assessment of qualitative olfactory dysfunction in different age groups. Laryngoscope. 1996;106:739-744.
Leopold DA, Loehrl TA, Schwob JE. Long-term follow-up of surgically treated phantosmia. Arch Otolaryngol Head Neck Surg. 2002;128:642-647.
Frasnelli J, Landis BN, Heilmann S, et al. Clinical presentation of qualitative olfactory dysfunction. Eur Arch Otorhinolaryngol. 2004;261:411-415.
Keller A, Malaspina D. Hidden consequences of olfactory dysfunction: a patient report series. BMC Ear Nose Throat Disord. 2013;13:8.
Stevenson RJ. An initial evaluation of the functions of human olfaction. Chem Senses. 2010;35:3-20.
Croy I, Nordin S, Hummel T. Olfactory disorders and quality of life-an updated review. Chem Senses. 2014;39:185-194.
Croy I, Hummel T. Olfaction as a marker for depression. J Neurol. 2017;264:631-638.
Kohli P, Soler ZM, Nguyen SA, Muus JS, Schlosser RJ. The association between olfaction and depression: a systematic review. Chem Senses. 2016;41:479-486.
Schablitzky S, Pause BM. Sadness might isolate you in a non-smelling world: Olfactory perception and depression. Front Psychol. 2014;5:45.
Rochet M, El-Hage W, Richa S, Kazour F, Atanasova B. Depression, olfaction, and quality of life: a mutual relationship. Brain Sci. 2018;8:80.
Erskine SE, Philpott CM. An unmet need: patients with smell and taste disorders. Clin Otolaryngol. 2020;45:197-203.
Philpott CM, Boak D. The impact of olfactory disorders in the United kingdom. Chem Senses. 2014;39:711-718.
Frasnelli J, Hummel T. Olfactory dysfunction and daily life. Eur Arch Otorhinolaryngol. 2005;262:231-235.
Desiato VM, Levy DA, Byun YJ, Nguyen SA, Soler ZM, Schlosser RJ. The prevalence of olfactory dysfunction in the general population: a systematic review and meta-analysis. Am J Rhinol Allergy. 2020;35:195-205.
Murr J, Hummel T, Ritschel G, Croy I. Individual significance of olfaction: a comparison between normosmics and dysosmic people. Psychosomatics. 2018;59:283-292.
Kollndorfer K, Reichert J, Brückler B, Hinterleitner V, Schöpf V. Self-esteem as an important factor in quality of life and depressive symptoms in anosmia: a pilot study. Clin Otolaryngol. 2017;42:1229-1234.
Keller A, Malaspina D. Hidden consequences of olfactory dysfunction: a patient report series. BMC Ear Nose Throat Disord. 2013;13:1-20.
Blomqvist EH, Brämerson A, Stjärne P, Nordin S. Consequences of olfactory loss and adopted coping strategies. Rhinology. 2004;42:189-194.
Oleszkiewicz A, Kunkel F, Larsson M, Hummel T. Consequences of undetected olfactory loss for human chemosensory communication and well-being. Philos Trans R Soc Lond B Biol Sci. 2020;375: 20190265.
Schäfer L, Schriever VA, Croy I. Human olfactory dysfunction: causes and consequences. Cell Tissue Res. 2021;383:569-579.
Lobmaier JS, Fischbacher U, Wirthmüller U, Knoch D. The scent of attractiveness: levels of reproductive hormones explain individual differences in women's body odour. Proc Biol Sci. 2018;285: 20181520
de Groot JH, Smeets MA, Rowson MJ, Bulsing PJ, Blonk CG, Wilkinson JE, Semin GR. A sniff of happiness. Psychol Sci. 2015;26:684-700.
Gelstein S, Yeshurun Y, Rozenkrantz L, Shushan S, Frumin I, Roth Y, Sobel N. Human tears contain a chemosignal. Science. 2011;331:226-230.
Prehn-Kristensen A, Wiesner C, Bergmann TO, et al. Pause, Induction of empathy by the smell of anxiety. PloS One. 2009;4: e5987.
Sorokowska A, Sorokowski, P, Szmajke A. Does personality smell? Accuracy of personality assessments based on body odour. Eur J Pers. 2012;26:496-503.
Wedekind C, Seebeck T, Bettens F, Paepke AJ. MHC-dependent mate preferences in humans. Proc Biol Sci. 1995;260:245-249.
Rattaz C, Goubet N, Bullinger A. The calming effect of a familiar odor on full-term newborns. J Dev Behav Pediatr. 2005;26:86-92.
Granqvist P, Vestbrant K, Döllinger L, et al. The scent of security: odor of romantic partner alters subjective discomfort and autonomic stress responses in an adult attachment-dependent manner. Physiol Behav. 2019;198:144-150.
Lundström JN, Jones-Gotman M. Romantic love modulates women's identification of men's body odors. Horm Behav. 2009;55:280-284.
Okamoto M, Shirasu M, Fujita R, Hirasawa Y, Touhara K. Child odors and parenting: a survey examination of the role of odor in child-rearing. PloS One. 2016;11: e0154392.
Drummond M, Douglas J, Olver J. ‘If I haven't got any smell… I'm out of work’: consequences of olfactory impairment following traumatic brain injury. Brain Inj. 2013;27:332-345.
Brämerson A, Nordin S, Bende M. Clinical experience with patients with olfactory complaints, and their quality of life. Acta Otolaryngol. 2007;127:167-174.
Lundström JN, Mathe A, Schaal B, et al. Maternal status regulates cortical responses to the body odor of newborns. Front Psychol. 2013;4:597.
Schäfer L, Michael M, Croy I. Olfactory cuteness: Baby body odors recruit pleasure network in the maternal brain. Poster presented at: Annual Meeting of the Organization for Human Brain Mapping; June 9-13, 2019; Rome, Italy.
Mahmut MK, Croy I. The role of body odors and olfactory ability in the initiation, maintenance and breakdown of romantic relationships-a review. Physiology Behav. 2019;207:179-184.
Herz RS, Inzlicht M. Sex differences in response to physical and social factors involved in human mate selection. Evol Hum Behav. 2002;23:359-364.
Sorokowska A, Pietrowski D, Schäfer L, et al. Human leukocyte antigen similarity decreases partners’ and strangers’ body odor attractiveness for women not using hormonal contraception. Horm Behav. 2018;106:144-149.
Bendas J, Hummel T, Croy I. Olfactory function relates to sexual experience in adults. Arch Sex Behav. 2018;47:1333-1339.
Croy I, Negoias S, Novakova L, Landis BN, Hummel T. Learning about the functions of the olfactory system from people without a sense of smell. PloS One. 2012;7: e33365.
Schäfer L, Mehler L, Hähner A, Walliczek U, Hummel T, Croy I. Sexual desire after olfactory loss: quantitative and qualitative reports of patients with smell disorders. Physiol Behav. 2019;201:64-69.
de Jong P, Sportel B, De Hullu, E, Nauta M. Co-occurrence of social anxiety and depression symptoms in adolescence: differential links with implicit and explicit self-esteem? Psychol Med. 2012;42; 475-484.
Lim MH, Rodebaugh TL, Zyphur MJ, Gleeson JF. Loneliness over time: the crucial role of social anxiety. J Abnorm Psychol. 2016;125:620-630.
Ahmedy F, Mazlan M, Danaee M, Abu Bakar MZ. Post-traumatic brain injury olfactory dysfunction: factors influencing quality of life. Eur Arch Otorhinolaryngol. 2020;277:1343-1351.
Miwa T, Furukawa M, Tsukatani T, Costanzo RM, DiNardo LJ, Reiter ER. Impact of olfactory impairment on quality of life and disability. Arch Otolaryngol Head Neck Surg. 2001;127:497-503.
Stevenson RJ. An initial evaluation of the functions of human olfaction. Chem Senses. 2010;35:3-20.
Chalke HD, Dewhurst JR, Ward CW. Loss of sense of smell in old people: a possible contributory factor in accidental poisoning from town gas. Public Health. 1958;72:223-230.
Barillo DJ, Goode R. Fire fatality study: Demographics of fire victims. Burns. 1996;22:85-88.
Santos DV, Reiter ER, DiNardo LJ, Costanzo RM. Hazardous events associated with impaired olfactory function. Arch Otolaryngol Head Neck Surg. 2004;130:317-319.
Bonfils P, Faulcon P, Tavernier L, Bonfils NA, Malinvaud D. [Home accidents associated with anosmia]. Presse Med. 2008;37(5 pt 1):742-745.
Pence TS, Reiter ER, DiNardo LJ, Costanzo RM. Risk factors for hazardous events in olfactory-impaired patients. JAMA Otolaryngol Head Neck Surg. 2014;140:951-955.
Croy I, Negoias S, Novakova L, Landis BN, Hummel T. Learning about the functions of the olfactory system from people without a sense of smell. PloS One. 2012;7: e33365.
Altundag A, Tekeli H, Salihoglu M, et al. A study on olfactory dysfunction in Turkish population with using survey method and validated olfactory testing. Indian J Otolaryngol Head Neck Surg. 2015;67:7-12.
Keller A, Malaspina D. Hidden consequences of olfactory dysfunction: a patient report series. BMC Ear Nose Throat Disord. 2013;13:8.
Temmel AF, Quint C, Schickinger-Fischer B, Klimek L, Stoller E, Hummel T. Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg. 2002;128:635-641
Blomqvist EH, Brämerson A, Stjärne P, Nordin S. Consequences of olfactory loss and adopted coping strategies. Rhinology. 2004;42:189-194.
Nordin S, Blomqvist EH, Olsson P, Stjärne P, Ehnhage A; NAF2S2 Study Group. Effects of smell loss on daily life and adopted coping strategies in patients with nasal polyposis with asthma. Acta Otolaryngol. 2011;131:826-832.
Croy I, Landis BN, Meusel T, Seo HS, Krone F, Hummel T. Patient adjustment to reduced olfactory function. Arch Otolaryngol Head Neck Surg. 2011;137:377-382.
Sorokowska A, Hummel T, Oleszkiewicz A. No olfactory compensation in food-related hazard detection among blind and deaf adults: a psychophysical approach. Neuroscience. 2020;440:56-64.
Wilson RS, Yu L, Bennett DA. Odor identification and mortality in old age. Chem Senses. 2011;36:63-67.
Gopinath B, Sue CM, Kifley A, Mitchell P. The association between olfactory impairment and total mortality in older adults. J Gerontol A Biol Sci Med Sci. 2012;67:204-209.
Pinto JM, Wroblewski KE, Kern DW, Schumm LP, McClintock MK. Olfactory dysfunction predicts 5-year mortality in older adults. PloS One. 2014;9: e107541.
Devanand DP, Lee S, Manly J, et al. Olfactory identification deficits and increased mortality in the community. Ann Neurol. 2015;78:401-411.
Schubert CR, Fischer ME, Pinto AA, et al. Sensory impairments and risk of mortality in older adults. J Gerontol A Biol Sci Med Sci. 2017;72:710-715.
Ekström I, Sjölund S, Nordin S, et al. Smell loss predicts mortality risk regardless of dementia conversion. J Am Geriatr Soc. 2017;65:1238-1243.
Leschak CJ, Eisenberger NI. The role of social relationships in the link between olfactory dysfunction and mortality. PloS One. 2018;13: e0196708.
Laudisio A, Navarini L, Margiotta DP, et al. The association of olfactory dysfunction, frailty, and mortality is mediated by inflammation: Results from the InCHIANTI study. J Immunol Res. 2019;2019: 3128231.
Liu B, Luo Z, Pinto JM, et al. Relationship between poor olfaction and mortality among community-dwelling older adults: a cohort study. Ann Intern Med. 2019;170:673-681.
Choi JS, Jang SS, Kim J, Hur K, Ference E, Wrobel B. Association between olfactory dysfunction and mortality in US adults. JAMA Otolaryngol Head Neck Surg. 2021;147:49-55.
Choi R, Goldstein BJ. Olfactory epithelium: Cells, clinical disorders, and insights from an adult stem cell niche. Laryngoscope Investig Otolaryngol. 2018;3:35-42.
Hadley K, Orlandi RR, Fong KJ. Basic anatomy and physiology of olfaction and taste. Otolaryngol Clin North Am. 2004;37:1115-1126.
Moran DT, Rowley JC, Jafek BW, Lovell MA. The fine structure of the olfactory mucosa in man. J Neurocytol. 1982;11:721-746.
Pinna FdR, Ctenas B, Weber R, Saldiva PH, Voegels RL. (2013). Olfactory neuroepithelium in the superior and middle turbinates: which is the optimal biopsy site?. Int Arch Otorhinolaryngol, 17(2), 131-138
Maresh A, Rodriguez Gil D, Whitman MC, Greer CA. Principles of glomerular organization in the human olfactory bulb-implications for odor processing. PloS One. 2008;3: e2640.
Buck L, Axel R. A novel multigene family may encode odorant receptors: A molecular basis for odor recognition. Cell. 1991;65:175-187.
DeMaria S, Ngai J. The cell biology of smell. J Cell Biol. 2010;191:443-452.
Glusman G, Yanai I, Rubin I, Lancet D. The complete human olfactory subgenome. Genome Res. 2001;11:685-702.
Durante MA, Kurtenbach S, Sargi ZB, et al. Single-cell analysis of olfactory neurogenesis and differentiation in adult humans. Nat Neurosci. 2020;23:323-326.
Jiang Y, Gong NN, Hu XS, Ni MJ, Pasi R, Matsunami H. Molecular profiling of activated olfactory neurons identifies odorant receptors for odors in vivo. Nat Neurosci. 2015;18:1446-1454.
Mombaerts P, Wang F, Dulac C, et al. Visualizing an olfactory sensory map. Cell. 1996;87:675-686.
Carr VM, Farbman AI. The dynamics of cell death in the olfactory epithelium. Exp Neurol. 1993;124:308-314.
Mackay-Sim A, Kittel PW. On the life span of olfactory receptor neurons. Eur J Neurosci. 1991;3:209-215.
Santoro SW, Dulac C. The activity-dependent histone variant H2BE modulates the life span of olfactory neurons. eLife. 2012;1: e00070.
Graziadei PP, Graziadei GA. Neurogenesis and neuron regeneration in the olfactory system of mammals. I. Morphological aspects of differentiation and structural organization of the olfactory sensory neurons. J Neurocytol. 1979;8:1-18.
Hinds JW, Hinds PL, McNelly NA. An autoradiographic study of the mouse olfactory epithelium: evidence for long-lived receptors. Anat Rec. 1984;210:375-383.
Huard JM, Youngentob SL, Goldstein BJ, Luskin MB, Schwob JE. Adult olfactory epithelium contains multipotent progenitors that give rise to neurons and non-neural cells. J Comp Neurol. 1998;400:469-486.
Goldstein BJ, Goss GM, Hatzistergos KE, et al. Adult c-Kit(+) progenitor cells are necessary for maintenance and regeneration of olfactory neurons. J Comp Neurol. 2015;523:15-31.
Leung CT, Coulombe PA, Reed RR. Contribution of olfactory neural stem cells to tissue maintenance and regeneration. Nat Neurosci. 2007;10:720-726.
Fletcher RB, Das D, Gadye L, et al. Deconstructing olfactory stem cell trajectories at single-cell resolution. Cell Stem Cell. 2017;20:817-830.e8.
Calof AL, Bonnin A, Crocker C, et al. Progenitor cells of the olfactory receptor neuron lineage. Microsc Res Tech. 2002;58:176-188.
Cleland TA, Linster C. Central olfactory structures. Handb Clin Neurol. 2019;164:79-96.
Price JL. An autoradiographic study of complementary laminar patterns of termination of afferent fibers to the olfactory cortex. J Comp Neurol. 1973;150:87-108.
Mombaerts P. Axonal wiring in the mouse olfactory system. Annu Rev Cell Dev Biol. 2006;22:713-737.
Lledo PM, Valley M. Adult olfactory bulb neurogenesis. Cold Spring Harb Perspect Biol. 2016;8: a018945.
Sosulski DL, Bloom ML, Cutforth T, Axel R, Datta SR. Distinct representations of olfactory information in different cortical centres. Nature. 2011;472:213-216.
Poo C, Isaacson JS. Odor representations in olfactory cortex: “sparse” coding, global inhibition, and oscillations. Neuron. 2009;62:850-861.
Blazing RM, Franks KM. Odor coding in piriform cortex: Mechanistic insights into distributed coding. Curr Opin Neurobiol. 2020;64:96-102.
Gadziola MA, Tylicki KA, Christian DL, Wesson DW. The olfactory tubercle encodes odor valence in behaving mice. J Neurosci. 2015;35:4515-4527.
Gottfried JA, Zelano C. The value of identity: Olfactory notes on orbitofrontal cortex function. Ann N Y Acad Sci. 2011;1239:138-148.
Yang J, Pinto JM. The epidemiology of olfactory disorders. Curr Otorhinolaryngol Rep. 2016;4:130-141.
Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54:1-30.
Doty RL. Office procedures for quantitative assessment of olfactory function. Am J Rhinol. 2007;21:460-473.
Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Prevalence of olfactory impairment in older adults. JAMA. 2002;288:2307-2312.
Rawal S, Hoffman HJ, Chapo AK, Duffy VB. Sensitivity and specificity of self-reported olfactory function in a home-based study of independent-living, healthy older women. Chemosens Percept. 2014;7:108-116.
Hoffman HJ, Ishii EK, MacTurk RH. Age-related changes in the prevalence of smell/taste problems among the United States adult population. Results of the 1994 disability supplement to the National Health Interview Survey (NHIS). Ann N Y Acad Sci. 1998;855:716-722.
Lee WH, Wee JH, Kim DK, et al. Prevalence of subjective olfactory dysfunction and its risk factors: Korean National Health and Nutrition Examination Survey. PloS One. 2013;8: e62725.
Hastan D, Fokkens WJ, Bachert C, et al. Chronic rhinosinusitis in Europe-an underestimated disease. A GA2LEN study. Allergy. 2011;66:1216-1223.
Hirsch AG, Stewart WF, Sundaresan AS, et al. Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample. Allergy. 2017;72:274-281.
Bhattacharyya N, Kepnes LJ. Contemporary assessment of the prevalence of smell and taste problems in adults. Laryngoscope. 2015;125:1102-1106.
Rawal S, Hoffman HJ, Bainbridge KE, Huedo-Medina TB, Duffy VB. Prevalence and risk factors of self-reported smell and taste alterations: Results from the 2011-2012 US National Health and Nutrition Examination Survey (NHANES). Chem Senses. 2016;41:69-76.
Hoffman HJ, Rawal S, Li CM, Duffy VB. New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): First-year results for measured olfactory dysfunction. Rev Endocr Metab Disord. 2016;17:221-240.
Liu G, Zong G, Doty RL, Sun Q. Prevalence and risk factors of taste and smell impairment in a nationwide representative sample of the US population: A cross-sectional study. BMJ Open. 2016;6:e013246-013246.
Bainbridge KE, Byrd-Clark D, Leopold D. Factors associated with phantom odor perception among US adults: Findings from the National Health and Nutrition Examination Survey. JAMA Otolaryngol Head Neck Surg. 2018;144:807-814.
Brämerson A, Johansson L, Ek L, Nordin S, Bende M. Prevalence of olfactory dysfunction: The skövde population-based study. Laryngoscope. 2004;114:733-737.
Nordin S, Brämerson A, Bende M. Prevalence of self-reported poor odor detection sensitivity: The skövde population-based study. Acta Otolaryngol. 2004;124:1171-1173.
Gopinath B, Anstey KJ, Kifley A, Mitchell P. Olfactory impairment is associated with functional disability and reduced independence among older adults. Maturitas. 2012;72:50-55.
Mullol J, Alobid I, Mariño-Sánchez F, et al. Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: A population-based survey (OLFACAT study). BMJ Open. 2012;2: e001256.
Boesveldt S, Lindau ST, McClintock MK, Hummel T, Lundstrom JN. Gustatory and olfactory dysfunction in older adults: A national probability study. Rhinology. 2011;49:324-330.
Kern DW, Wroblewski KE, Schumm LP, Pinto JM, Chen RC, McClintock MK. Olfactory function in Wave 2 of the National Social Life, Health, and Aging Project. J Gerontol B Psychol Sci Soc Sci. 2014;69 suppl 2(suppl 2): S134-S143.
Wilson RS, Arnold SE, Tang Y, Bennett DA. Odor identification and decline in different cognitive domains in old age. Neuroepidemiology. 2006;26:61-67.
Ross GW, Petrovitch H, Abbott RD, et al. Association of olfactory dysfunction with risk for future parkinson's disease. Ann Neurol. 2008;63:167-173.
Devanand DP, Lee S, Manly J, et al. Olfactory identification deficits and increased mortality in the community. Ann Neurol. 2015;78:401-411.
Schubert CR, Cruickshanks KJ, Fischer ME, et al. Olfactory impairment in an adult population: The Beaver Dam Offspring Study. Chem Senses. 2012;37:325-334.
Schlosser RJ, Desiato VM, Storck KA, et al. A community-based study on the prevalence of olfactory dysfunction. Am J Rhinol Allergy. 2020;34:661-670.
Deems DA, Doty RL, Settle RG, et al. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg. 1991;117:519-528.
Mott AE, Leopold DA. Disorders in taste and smell. Med Clin North Am. 1991;75:1321-1353.
Seiden AM, Duncan HJ. The diagnosis of a conductive olfactory loss. Laryngoscope. 2001;111:9-14.
Pfaar O, Landis BN, Frasnelli J, Huttenbrink KB, Hummel T. Mechanical obstruction of the olfactory cleft reveals differences between orthonasal and retronasal olfactory functions. Chem Senses. 2006;31:27-31.
Landis BN, Giger R, Ricchetti A, et al. Retronasal olfactory function in nasal polyposis. Laryngoscope. 2003;113:1993-1997.
Youngentob SL, Stern NM, Mozell MM, Leopold DA, Hornung DE. Effect of airway resistance on perceived odor intensity. Am J Otolaryngol. 1986;7:187-193.
Hornung DE, Chin C, Kurtz DB, Kent PF, Mozell MM. Effect of nasal dilators on perceived odor intensity. Chem Senses. 1997;22:177-180.
Zhao K, Pribitkin EA, Cowart BJ, Rosen D, Scherer PW, Dalton P. Numerical modeling of nasal obstruction and endoscopic surgical intervention: outcome to airflow and olfaction. Am J Rhinol. 2006;20:308-316.
Nishijima H, Kondo K, Yamamoto T, et al. Influence of the location of nasal polyps on olfactory airflow and olfaction. Int Forum Allergy Rhinol. 2018;8:695-706.
Loftus C, Schlosser RJ, Smith TL, et al. Olfactory cleft and sinus opacification differentially impact olfaction in chronic rhinosinusitis. Laryngoscope. 2020;130:2311-2318.
Mori E, Matsuwaki Y, Mitsuyama C, Okushi T, Nakajima T, Moriyama H. Risk factors for olfactory dysfunction in chronic rhinosinusitis. Auris Nasus Larynx. 2013;40:465-469.
Stevens MH. Steroid-dependent anosmia. Laryngoscope. 2001;111:200-203.
Kohli P, Naik AN, Harruff EE, Nguyen SA, Schlosser RJ, Soler ZM. The prevalence of olfactory dysfunction in chronic rhinosinusitis. Laryngoscope. 2017;127:309-320.
Valsamidis K, Printza A, Titelis K, Constantinidis J, Triaridis S. Olfaction and quality of life in patients with nasal septal deviation treated with septoplasty. Am J Otolaryngol. 2019;40:747-754.
DeConde AS, Mace JC, Alt JA, Schlosser RJ, Smith TL, Soler ZM. Comparative effectiveness of medical and surgical therapy on olfaction in chronic rhinosinusitis: a prospective, multi-institutional study. Int Forum Allergy Rhinol. 2014;4:725-733.
Alobid I, Benitez P, Cardelus S, et al. Oral plus nasal corticosteroids improve smell, nasal congestion, and inflammation in sino-nasal polyposis. Laryngoscope. 2014;124:50-56.
Selvaraj S, Liu K, Robinson AM, et al. In vivo determination of mouse olfactory mucus cation concentrations in normal and inflammatory states. PloS One. 2012;7: e39600.
Lane AP, Zweiman B, Lanza DC, et al. Acoustic rhinometry in the study of the acute nasal allergic response. Ann Otol Rhinol Laryngol. 1996;105:811-818.
Klimek L, Eggers G. Olfactory dysfunction in allergic rhinitis is related to nasal eosinophilic inflammation. J Allergy Clin Immunol. 1997;100:158-164.
Hox V, Bobic S, Callebaux I, Jorissen M, Hellings PW. Nasal obstruction and smell impairment in nasal polyp disease: correlation between objective and subjective parameters. Rhinology. 2010;48:426-432.
Schwob JE, Jang W, Holbrook EH, et al. Stem and progenitor cells of the mammalian olfactory epithelium: Taking poietic license. J Comp Neurol. 2017;525:1034-1054.
Caggiano M, Kauer JS, Hunter DD. Globose basal cells are neuronal progenitors in the olfactory epithelium: a lineage analysis using a replication-incompetent retrovirus. Neuron. 1994;13:339-352.
Chen M, Tian S, Yang X, Lane AP, Reed RR, Liu H. Wnt-responsive Lgr5(+) globose basal cells function as multipotent olfactory epithelium progenitor cells. J Neurosci. 2014;34:8268-8276.
Leung CT, Coulombe PA, Reed RR. Contribution of olfactory neural stem cells to tissue maintenance and regeneration. Nat Neurosci. 2007;10:720-726.
Durante MA, Kurtenbach S, Sargi ZB, et al. Single-cell analysis of olfactory neurogenesis and differentiation in adult humans. Nat Neurosci. 2020;23:323-326.
Schnittke N, Herrick DB, Lin B, et al. Transcription factor p63 controls the reserve status but not the stemness of horizontal basal cells in the olfactory epithelium. Proc Natl Acad Sci U S A. 2015;112:E5068-E5077.
Fletcher RB, Prasol MS, Estrada J, et al. p63 regulates olfactory stem cell self-renewal and differentiation. Neuron. 2011;72:748-759.
Herrick DB, Lin B, Peterson J, Schnittke N, Schwob JE. Notch1 maintains dormancy of olfactory horizontal basal cells, a reserve neural stem cell. Proc Natl Acad Sci U S A. 2017;114:E5589-E5598.
Suzuki Y, Farbman AI. Tumor necrosis factor-alpha-induced apoptosis in olfactory epithelium in vitro: possible roles of caspase 1 (ICE), caspase 2 (ICH-1), and caspase 3 (CPP32). Exp Neurol. 2000;165:35-45.
Kern RC, Conley DB, Haines GK, Robinson AM. Pathology of the olfactory mucosa: implications for the treatment of olfactory dysfunction. Laryngoscope. 2004;114:279-285.
Turner JH, Liang KL, May L, Lane AP. Tumor necrosis factor alpha inhibits olfactory regeneration in a transgenic model of chronic rhinosinusitis-associated olfactory loss. Am J Rhinol Allergy. 2010;24:336-340.
Turner JH, May L, Reed RR, Lane AP. Reversible loss of neuronal marker protein expression in a transgenic mouse model for sinusitis-associated olfactory dysfunction. Am J Rhinol Allergy. 2010;24:192-196.
Lane AP, Turner J, May L, Reed R. A genetic model of chronic rhinosinusitis-associated olfactory inflammation reveals reversible functional impairment and dramatic neuroepithelial reorganization. J Neurosci. 2010;30:2324-2329.
Pozharskaya T, Liang J, Lane AP. Regulation of inflammation-associated olfactory neuronal death and regeneration by the type II tumor necrosis factor receptor. Int Forum Allergy Rhinol. 2013;3:740-747.
Sousa Garcia D, Chen M, Smith AK, Lazarini PR, Lane AP. Role of the type I tumor necrosis factor receptor in inflammation-associated olfactory dysfunction. Int Forum Allergy Rhinol. 2017;7:160-168.
Chen M, Reed RR, Lane AP. Acute inflammation regulates neuroregeneration through the NF-kappaB pathway in olfactory epithelium. Proc Natl Acad Sci U S A. 2017;114:8089-8094.
Chen M, Reed RR, Lane AP. Chronic inflammation directs an olfactory stem cell functional switch from neuroregeneration to immune defense. Cell Stem Cell. 2019;25:501-513.e5.
Aiba T, Nakai Y. Influence of experimental rhino-sinusitis on olfactory epithelium. Acta Otolaryngol Suppl. 1991;486:184-192.
Ge Y, Tsukatani T, Nishimura T, Furukawa M, Miwa T. Cell death of olfactory receptor neurons in a rat with nasosinusitis infected artificially with Staphylococcus. Chem Senses. 2002;27:521-527.
EPST®ein VA, Bryce PJ, Conley DB, Kern RC, Robinson AM. Intranasal Aspergillus fumigatus exposure induces eosinophilic inflammation and olfactory sensory neuron cell death in mice. Otolaryngol Head Neck Surg. 2008;138:334-339.
Rouyar A, Classe M, Gorski R, et al. Type 2/Th2-driven inflammation impairs olfactory sensory neurogenesis in mouse chronic rhinosinusitis model. Allergy. 2019;74:549-559.
Lee SH, Lim HH, Lee HM, Park HJ, Choi JO. Olfactory mucosal findings in patients with persistent anosmia after endoscopic sinus surgery. Ann Otol Rhinol Laryngol. 2000;109(8 pt 1): 720-725.
Kern RC. Chronic sinusitis and anosmia: pathologic changes in the olfactory mucosa. Laryngoscope. 2000;110:1071-1077.
Yee KK, Pribitkin EA, Cowart BJ, et al. Neuropathology of the olfactory mucosa in chronic rhinosinusitis. Am J Rhinol Allergy. 2010;24:110-120.
Lavin J, Min JY, Lidder AK, et al. Superior turbinate eosinophilia correlates with olfactory deficit in chronic rhinosinusitis patients. Laryngoscope. 2017;127:2210-2218.
Hauser LJ, Chandra RK, Li P, Turner JH. Role of tissue eosinophils in chronic rhinosinusitis-associated olfactory loss. Int Forum Allergy Rhinol. 2017;7:957-962.
Wu J, Chandra RK, Li P, Hull BP, Turner JH. Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitis. Laryngoscope. 2018;128: E304-E310.
Schlosser RJ, Mulligan JK, Hyer JM, Karnezis TT, Gudis DA, Soler ZM. Mucous Cytokine Levels in Chronic Rhinosinusitis-Associated Olfactory Loss. JAMA Otolaryngol Head Neck Surg. 2016;142:731-737.
Henkin RI, Schmidt L, Velicu I. Interleukin 6 in hyposmia. JAMA Otolaryngol Head Neck Surg. 2013;139:728-734.
Morse JC, Shilts MH, Ely KA, et al. Patterns of olfactory dysfunction in chronic rhinosinusitis identified by hierarchical cluster analysis and machine learning algorithms. Int Forum Allergy Rhinol. 2019;9:255-264.
Soler ZM, Yoo F, Schlosser RJ, et al. Correlation of mucus inflammatory proteins and olfaction in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2020;10:343-355.
Banglawala SM, Oyer SL, Lohia S, Psaltis AJ, Soler ZM, Schlosser RJ. Olfactory outcomes in chronic rhinosinusitis with nasal polyposis after medical treatments: A systematic review and meta-analysis. Int Forum Allergy Rhinol. 2014;4:986-994.
Robinson AM, Kern RC, Foster JD, Fong KJ, Pitovski DZ. Expression of glucocorticoid receptor mRNA and protein in the olfactory mucosa: physiologic and pathophysiologic implications. Laryngoscope. 1998;108(8 pt 1): 1238-1242.
Robinson AM, Kern RC, Foster JD, Krozowski ZS, Pitovski DZ. Mineralocorticoid receptors in the mammalian olfactory mucosa. Ann Otol Rhinol Laryngol. 1999;108:974-981.
Crisafulli U, Xavier AM, Dos Santos FB, et al. Topical dexamethasone administration impairs protein synthesis and neuronal regeneration in the olfactory epithelium. Front Mol Neurosci. 2018;11:50.
Victores AJ, Chen M, Smith A, Lane AP. Olfactory loss in chronic rhinosinusitis is associated with neuronal activation of c-Jun N-terminal kinase. Int Forum Allergy Rhinol. 2018;8:415-420.
Kurtenbach S, Goss GM, Goncalves S, et al. Cell-based therapy restores olfactory function in an inducible model of hyposmia. Stem Cell Reports. 2019;12:1354-1365.
Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinology Supplement 2017;54:1-30.
Haxel BR. Recovery of olfaction after sinus surgery for chronic rhinosinusitis: A review. Laryngoscope. 2019;129:1053-1059.
Klimek L, Hummel T, Moll B, Kobal G, Mann WJ. Lateralized and bilateral olfactory function in patients with chronic sinusitis compared with healthy control subjects. Laryngoscope. 1998;108:111-114.
Litvack JR, Mace JC, Smith TL. Olfactory function and disease severity in chronic rhinosinusitis. Am J Rhinol Allergy. 2009;23:139-144.
Kohli P, Naik AN, Harruff EE, Nguyen SA, Schlosser RJ, Soler ZM. The prevalence of olfactory dysfunction in chronic rhinosinusitis. Laryngoscope. 2017;127:309-320.
Soler ZM, Kohli P, Storck KA, Schlosser RJ. Olfactory impairment in chronic rhinosinusitis using threshold, discrimination, and identification scores. Chem Sens. 2016;41:713-719.
Rombaux P, Huart C, Levie P, Cingi C, Hummel T. Olfaction in Chronic Rhinosinusitis. Curr Allergy Asthma Rep. 2016;16:41.
Alt JA, Mace JC, Buniel MC, Soler ZM, Smith TL. Predictors of olfactory dysfunction in rhinosinusitis using the brief smell identification test. Laryngoscope. 2014;124:E259-E266.
Vandenhende-Szymanski C, Hochet B, Chevalier D, Mortuaire G. Olfactory cleft opacity and ct score are predictive factors of smell recovery after surgery in nasal polyposis. Rhinology. 2015;53:29-34.
Landis BN, Giger R, Ricchetti A, et al. Retronasal olfactory function in nasal polyposis. Laryngoscope. 2003;113:1993-1997.
Soler ZM, Sauer DA, Mace J, Smith TL. Relationship between clinical measures and histopathologic findings in chronic rhinosinusitis. Otolaryngol Neck Surg Off J Am Acad Otolaryngol Neck Surg. 2009;141:454-461.
Pade J, Hummel T. Olfactory function following nasal surgery. Laryngoscope. 2008;118:1260-1264.
Zhang L, Hu C, Sun Z, et al. Correlation of tissue eosinophil count and chemosensory functions in patients with chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery. Eur Arch Otorhinolaryngol. 2019;276:1987-1994.
Oka H, Tsuzuki K, Takebayashi H, Kojima Y, Daimon T, Sakagami M. Olfactory changes after endoscopic sinus surgery in patients with chronic rhinosinusitis. Auris Nasus Larynx. 2013;40:452-457.
Jafek BW, Murrow B, Michaels R, Restrepo D, Linschoten M. Biopsies of human olfactory epithelium. Chem Senses. 2002;27:623-628.
Jafek BW, Murrow B, Johnson EW. Olfaction and endoscopic sinus surgery.Ear Nose Throat J.1994;73:548-552.
Seiden AM. Smell and Taste Disorders. Thieme; 1997
Lavin J, Min JY, Lidder AK, et al. Superior turbinate eosinophilia correlates with olfactory deficit in chronic rhinosinusitis patients. Laryngoscope. 2017;127:2210-2218.
Rombaux P, Potier H, Bertrand B, Duprez T, Hummel T. Olfactory bulb volume in patients with sinonasal disease. Am J Rhinol. 2008;22:598-601.
Gudziol V, Buschhüter D, Abolmaali N, Gerber J, Rombaux P, Hummel T. Increasing olfactory bulb volume due to treatment of chronic rhinosinusitis-a longitudinal study. Brain. 2009;132:3096-3101.
Wu J, Chandra RK, Li P, Hull BP, Turner JH. Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitis. Laryngoscope. 2018;128:E304-E310.
Kern RC. Chronic sinusitis and anosmia: Pathologic changes in the olfactory mucosa. Laryngoscope. 2000;110:1071-1077.
Soler ZM, Yoo F, Schlosser RJ, et al. Correlation of mucus inflammatory proteins and olfaction in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2020;10:343-355.
Hauser LJ, Chandra RK, Li P, Turner JH. Role of tissue eosinophils in chronic rhinosinusitis-associated olfactory loss. Int Forum Allergy Rhinol. 2017;7:957-962.
Ganjaei KG, Soler ZM, Storck KA, Rowan NR, Othieno FA, Schlosser RJ. Variability in retronasal odor identification among patients with chronic rhinosinusitis. Am J Rhinol Allergy. 2018;32:424-431.
Othieno F, Schlosser RJ, Storck KA, Rowan NR, Smith TL, Soler ZM. Retronasal olfaction in chronic rhinosinusitis. Laryngoscope. 2018;128:2437-2442.
Lavin J, Min JY, Lidder AK, et al. Superior turbinate eosinophilia correlates with olfactory deficit in chronic rhinosinusitis patients. Laryngoscope. 2017;127:2210-2218.
Akdis CA, Bachert C, Cingi C, et al. Endotypes and phenotypes of chronic rhinosinusitis: A PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2013;131:1479-1490.
Succar EF, Turner JH. Recent advances in understanding chronic rhinosinusitis endotypes. F1000Res. 2018;7: F1000.
Bachert C, Akdis CA. Phenotypes and emerging endotypes of chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2016;4:621-628.
Husain Q, Sedaghat AR. Understanding and clinical relevance of chronic rhinosinusitis endotypes. Clin Otolaryngol. 2019;44:887-897.
Cao PP, Wang ZC, Schleimer RP, Liu Z. Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes. Ann Allergy Asthma Immunol. 2019;122:33-40.
Tan BK, Klingler AI, Poposki JA, et al. Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois. J Allergy Clin Immunol. 2017;139: 699-703 e7.
Stevens WW, Peters AT, Tan BK, et al. Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2019;7:2812-2820.e3.
Wang X, Zhang N, Bo M, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. 2016;138:1344-1353.
Schlosser RJ, Mulligan JK, Hyer JM, Karnezis TT, Gudis DA, Soler ZM. Mucous cytokine levels in chronic rhinosinusitis-associated olfactory loss. JAMA Otolaryngol Head Neck Surg. 2016;142:731-737.
Lavin J, Min JY, Lidder AK, et al. Superior turbinate eosinophilia correlates with olfactory deficit in chronic rhinosinusitis patients. Laryngoscope. 2017;127:2210-2218.
Wu J, Chandra RK, Li P, Hull BP, Turner JH. Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitis. Laryngoscope. 2018;128:E304-E310.
Soler ZM, Yoo F, Schlosser RJ, et al. Correlation of mucus inflammatory proteins and olfaction in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2020;10:343-355.
Morse JC, Shilts MH, et al. Patterns of olfactory dysfunction in chronic rhinosinusitis identified by hierarchical cluster analysis and machine learning algorithms. Int Forum Allergy Rhinol. 2019;9:255-264.
Wu D, Li Y, Bleier BS, Wei Y. Superior turbinate eosinophilia predicts olfactory decline in patients with chronic rhinosinusitis. Ann Allergy Asthma Immunol. 2020;125:304-310.e1.
Bachert C, Mannent L, Naclerio RM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016;315:469-479.
Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): Results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394:1638-1650.
Gevaert P, Omachi TA, et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020;146:595-605.
Kuperman DA, Huang X, Koth LL, et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med. 2002;8:885-889.
Schleimer RP. Immunopathogenesis of chronic rhinosinusitis and nasal polyposis. Annu Rev Pathol. 2017;12:331-357.
Olsson P, Berglind N, Bellander T, Stjärne P. Prevalence of self-reported allergic and non-allergic rhinitis symptoms in Stockholm: Relation to age, gender, olfactory sense and smoking. Acta Otolaryngol. 2003;123:75-80.
Rhee CS, Wee JH, Ahn JC, et al. Prevalence, risk factors and comorbidities of allergic rhinitis in South Korea: The Fifth Korea National Health and Nutrition Examination Survey. Am J Rhinol Allergy. 2014;28:e107-e114.
Stuck BA, Hummel T. Olfaction in allergic rhinitis: A systematic review. J Allergy Clin Immunol. 2015;136:1460-1470.
Aksoy C, Elsürer Ç, Artaç H, Bozkurt MK. Evaluation of olfactory function in children with seasonal allergic rhinitis and its correlation with acoustic rhinometry. Int J Pediatr Otorhinolaryngol. 2018;113:188-191.
Mariño-Sanchez F, Valls-Mateus M, Haag O, Alobid I, Bousquet J, Mullol J. Smell loss is associated with severe and uncontrolled disease in children and adolescents with persistent allergic rhinitis. J Allergy Clin Immunol Pract. 2018;6:1752-1755.e3.
Langdon C, Guilemany JM, Valls M, et al. Allergic rhinitis causes loss of smell in children: The OLFAPEDRIAL study. Pediatr Allergy Immunol. 2016;27:867-870.
Kutlug S, Gunbey E, Sogut A, et al. Evaluation of olfactory function in children with allergic rhinitis and nonallergic rhinitis. Int J Pediatr Otorhinolaryngol. 2016;86:172-176.
Katotomichelakis M, Riga M, Tripsianis G, et al. Predictors of quality of life improvement in allergic rhinitis patients after sublingual immunotherapy. Ann Otol Rhinol Laryngol. 2015;124:430-436.
Klimek L, Poletti SC, Sperl A, et al. Olfaction in patients with allergic rhinitis: an indicator of successful MP-AzeFlu therapy. Int Forum Allergy Rhinol. 2017;7:287-292.
Moll B, Klimek L, Eggers G, Mann W. Comparison of olfactory function in patients with seasonal and perennial allergic rhinitis. Allergy. 1998;53:297-301.
Klimek L, Eggers G. Olfactory dysfunction in allergic rhinitis is related to nasal eosinophilic inflammation. J Allergy Clin Immunol. 1997;100:158-164.
Suzuki M, Yokota M, Ozaki S, Nakamura Y. Olfactory dysfunction out of season in seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2018;121:377-378.
Lamantia I, Cupido F, Castro V, Andaloro C. Olfactory function in chronic rhinitis subtypes: Any differences? Acta Medica Mediterranea. 2018;34:525-529.
Guss J, Doghramji L, Reger C, Chiu AG. Olfactory dysfunction in allergic rhinitis. ORL J Otorhinolaryngol Relat Spec. 2009;71:268-272.
Sivam A, Jeswani S, Reder L, et al. Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. Am J Rhinol Allergy. 2010;24:286-290.
Becker S, Pflugbeil C, Gröger M, Canis M, Ledderose GJ, Kramer MF. Olfactory dysfunction in seasonal and perennial allergic rhinitis. Acta Otolaryngol. 2012;132:763-768.
Kim YH, Jung AY. Reversal of olfactory disturbance in allergic rhinitis related to OMP suppression by intranasal budesonide treatment. Allergy Asthma Immunol Res. 2020;12:110-124.
Kim DK, Choi SA, Eun KM, Kim SK, Kim DW, Phi JH. Tumour necrosis factor alpha and interleukin-5 inhibit olfactory regeneration via apoptosis of olfactory sphere cells in mice models of allergic rhinitis. Clin Exp Allergy. 2019;49:1139-1149.
Ozaki S, Toida K, Suzuki M, et al. Impaired olfactory function in mice with allergic rhinitis. Auris Nasus Larynx. 2010;37:575-583.
Rombaux P, Martinage S, Huart C, Collet S. Post-infectious olfactory loss: A cohort study and update. B-ENT. 2009;5 suppl 13: 89-95.
Lee JC, Nallani R, Cass L, Bhalla V, Chiu AG, Villwock JA. A systematic review of the neuropathologic findings of post-viral olfactory dysfunction: Implications and novel insight for the COVID-19 pandemic. Am J Rhinol Allergy. 2021;35:323-333.
Suzuki M, Saito K, Min W, Vladau C, Kazunori T, Hirotaka I, Murakami S. Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope. 2007;117:272-277.
Wang JH, Kwon HJ, Jang YJ. Detection of parainfluenza virus 3 in turbinate epithelial cells of postviral olfactory dysfunction patients. Laryngoscope. 2007;117:1445-1449.
Tian J, Pinto JM, Li L, Zhang S, Sun Z, Wei Y. Identification of viruses in patients with postviral olfactory dysfunction by multiplex reverse-transcription polymerase chain reaction. Laryngoscope. 2021; 2020;131:158-164.
Jafek BW. Biopsies of human olfactory epithelium. Chem Senses. 2002;27:623-628.
Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinology. 2017;54:7.
Schwob JE, Saha S, Youngentob SL, Jubelt B. Intranasal inoculation with the olfactory bulb line variant of mouse hepatitis virus causes extensive destruction of the olfactory bulb and accelerated turnover of neurons in the olfactory epithelium of mice. Chem Senses. 2001;26:937-952.
Dumm RE, Wellford SA, Moseman EA, Heaton NS. Heterogeneity of antiviral responses in the upper respiratory tract mediates differential non-lytic clearance of influenza viruses. Cell Rep. 2020;32: 108103.
Mori I, Komatsu T, Takeuchi K, Nakakuki K, Sudo M, Kimura Y. Parainfluenza virus type 1 infects olfactory neurons and establishes long-term persistence in the nerve tissue. J Gen Virol. 1995;76:1251-1254.
Kattar N, Do TM, Unis GD, Migneron MR, Thomas AJ, McCoul ED. Olfactory training for postviral olfactory dysfunction: Systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2021: 164:244-254.
Seiden AM. Postviral olfactory loss. Otolaryngol Clin North Am. 2004 Dec;37(6):1159-66.
Cavazzana A, Larsson M, Münch M, Hähner A, Hummel T. Postinfectious olfactory loss: A retrospective study on 791 patients. Laryngoscope. 2018;128:10-15.
Mueller A, Rodewald A, Reden J, Gerber J, von Kummer R, Hummel T. Reduced olfactory bulb volume in post-traumatic and post-infectious olfactory dysfunction. Neuroreport. 2005;16:475-478.
Yao L, Yi X, Pinto J, Yuan X, Guo Y, Liu Y, Wei Y. Olfactory cortex and olfactory bulb volume alterations in patients with post-infectious olfactory loss. Brain Imaging Behav. 2018;12:1355-1362.
Chung MS, Choi WR, Jeong H, Lee JH, Kim JH. MR imaging-based evaluations of olfactory bulb atrophy in patients with olfactory dysfunction. AJNR Am J Neuroradiol. 2018;39:532-537.
Leyva-Grado VH, Churchill L, Harding J, Krueger JM. The olfactory nerve has a role in the body temperature and brain cytokine responses to influenza virus. Brain Behav Immun. 2010;24:281-288.
Kanaya K, Kondo K, Suzukawa K, et al. Innate immune responses and neuroepithelial degeneration and regeneration in the mouse olfactory mucosa induced by intranasal administration of Poly(I:C). Cell Tissue Res. 2014;357:279-299.
Henkin RI, Schmidt L, Velicu I. Interleukin 6 in hyposmia. JAMA Otolaryngol Head Neck Surg. 2013;139:728-734.
Patel ZM, Fernandez-Miranda J, Hwang PH, Nayak JV, Dodd R, Sajjadi H, Jackler RK. Letter: Precautions for Endoscopic Transnasal Skull Base Surgery During the COVID-19 Pandemic. Neurosurgery. 2020 Jul 1;87(1):E66-E67.
Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020 Jul;10(7):806-813.
Xydakis MS, Dehgani-Mobaraki P, Holbrook EH, Geisthoff UW, Bauer C, Hautefort C, Herman P, Manley GT, Lyon DM, Hopkins C. Smell and taste dysfunction in patients with COVID-19. Lancet Infect Dis. 2020 Sep;20(9):1015-1016.
Akerlund A, Bende M, Murphy C. Olfactory threshold and nasal mucosal changes in experimentally induced common cold. Acta Otolaryngol. 1995;115:88-92.
Greenberg SB. Update on rhinovirus and coronavirus infections. Semin Respir Crit Care Med. 2011;32:433-446.
Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020;288:335-344.
Spinato G, Fabbris C, Polesel J, Cazzador D, Borsetto D, Hopkins C, et al. Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA. 2020;323:2089-2090.
Eliezer M, Hamel AL, Houdart E, et al. Loss of smell in COVID-19 patients: MRI data reveals a transient edema of the olfactory clefts. Neurology. 2020;95:e3145-e3152.
Lechien JR, Michel J, Radulesco T, et al. Clinical and radiological evaluations of COVID-19 patients with anosmia: Preliminary report. Laryngoscope. 2020;130:2526-2531.
Yamagishi M, Hasegawa S, Nakano Y. Examination and classification of human olfactory mucosa in patients with clinical olfactory disturbances. Arch Otorhinolaryngol. 1988;245:316-320.
Kirschenbaum D, Imbach LL, Ulrich S, et al. Inflammatory olfactory neuropathy in two patients with COVID-19. Lancet. 2020;396:166.
Bryche B, St Albin A, Murri S, et al. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain Behav Immun. 2020;89:579-586.
Brann DH, Tsukahara T, Weinreb C, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020;6: eabc5801.
Bilinska K, Jakubowska P, Von Bartheld CS, Butowt R. Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: identification of cell types and trends with age. ACS Chem Neurosci. 2020;11:1555-1562.
Chiesa-Estomba CM, Lechien JR, Radulesco T, Michel J, Sowerby LJ, Hopkins C, et al. Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak. Eur J Neurol. 2020;27:2318-2321.
Vaira LA, Hopkins C, Petrocelli M, et al. Smell and taste recovery in coronavirus disease 2019 patients: A 60-day objective and prospective study. J Laryngol Otol. 2020;134:703-709.
Hopkins C, Surda P, Whitehead E, Kumar BN. Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study. J Otolaryngol Head Neck Surg. 2020;49:26.
Schwob JE, Youngentob SL, Mezza RC. Reconstitution of the rat olfactory epithelium after methyl bromide-induced lesion. J Comp Neurol. 1995;359:15-37.
Chen M, Reed RR, Lane AP. Chronic inflammation directs an olfactory stem cell functional switch from neuroregeneration to immune defense. Cell Stem Cell. 2019;25:501-513.e5.
Torabi A, Mohammadbagheri E, Akbari Dilmaghani N, et al. Proinflammatory cytokines in the olfactory mucosa result in COVID-19 induced anosmia. ACS Chem Neurosci. 2020;11:1909-1913.
Rodriguez S, Cao L, Rickenbacher T, et al. Innate immune signaling in the olfactory epithelium reduces odorant receptor levels: modeling transient smell loss in COVID-19 patients. medRxiv. 2020; 2020.06.14.20131128.
Zazhytska M, Kodra A, Hoagland DA, et al. Disruption of nuclear architecture as a cause of COVID-19 induced anosmia. bioRxiv. 2021; 2021.02.09.430314.
Vaira LA, Hopkins C, Sandison A, et al. Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia. J Laryngol Otol. 2020;134:1123-1127.
Dube M, Le Coupanec A, Wong AH, Rini JM, Desforges M, Talbot PJ. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol. 2018;92:e00404-18.
Landis BN, Vodicka J, Hummel T. Olfactory dysfunction following herpetic meningoencephalitis. J Neurol. 2010;257:439-443.
Perlman S, Jacobsen G, Afifi A. Spread of a neurotropic murine coronavirus into the CNS via the trigeminal and olfactory nerves. Virology. 1989;170:556-560.
McCray PB Jr, Pewe L, Wohlford-Lenane C, et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol. 2007;81:813-821.
Klironomos S, Tzortzakakis A, Kits A, et al. Nervous system involvement in coronavirus disease 2019: Results from a retrospective consecutive neuroimaging cohort. Radiology. 2020;297:E324-E334.
Aragao M, Leal MC, Cartaxo Filho OQ, Fonseca TM, Valenca MM. Anosmia in COVID-19 associated with injury to the olfactory bulbs evident on MRI. AJNR Am J Neuroradiol. 2020;41:1703-1706.
Politi LS, Salsano E, Grimaldi M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and Anosmia. JAMA Neurology. 2020;77:1028-1029.
Laurendon T, Radulesco T, Mugnier J, et al. Bilateral transient olfactory bulb edema during COVID-19-related anosmia. Neurology. 2020;95:224-225.
Yao L, Yi X, Pinto JM, et al. Olfactory cortex and olfactory bulb volume alterations in patients with post-infectious olfactory loss. Brain Imaging Behav. 2018;12:1355-1362.
Chiu A, Fischbein N, Wintermark M, Zaharchuk G, Yun PT, Zeineh M. COVID-19-induced anosmia associated with olfactory bulb atrophy. Neuroradiology. 2021;36:147-148.
Guedj E, Million M, Dudouet P, et al. (18)F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging. 2021;48:592-595.
Morbini P, Benazzo M, Verga L, et al. Ultrastructural evidence of direct viral damage to the olfactory complex in patients testing positive for SARS-CoV-2. JAMA Otolaryngol Head Neck Surg. 2020;146:972-973.
Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168-175.
Kantonen J, Mahzabin S, Mayranpaa MI, et al. Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol. 2020;30:1012-1016 .
Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the Nervous System. Cell. 2020 Oct 1;183(1):16-27.e1.
Butowt R, von Bartheld CS. Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection. Neuroscientist. 2020:1073858420956905.
Yan CH, Faraji F, Prajapati DP, Ostrander BT, DeConde AS. Self-reported olfactory loss associates with outpatient clinical course in COVID-19. Int Forum Allergy Rhinol. 2020;10:21-31.
Borsetto D, Hopkins C, Philips V, et al. Self-reported alteration of sense of smell or taste in patients with COVID-19: A systematic review and meta-analysis on 3563 patients. Rhinology. 2020;58:430-436.
Vaira LA, Hopkins C, Petrocelli M, et al. Do olfactory and gustatory psychophysical scores have prognostic value in COVID-19 patients? A prospective study of 106 patients. J Otolaryngol Head Neck Surg. 2020;49:56.
Lechien JR, Chiesa-Estomba CM, Beckers E, et al. Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients. J Intern Med. 2021 Jan 5. Online ahead of print.
Le Bon SD, Horoi M. Is anosmia the price to pay in an immune-induced scorched-earth policy against COVID-19? Med Hypotheses. 2020;143: 109881.
Perlman S, Evans G, Afifi A. Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain. J Exp Med. 1990;172:1127-1132.
Hoffman HJ, Rawal S, Li CM, Duffy VB. New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): First-year results for measured olfactory dysfunction. Rev Endocr Metab Disord. 2016;17:221-240.
Schriever VA, Hummel T. Etiologies of olfactory dysfunction in a pediatric population: Based on a retrospective analysis of data from an outpatient clinic. Eur Arch Otorhinolaryngol. 2020;277:3213-3216
Costanzo RM, Becker DP. Smell and taste disorders in head injury and neurosurgery patients. In: Meiselman HL, Rivlin RS, eds. Clinical Measurements of Taste and Smell. MacMillian Publishing Company; 1986: 565-578.
Ogawa T, Rutka J. Olfactory dysfunction in head injured workers. Acta Otolaryngol Suppl. 1999;540:50-57.
Singh R, Humphries T, Mason S, Lecky F, Dawson J, Sinha S. The incidence of anosmia after traumatic brain injury: The SHEFBIT cohort. Brain Inj. 2018;32:1122-1128.
Sumner D. Post-traumatic anosmia. Brain. 1964;87:107-120.
Temmel AF, Quint C, Schickinger-Fischer B, Klimek L, Stoller E, Hummel T. Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg. 2002;128:635-641.
Yamagishi M, Okazoe R, Ishizuka Y. Olfactory mucosa of patients with olfactory disturbance following head trauma. Ann Otol Rhinol Laryngol. 1994;103(4 pt 1): 279-284.
Zusho H. Posttraumatic anosmia. Arch Otolaryngol. 1982;108:90-92.
Coello AF, Canals AG, Gonzalez JM, Martin JJ. Cranial nerve injury after minor head trauma. J Neurosurgery. 2010;113:547-555.
Costanzo RM, Reiter ER, Yelverton JC. Smell and Taste. In: Zasler ND, Katz DI, Zafonte RD, eds. Brain Injury Medicine: Principles and Practice. 2nd ed. Demos; 2012: 794-808.
Delank KW, Fechner G. Pathophysiology of post-traumatic anosmia. Laryngorhinootologie. 1996;75:154-159.
Lötsch J, Ultsch A, Eckhardt M, Huart C, Rombaux P, Hummel T. Brain lesion-pattern analysis in patients with olfactory dysfunctions following head trauma. Neuroimage Clin. 2016;11:99-105.
Yousem DM, Geckle RJ, Bilker WB, Kroger H, Doty RL. Posttraumatic smell loss: Relationship of psychophysical tests and volumes of the olfactory bulbs and tracts and the temporal lobes. Acad Radiol. 1999;6:264-272.
Xydakis MS, Mulligan LP, Smith AB, Olsen CH, Lyon DM, Belluscio L. Olfactory impairment and traumatic brain injury in blast-injured combat troops: A cohort study. Neurology. 2015;84:1559-1567.
Doty RL, Yousem DM, Pham LT, Kreshak AA, Geckle R, Lee WW. Olfactory dysfunction in patients with head trauma. Arch Neurol. 1997;54:1131-1140.
Swann IJ, Bauza-Rodriguez B, Currans R, Riley J, Shukla V. The significance of post-traumatic amnesia as a risk factor in the development of olfactory dysfunction following head injury. Emerg Med J. 2006;23:618-621.
Querzola G, Lovati C, Mariani C, Pantoni L. A semi-quantitative sport-specific assessment of recurrent traumatic brain injury: The TraQ questionnaire and its application in American football. Neurol Sci. 2019;40:1909-1915.
Green P, Rohling ML, Iverson GL, Gervais RO. Relationships between olfactory discrimination and head injury severity. Brain Inj. 2003;17:479-496.
Gudziol V, Hoenck I, Landis B, Podlesek D, Bayn M, Hummel T. The impact and prospect of traumatic brain injury on olfactory function: A cross-sectional and prospective study. Eur Arch Otorhinolaryngol. 2014;271:1533-1540.
Schriever VA, Studt F, Smitka M, Grosser K, Hummel T. Olfactory function after mild head injury in children. Chem Senses. 2014;39:343-347.
Sandford AA, Davidson TM, Herrera N, et al. Olfactory dysfunction: A sequela of pediatric blunt head trauma. Int J Pediatr Otorhinolaryngol. 2006;70:1015-1025.
Gobba F. Olfactory toxicity: long-term effects of occupational exposures. Int Arch Occup Environ Health. 2006;79:322-331.
Upadhyay UD, Holbrook EH. Olfactory loss as a result of toxic exposure. Otolaryngol Clin North Am. 2004;37:1185-1207.
Werner S, Nies E. Olfactory dysfunction revisited: A reappraisal of work-related olfactory dysfunction caused by chemicals. J Occup Med Toxicol. 2018;13:28.
Mascagni P, Consonni D, Bregante G, Chiappino G, Toffoletto F. Olfactory function in workers exposed to moderate airborne cadmium levels. Neurotoxicology. 2003;24:717-724.
Lee JS, White KL. A review of the health effects of cadmium. Am J Ind Med. 1980;1:307-317.
Adams RG, Crabtree N. Anosmia in alkaline battery workers. Br J Ind Med. 1961;18:216-221.
Potts CL. Cadmium proteinuria-the health of battery workers exposed to cadmium oxide dust. Ann Occup Hyg. 1965;8:55-61.
Antunes MB, Bowler R, Doty RL. San Francisco/Oakland Bay Bridge Welder Study: Olfactory function. Neurology. 2007;69:1278-1284.
Sulkowski WJ, Rydzewski B, Miarzynska M. Smell impairment in workers occupationally exposed to cadmium. Acta Otolaryngol. 2000;120:316-318.
Rydzewski B, Sułkowski W, Miarzyńska M. Olfactory disorders induced by cadmium exposure: A clinical study. Int J Occup Med Environ Health. 1998;11:235-245.
Suruda AJ. Measuring olfactory dysfunction from cadmium in an occupational and environmental medicine office practice. J Occup Environ Med. 2000;42:337.
Rose CS, Heywood PG, Costanzo RM. Olfactory impairment after chronic occupational cadmium exposure. J Occup Med. 1992;34:600-605.
Lucchini RG, Guazzetti S, Zoni S, et al. Tremor, olfactory and motor changes in Italian adolescents exposed to historical ferro-manganese emission. Neurotoxicology. 2012;33:687-696.
Lehallier B, Coureaud G, Maurin Y, Bonny JM. Effects of manganese injected into rat nostrils: Implications for in vivo functional study of olfaction using MEMRI. Magn Reson Imaging. 2012;30:62-69.
Noel J, Habib AR, Thamboo A, Patel ZM. Variables associated with olfactory disorders in adults: A U.S. population-based analysis. World J Otorhinolaryngol Head Neck Surg. 2017;3:9-16.
Mergler D, Huel G, Bowler R, et al. Nervous system dysfunction among workers with long-term exposure to manganese. Environ Res. 1994;64:151-180.
Lucchini R, Bergamaschi E, Smargiassi A, Festa D, Apostoli P. Motor function, olfactory threshold, and hematological indices in manganese-exposed ferroalloy workers. Environ Res. 1997;73:175-180.
Henriksson J, Tallkvist J, Tjälve H. Transport of manganese via the olfactory pathway in rats: Dosage dependency of the uptake and subcellular distribution of the metal in the olfactory epithelium and the brain. Toxicol Appl Pharmacol. 1999;156:119-128.
Green T, Lee R, Toghill A, Meadowcroft S, Lund V, Foster J. The toxicity of styrene to the nasal epithelium of mice and rats: Studies on the mode of action and relevance to humans. Chem Biol Interact. 2001;137:185-202.
Dalton P, Cowart B, Dilks D, et al. Olfactory function in workers exposed to styrene in the reinforced-plastics industry. Am J Ind Med. 2003;44:1-11.
Ahlström R, Berglund B, Berglund U, Lindvall T, Wennberg A. Impaired odor perception in tank cleaners. Scand J Work Environ Health. 1986;12:574-581.
Sandmark B, Broms I, Löfgren L, Ohlson CG. Olfactory function in painters exposed to organic solvents. Scand J Work Environ Health. 1989;15:60-63.
Wieslander G, Norbäck D, Edling C. Occupational exposure to water based paint and symptoms from the skin and eyes. Occup Environ Med. 1994;51:181-186.
Hotz P, Tschopp A, Söderström D, Holtz J, Boillat MA, Gutzwiller F. Smell or taste disturbances, neurological symptoms, and hydrocarbon exposure. Int Arch Occup Environ Health. 1992;63:525-530.
Mergler D, Beauvais B. Olfactory threshold shift following controlled 7-hour exposure to toluene and/or xylene. Neurotoxicology. 1992;13:211-215.
Schwartz BS, Ford DP, Bolla KI, Agnew J, Rothman N, Bleecker ML. Solvent-associated decrements in olfactory function in paint manufacturing workers. Am J Ind Med. 1990;18:697-706.
Cheng SF, Chen ML, Hung PC, Chen CJ, Mao IF. Olfactory loss in poly (acrylonitrile-butadiene-styrene) plastic injection-moulding workers. Occup Med (Lond). 2004;54:469-474.
Lee SJ, Kim EM, Cho SH, Song J, Jang TW, Lee MY. Risk of olfactory dysfunction of the workers in the automobile repair, printing, shoemaking and plating industries in Korea: A cross-sectional study. BMJ Open. 2018;8: e022678.
Ajmani GS, Suh HH, Pinto JM. Effects of ambient air pollution exposure on olfaction: A review. Environ Health Perspect. 2016;124:1683-1693.
Adams DR, Ajmani GS, Pun VC, et al. Nitrogen dioxide pollution exposure is associated with olfactory dysfunction in older U.S. adults. Int Forum Allergy Rhinol. 2016;6:1245-1252.
Calderón-Garcidueñas L, Franco-Lira M, Henríquez-Roldán C, et al. Urban air pollution: Influences on olfactory function and pathology in exposed children and young adults. Exp Toxicol Pathol. 2010;62:91-102.
Ishinishi N, Kodama Y, Nobutomo K, Inamasu T, Kunitake E, Suenaga Y. Outbreak of chronic arsenic poisoning among retired workers from an arsenic mine in Japan. Environ Health Perspect. 1977;19:121-125.
Schwartz BS, Stewart WF, Bolla KI, et al. Past adult lead exposure is associated with longitudinal decline in cognitive function. Neurology. 2000;55:1144-1150.
Hudson R, Arriola A, Martínez-Gómez M, Distel H. Effect of air pollution on olfactory function in residents of Mexico City. Chem Senses. 2006;31:79-85.
Guarneros M, Hummel T, Martínez-Gómez M, Hudson R. Mexico City air pollution adversely affects olfactory function and intranasal trigeminal sensitivity. Chem Senses. 2009;34:819-826.
Ranft U, Schikowski T, Sugiri D, Krutmann J, Krämer U. Long-term exposure to traffic-related particulate matter impairs cognitive function in the elderly. Environ Res. 2009;109:1004-1011.
Sorokowska A, Sorokowski P, Hummel T, Huanca T. Olfaction and environment: Tsimane' of Bolivian rainforest have lower threshold of odor detection than industrialized German people. PLoS One. 2013;8: e69203.
Grashow R, Sparrow D, Hu H, Weisskopf MG. Cumulative lead exposure is associated with reduced olfactory recognition performance in elderly men: The Normative Aging Study. Neurotoxicology. 2015;49:158-164.
Riccó M, Signorelli C, Pistelli E, Cattani S. Quantitative olfactory disorders and occupational exposure to phenolic resins. Med Pr. 2016;67:173-186.
Schiffman SS. Influence of medications on taste and smell. World J Otorhinolaryngol Head Neck Surg. 2018;4:84-91.
Lötsch J, Knothe C, Lippmann C, Ultsch A, Hummel T, Walter C. Olfactory drug effects approached from human-derived data. Drug Discov Today. 2015;20:1398-1406.
Lötsch J, Geisslinger G, Hummel T. Sniffing out pharmacology: Interactions of drugs with human olfaction. Trends Pharmacol Sci. 2012;33:193-199.
Wishart DS, Feunang YD, Guo AC, et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46:D1074-D1082.
Walter C, Oertel BG, Ludyga D, Ultsch A, Hummel T, Lötsch J. Effects of 20 mg oral Δ9-tetrahydrocannabinol on the olfactory function of healthy volunteers. Br J Clin Pharmacol. 2014;78:961-969.
Lötsch J, Darimont J, Skarke C, Zimmermann M, Hummel T, Geisslinger G. Effects of the opioid remifentanil on olfactory function in healthy volunteers. Life Sci. 2001;69:2279-2285.
Gudziol V, Mück-Weymann M, Seizinger O, Rauh R, Siffert W, Hummel T. Sildenafil affects olfactory function. J Urol. 2007;177:258-261.
Steinbach S, Hummel T, Böhner C, et al. Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies. J Clin Oncol. 2009;27:1899-1905.
Du W, Xu Z, Wang W, Liu Z. A case of anosmia and hypogeusia as a complication of propofol. J Anesth. 2018;32:293-296.
Yoshida K, Fukuchi T, Sugawara H. Dysosmia and dysgeusia associated with duloxetine. BMJ Case Rep. 2017;2017: bcr2017222470.
Horger S, Kandrac S, Longyhore DS. Taste and smell disturbance resulting from midodrine. J Pharm Pract. 2016;29:571-573.
Che X, Li Y, Fang Y, Reis C, Wang H. Antiarrhythmic drug-induced smell and taste disturbances: A case report and literature review. Medicine (Baltimore). 2018;97: e11112.
Welge-Lüssen A, Wille C, Renner B, Kobal G. Anesthesia affects olfaction and chemosensory event-related potentials. Clin Neurophysiol. 2004;115:1384-1391.
Jung YG, Ha SY, Eun YG, Kim MG. Influence of intranasal epinephrine and lidocaine spray on olfactory function tests in healthy human subjects. Otolaryngol Head Neck Surg. 2011;145:946-950.
Hari C, Grimshaw B, Jacob T. Effect of lidocaine on olfactory perception in humans. Int J Appl Basic Med Res. 2018;8:164-168.
Lötsch J, Daiker H, Hähner A, Ultsch A, Hummel T. Drug-target based cross-sectional analysis of olfactory drug effects. Eur J Clin Pharmacol. 2015;71:461-471.
Hura N, Xie DX, Choby GW, et al. Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2020;10:1065-1086.
Tisdall FF, Brown A, Defries RD. Persistent anosmia following zinc sulfate nasal spraying. J Pediatr. 1938;13:60-62.
Jafek BW, Linschoten MR, Murrow BW. Anosmia after intranasal zinc gluconate use. Am J Rhinol. 2004;18:137-141.
Alexander TH, Davidson TM. Intranasal zinc and anosmia: The zinc-induced anosmia syndrome. Laryngoscope. 2006;116:217-220.
Davidson TM, Smith WM. The Bradford Hill criteria and zinc-induced anosmia: A causality analysis. Arch Otolaryngol Head Neck Surg. 2010;136:673-676.
DeCook C, Hirsch A. Anosmia due to inhalational zinc: A case report. Chem Senses. 2000;25:593-659.
Hsieh H, Horwath MC, Genter MB. Zinc gluconate toxicity in wild-type vs. MT1/2-deficient mice. Neurotoxicology. 2017;58:130-136.
Hsieh H, Vignesh KS, Deepe GS, Choubey D, Shertzer HG, Genter MB. Mechanistic studies of the toxicity of zinc gluconate in the olfactory neuronal cell line Odora. Toxicol Vitr. 2016;35:24-30.
Gurushekar PR, Isiah R, John S, Sebastian T, Varghese L. Effects of radiotherapy on olfaction and nasal function in head and neck cancer patients. Am Journal Otolaryngol. 2020;41: 102537
Riva G, Franco P, Provenzano E, et al. radiation-induced rhinitis: Cytological and olfactory changes. Am J Rhinol Allergy. 2019;33:153-161.
Hölscher T, Seibt A, Appold S, et al. Effects of radiotherapy on olfactory function. Radiother Oncol. 2005;77:157-163.
Bramerson A, Nyman J, Nordin S, Bende M. Olfactory loss after head and neck cancer radiation therapy. Rhinology. 2013;51:206-209.
Wang JJ, Liang KL, Twu CW, Lin JC, Jiang RS. Olfactory change after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int Forum Allergy Rhinol. 2015;5:1059-1062.
Riva G, Raimondo L, Ravera M, et al. Late sensorial alterations in different radiotherapy techniques for nasopharyngeal cancer. Chem Senses. 2015;40:285-292.
Álvarez-Camacho M, Gonella S, Campbell S, Scrimger RA, Wismer WV. A systematic review of smell alterations after radiotherapy for head and neck cancer. Cancer Treat Rev. 2017;54:110-121.
Galletti B, Santoro RR, Mannella VK, et al. Olfactory event-related potentials: A new approach for the evaluation of olfaction in nasopharyngeal carcinoma patients treated with chemo-radiotherapy. J Laryngol Otol. 2016;130:453-461.
Veyseller B, Ozucer B, Degirmenci N, et al. Olfactory bulb volume and olfactory function after radiotherapy in patients with nasopharyngeal cancer. Auris Nasus Larynx. 2014;41:436-440.
Perez EC, Rodgers SP, Inoue T, Pedersen SE, Leasure JL, Gaber MW. Olfactory memory impairment differs by sex in a rodent model of pediatric radiotherapy. Front Behav Neurosci. 2018;12:158.
Díaz D, Muñoz-Castañeda R, Ávila-Zarza C, Carretero J, Alonso JR, Weruaga E. Olfactory bulb plasticity ensures proper olfaction after severe impairment in postnatal neurogenesis. Sci Rep. 2017;7:5654.
Jalali MM, Gerami H, Rahimi A, Jafari M. Assessment of olfactory threshold in patients undergoing radiotherapy for head and neck malignancies. Iran J Otorhinolaryngol. 2014;26:211-217.
Al-Ezzi MY, Pathak N, Tappuni AR, Khan KS. Primary Sjögren's syndrome impact on smell, taste, sexuality and quality of life in female patients: A systematic review and meta-analysis. Mod Rheumatol. 2017;27:623-629.
Henkin RI, Talal N, Larson AL, Mattern CF. Abnormalities of taste and smell in Sjogren's syndrome. Ann Intern Med. 1972;76:375-383.
Jones AE, Larson AL, Powell RD, Johnston GS, Henkin RI. Localization of 99mtechnetium in the region of the nose in Sjögren's syndrome. Anno Otol Rhinol Laryngol. 1974;83:370-378.
Weiffenbach JM, Fox PC. Odor identification ability among patients with Sjögren's syndrome. Arthritis Rheum. 1993;36:1752-1754.
Kamel UF, Maddison P, Whitaker R. Impact of primary Sjogren's syndrome on smell and taste: effect on quality of life. Rheumatology (Oxford). 2009;48:1512-1514.
Midilli R, Gode S, Oder G, Kabasakal, Karci B. Nasal and paranasal involvement in primary Sjogren`s syndrome. Rhinology. 2013;51:265-267.
Su N, Poon R, Grushka M. Does Sjogren's syndrome affect odor identification abilities? Eur Arch Otorhinolaryngol. 2015;272:773-774.
Rasmussen N, Brofeldt S, Manthorpe R. Smell and nasal findings in patients with primary Sjogren's syndrome. Scand J Rheumatol Suppl. 1986;61:142-145.
Amital H, Agmon-Levin N, Shoenfeld N, et al. Olfactory impairment in patients with the fibromyalgia syndrome and systemic sclerosis. Immunol Res. 2014;60:201-207.
Bombini MF, Peres FA, Lapa AT, et al. Olfactory function in systemic lupus erythematosus and systemic sclerosis. A longitudinal study and review of the literature. Autoimmun Rev. 2018;17:405-412.
Ansari KA. Olfaction in multiple sclerosis. With a note on the discrepancy between optic and olfactory involvement. Eur Neurol. 1976;14:138-145.
Samkoff LM, Tuchman AJ, Daras M, Koppel BS. A quantitative study of olfaction in multiple sclerosis. J Neuro Rehab. 1996;10:97-99.
Doty RL, Li C, Mannon LJ, Yousem DM. Olfactory dysfunction in multiple sclerosis. N Engl J Med. 1997;336:1918-1919.
Hawkes CH, Shephard BC, Kobal G. Assessment of olfaction in multiple sclerosis: Evidence of dysfunction by olfactory evoked response and identification tests. J Neurol Neurosurg Psychiatry. 1997;63:145-151.
Zivadinov R, Zorzon M, Monti-Bragadin L, Pagliaro G, Cazzato G. Olfactory loss in multiple sclerosis. J Neurol Sci. 1999;168:127-130.
Zorzon M, et al. Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis: a clinical and MR study. Mult Scler. 2000;6:386-390.
Fleiner F, Dahlslett SB, Schmidt F, Harms L, Goektas O. Olfactory and gustatory function in patients with multiple sclerosis. Am J Rhinol Allergy. 2010;24:e93-e97.
Goektas O, Schmidt F, Bohner G, et al. Olfactory bulb volume and olfactory function in patients with multiple sclerosis. Rhinology. 2011;49:221-226.
Lutterotti A, Vedovello M, Reindl M, et al. Olfactory threshold is impaired in early, active multiple sclerosis. Mult Scler. 2011;17:964-969.
Dahlslett SB, Goektas O, Schmidt F, Harms L, Olze H, Fleiner F. Psychophysiological and electrophysiological testing of olfactory and gustatory function in patients with multiple sclerosis. Eur Arch Otorhinolaryngol. 2012;269:1163-1169.
Erb K, Bohner G, Harms L, et al. Olfactory function in patients with multiple sclerosis: A diffusion tensor imaging study. J Neurol Sci. 2012;316:56-60.
Silva AM, Santos E, Moreira I, et al. Olfactory dysfunction in multiple sclerosis: association with secondary progression. Mult Scler. 2012;18:616-621.
Rolet A, Magnin E, Millot JL, et al. Olfactory dysfunction in multiple sclerosis: Evidence of a decrease in different aspects of olfactory function. Eur Neurol. 2013;69:166-170.
Caminiti F, De Salvo S, De Cola MC, et al. Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis. PLoS One. 2014;9: e103151.
Erb-Eigner K, Bohner G, Goektas O, et al. Tract-based spatial statistics of the olfactory brain in patients with multiple sclerosis. J Neurol Sci. 2014;346:235-240.
Holinski F, Schmidet F, Dahlslett SB, Harms L, Bohner G, Olze H. MRI study: Objective olfactory function and CNS pathologies in patients with multiple sclerosis. Eur Neurol. 2014;72:157-162.
Caglayan HZ, Irkec C, Nazliel B, Gurses AA, Capraz I. Olfactory functioning in early multiple sclerosis: Sniffin’ sticks test study. Neuropsychiatr Dis Treat. 2016;12:2143-2147.
Jordy SS, Starzewski A Jr, Macedo FA, Manica GR, Tilbery CP, Carabetta EG. Olfactory alterations in patients with multiple sclerosis. Arq Neuropsiquiatr. 2016;74:697-700.
Kandemir S, Muluk NB, Melikoglu B, Dag E, Inal M, Sarin O. Smell functions in patients with multiple sclerosis: a prospective case-control study. B-ENT. 2016;12:323-331.
Li LM, Yang LN, Zhang LJ, et al. Olfactory dysfunction in patients with multiple sclerosis. J Neurol Sci. 2016;365:34-39.
Good KP, Tourbier IA, Moberg P, et al. Unilateral olfactory sensitivity in multiple sclerosis. Physiol Behav. 2017;168:24-30.
Uecker FC, Olze H, Kunte H, et al. Longitudinal testing of olfactory and gustatory function in patients with multiple sclerosis. PLoS One. 2017;12: e0170492.
Atalar AÇ, Erdal Y, Tekin B, Yıldız M, Akdoğan Ö, Emre U. Olfactory dysfunction in multiple sclerosis. Mult Scler Relat Disord. 2018;21:92-96.
Bsteh G, Hegen H, Ladstätter F, et al. Transient impairment of olfactory threshold in acute multiple sclerosis relapse. Mult Scler Relat Disord. 2018;23:74-77.
Ciurleo R, Bonanno L, De Salvo S, et al. Olfactory dysfunction as a prognostic marker for disability progression in multiple sclerosis: An olfactory event related potential study. PLoS One. 2018;13: e0196006.
Li LM, Guo HY, Zhao N, et al. Comparison of olfactory function between neuromyelitis optica and multiple sclerosis. Int J Neurosci. 2018;128:772-777.
Bsteh G, Hegen H, Ladstätter F, et al. Change of olfactory function as a marker of inflammatory activity and disability progression in MS. Mult Scler. 2019;25:267-274.
Carotenuto A, Costabile T, Moccia M, et al. Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosis. Mult Scler Relat Disord. 2019;27:1-6.
Göktas O, Cao Van H, Fleiner F, Lacroix JS, Landis BN. Chemosensory function in Wegener's granulomatosis: A preliminary report. Eur Arch Otorhinolaryngol. 2010;267:1089-1093.
Laudien M, Lamprecht P, Hedderich J, Holle J, Ambrosch P. Olfactory dysfunction in Wegener's granulomatosis. Rhinology. 2009;47:254-259.
Fasunla JA, Hundt W, Lutz J, Förger F, Thürmel K, Steinbach S. Evaluation of smell and taste in patients with Wegener's granulomatosis. Eur Arch Otorhinolaryngol. 2012;269:179-186.
Proft F, Steinbach S, Dechant C, et al. Gustatory and olfactory function in patients with granulomatosis with polyangiitis (Wegener's). Scand J Rheumatol. 2014;43:512-518.
Zycinska K, Straburzynski M, Nitsch-Osuch A, et al. Prevalence of olfactory impairment in granulomatosis with polyangiitis. Adv Exp Med Biol. 2016;878:1-7.
Cavaco S, Martins da Silva A, Santos E, et al. Are cognitive and olfactory dysfunctions in neuropsychiatric lupus erythematosus dependent on anxiety or depression? J Rheumatol. 2012;39:770-776.
Chen Q, Qiu F, Liu H, Li X, Li J. altered olfactory function in patients with systemic lupus erythematosus. Med Sci Monit. 2019;25:5929-5933.
Shoenfeld N, Agmon-Levin N, Flitman-Katzevman I, et al. The sense of smell in systemic lupus erythematosus. Arthritis Rheum. 2009;60:1484-1487.
Steinbach S, Proft F, Schulze-Koops H, et al. Gustatory and olfactory function in rheumatoid arthritis. Scand J Rheumatol. 2011;40:169-177.
Leon-Sarmiento FE, Bayona EA, Bayona-Prieto J, Osman A, Doty RL. Profound olfactory dysfunction in myasthenia gravis. PLoS One. 2012;7: e45544.
Tekeli H, Senol MG, Altundag A, et al. Olfactory and gustatory dysfunction in Myasthenia gravis: A study in Turkish patients. J Neurol Sci. 2015;356:188-192.
Leon-Sarmiento FE, Leon-Ariza DS, Doty RL. Dysfunctional chemosensation in myasthenia gravis: A systematic review. J Clin Neuromuscul Dis. 2013;15:1-6.
Zhang LJ, Zhao N, Fu Y, et al. Olfactory dysfunction in neuromyelitis optica spectrum disorders. J Neurol. 2015;262:1890-1898.
Veyseller B, Doğan R, Ozücer B, et al. Olfactory function and nasal manifestations of Behçet's disease. Auris Nasus Larynx. 2014;41:185-189.
Akyol L, Günbey E, Karlı R, Önem S, Özgen M, Sayarlıoğlu M. Evaluation of olfactory function in B'ehcet's disease. Eur J Rheumatol. 2016;3:153-156.
Doğan R, Ertaş B, Özücer B, Birday E, Özturan O, Veyseller B. Olfactory dysfunction associated with Neuro-Behçet disease. J Craniofac Surg. 2017;28:e707-e710.
Takano K, Yamamoto M, Kondo A, Takahashi H, Himi T. A clinical study of olfactory dysfunction in patients with Mik'ulicz's disease. Auris Nasus Larynx. 2011;38:347-351.
Miwa T, Ikeda K, Ishibashi T, et al. Clinical practice guidelines for the management of olfactory dysfunction. Auris Nasus Larynx. 2019;46:653-662.
Aiba T, Sugiura M, Mori J, et al. Effect of zinc sulfate on sensoryneural olfactory disorder. Acta Otolaryngol Suppl. 1998;538:202-204
Fosmire GJ. Zinc toxicity. Am J Clin Nutr. 1990;51:225-227.
Lyckholm L, Heddinger SP, Parker G, et al. A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders. J Pain Palliat Care Pharmacother. 2012;26:111-114.
Berkowicz DA, Trombley PQ. Dopaminergic modulation at the olfactory nerve synapse. Brain Res. 2000;855:90-99
Olichney JM, Murphy C, Hofstetter CR, et al. Anosmia is very common in the Lewy body variant of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005;76:1342-1347.
Henkin RI, Hoetker JD. Deficient dietary intake of vitamin E in patients with taste and smell dysfunctions: is vitamin E a cofactor in taste bud and olfactory epithelium apoptosis and in stem cell maturation and development? Nutrition. 2003;19:1013-1021.
Reden J, Lill K, Zahnert T, Haehner A, Hummel T. Olfactory function in patients with postinfectious and posttraumatic smell disorders before and after treatment with vitamin A: A double-blind, placebo-controlled, randomized clinical trial. Laryngoscope. 2012;122:1906-1909.
Hummel T, Whitcroft KL, Rueter G, Haehner A. Intranasal vitamin A is beneficial in post-infectious olfactory loss. Eur Arch Otorhinolaryngol. 2017;274:2819-2825.
Harless L, Liang J. Pharmacologic treatment for postviral olfactory dysfunction: A systematic review. Int Forum Allergy Rhinol. 2016;6:760-767.
Gleeson M, Browning GG, Burton MJ, et al. Scott-Brown's Otorhinolaryngology, Head and Neck Surgery, 7TH ed. Ann R Coll Surg Engl. 2011;93:559
Sykiotis GP, Hoang XH, Avbelj M, et al. Congenital idiopathic hypogonadotropic hypogonadism: Evidence of defects in the hypothalamus, pituitary, and testes. J Clin Endocrinol Metab. 2010;95:3019-3027.
Henkin RI, Bartter FC. Studies on olfactory thresholds in normal man and in patients with adrenal cortical insufficiency: the role of adrenal cortical steroids and of serum sodium concentration. J Clin Invest. 1966;45:1631-1639.
Henkin RI. Effects of ACTH, adrenocorticosteroids and thyroid hormone on sensory function. In: Stumpf WE, Grant LD, eds. Anatomical Neuroendocrinology. Karger, A.G.; 1975: 298-316
de Gennes JL, Turpin G, de Grouchy J, Pialoux P. [Clinical, biological, histological and genetic studies of De Morsier's syndrome (hypogonadotrophic hypogonadism with anosmia). 7 cases]. Ann Endocrinol (Paris). 1970;31:234-236.
McConnell RJ, Menendez CE, Smith FR, Henkin RI, Rivlin RS. Defects of taste and smell in patients with hypothyroidism. Am J Med. 1975;59:354-364.
Stamou MI, Georgopoulos NA. Kallmann syndrome: Phenotype and genotype of hypogonadotropic hypogonadism. Metabolism. 2018;86:124-134.
Forni PE, Wray S. GnRH, anosmia and hypogonadotropic hypogonadism-where are we? Front Neuroendocrinol. 2015;36:165-177.
Ros C, Alobid I, Centellas S, Balasch J, Mullol J, Castelo-Branco C. Loss of smell but not taste in adult women with Turner's syndrome and other congenital hypogonadisms. Maturitas. 2012;73:244-250.
Kamel UF, Maddison P, Whitaker R. Impact of primary Sjögren's syndrome on smell and taste: effect on quality of life. Rheumatology. 2009;48:1512-1514.
Cameron EL. Pregnancy and olfaction: A review. Front Psychol. 2014;5:67.
Chan JYK, García-Esquinas E, Ko OH, Tong MCF, Lin SY. The association between diabetes and olfactory function in adults. Chem Senses. 2017;43:59-64
Brady S, Lalli P, Midha N, Chan A, Garven A, Chan C, Toth C. Presence of Neuropathic Pain May Explain Poor Performances on Olfactory Testing in Diabetes Mellitus Patients, Chemical Senses, Volume 38, Issue 6, July 2013: 497-507.
Deniz F, Ay SA, Salihoglu M, et al. Thyroid Hormone Replacement Therapy Improves Olfaction and Taste Sensitivity in Primary Hypothyroid Patients: A Prospective Randomised Clinical Trial. Exp Clin Endocrinol Diabetes. 2016;124(9):562-567.
Raff AC, Lieu S, Melamed ML, et al. Relationship of impaired olfactory function in ESRD to malnutrition and retained uremic molecules. Am J Kidney Dis. 2008;52:102-110.
Landis BN, Marangon N, Saudan P, et al. Olfactory function improves following hemodialysis. Kidney Int. 2011;80:886-893.
Robles-Osorio ML, Corona R, Morales T, Sabath E. Chronic kidney disease and the olfactory system. Nefrologia (Engl Ed). 2020;40:120-125.
Frasnelli JA, et al. Olfactory function in chronic renal failure. Am J Rhinol. 2002;16:275-279.
Armstrong JE, Temmel AF, Quint C, Oberbauer R, Hummel T. Smell and taste function in children with chronic kidney disease. Pediatr Nephrol. 2010;25:1497-1504.
Griep MI, Van der Niepen P, Sennesael JJ, Mets TF, Massart DL, Verbeelen DL. Odour perception in chronic renal disease. Nephrol Dial Transplant. 1997;12:2093-2098.
Conrad P, Corwin J, Katz L, Serby M, LeFavour G, Rotrosen J. Olfaction and hemodialysis: Baseline and acute treatment decrements. Nephron. 1987;47:115-118.
Corwin J. Olfactory identification in hemodialysis: acute and chronic effects on discrimination and response bias. Neuropsychologia. 1989;27:513-522.
Schiffman SS, Nash ML, Dackis C. Reduced olfactory discrimination in patients on chronic hemodialysis. Physiol Behav. 1978;21:239-242.
Vreman HJ, Venter C, Leegwater J, Oliver C, Weiner MW. Taste, smell and zinc metabolism in patients with chronic renal failure. Nephron. 1980;26:163-170.
Korytowska A, Szmeja Z. [Smell and taste in patients with chronic renal failure treated by hemodialysis]. Otolaryngol Pol. 1993;47:144-152.
Koseoglu S, Derin S, Huddam B, Sahan M. The effect of non-diabetic chronic renal failure on olfactory function. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134:161-164.
Nigwekar SU, Weiser JM, Kalim S, et al. Characterization and correction of olfactory deficits in kidney disease. J Am Soc Nephrol. 2017;28:3395-3403.
Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329:1001-1006.
Bomback AS, Raff AC. Olfactory function in dialysis patients: A potential key to understanding the uremic state. Kidney Int. 2011;80:803-805.
Jennekens FG, Jennekens-Schinkel A. Replacement of renal function by dialysis. In: Maher JF, ed. Neurological Aspects of Dialysis Patients. Kluwer Academic Publishers; 1989: 972-987.
Morrison EE, Moran DT. Anatomy and ultrastructure of the human olfactory neuroepithelium. In: Doty, RL ed. Handbook of Olfaction and Gustation. Marcel Dekker; 1995: 75-103.
Reaich D. Odour perception in chronic renal disease. Lancet. 1997;350:1191.
Landis BN, Hummel T, Hugentobler M, Giger R, Lacroix JS. Ratings of overall olfactory function. Chem Senses. 2003;28:691-694.
Welge-Luessen A, Hummel T, Stojan T, Wolfensberger M. What is the correlation between ratings and measures of olfactory function in patients with olfactory loss? Am J Rhinol. 2005;19:567-571.
Mattes RD. Nutritional implications of taste and smell disorders. In: Doty RL, ed. Handbook of Olfaction and Gustation. Marcel Dekker; 1995: 731-744.
Dobell E, Chan M, Williams P, Allman M. Food preferences and food habits of patients with chronic renal failure undergoing dialysis. J Am Diet Assoc. 1993;93:1129-1135.
Schwartz JS, Tajudeen BA, Kennedy DW. Diseases of the nasal cavity. Handb Clin Neurol. 2019;164:285-302.
Doty RL. The olfactory system and its disorders. Semin Neurol. 2009;29:74-81.
Allis TJ, Leopold DA. Smell and taste disorders. Facial Plast Surg Clin North Am. 2012;20:93-111.
Wrobel BB, Leopold DA. Clinical assessment of patients with smell and taste disorders. Otolaryngol Clin North Am. 2004;37:1127-1142.
Ye T, Hwang PH, Huang Z, et al. Frontal ostium neo-osteogenesis and patency after Draf III procedure: a computer-assisted study. Int Forum Allergy Rhinol. 2014;4:739-744.
Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001;2:683-690.
Bachar G, Goldstein DP, Shah M, et al. Esthesioneuroblastoma: The Princess Margaret Hospital experience. Head Neck. 2008;30:1607-1614.
Wrobel BB, Leopold DA. Smell and taste disorders. Facial Plast Surg Clin North Am. 2004;12:459-468, vii.
Bakay L. Olfactory meningiomas. The missed diagnosis. JAMA. 1984;251:53-55.
Hendrix P, Fischer G, Linnebach AC, et al. Perioperative olfactory dysfunction in patients with meningiomas of the anteromedial skull base. Clin Anat. 2019;32:524-533.
Karavitaki N, Cudlip S, Adams CBT, Wass JA. Craniopharyngiomas. Endocr Rev. 2006;27:371-397.
Kesari S. Disturbances of Smell and Taste. In: Mushlin SB, Greene HL, eds. Decision Making in Medicine. 3rd ed. Mosby; 2010: 458-459.
Kim BY, Kang SG, Kim SW, et al. Olfactory changes after endoscopic endonasal transsphenoidal approach for skull base tumors. Laryngoscope. 2014;124:2470-2475.
Puccinelli CL, Yin LX, O'Brien EK, et al. Long-term olfaction outcomes in transnasal endoscopic skull-base surgery: A prospective cohort study comparing electrocautery and cold knife upper septal limb incision techniques. Int Forum Allergy Rhinol. 2019;9:493-500.
Adelman BT. Altered taste and smell after anesthesia: cause and effect? Anesthesiology. 1995;83:647-649.
Thompson CF, Suh JD, Liu Y, Bergsneider M, Wang MB. Modifications to the endoscopic approach for anterior skull base lesions improve postoperative sinonasal symptoms. J Neurol Surg B Skull Base. 2014;75:65-72.
Thompson CF, Kern RC, Conley DB. Olfaction in Endoscopic Sinus and Skull Base Surgery. Otolaryngol Clin North Am. 2015;48:795-804.
Kahilogullari G, Beton S, Al-Beyati ES, et al. Olfactory functions after transsphenoidal pituitary surgery: endoscopic versus microscopic approach. Laryngoscope. 2013;123:2112-2119.
Baudracco I, Ekanayake J, Warner E, Grieve JP, Dorward NL. Olfactory outcomes after transsphenoidal endonasal surgery. Br J Neurosurg. 2020;34:35-39.
Griffiths CF, Cutler AR, Duong HT, et al. Avoidance of postoperative epistaxis and anosmia in endonasal endoscopic skull base surgery: A technical note. Acta Neurochir (Wien). 2014;156:1393-1401.
Harvey RJ, Winder M, Davidson A, et al. The olfactory strip and its preservation in endoscopic pituitary surgery maintains smell and sinonasal function. J Neurol Surg B Skull Base. 2015;76:464-470.
Kim SW, Park KB, Khalmuratova R, Lee HK, Jeon SY, Kim DW. Clinical and histologic studies of olfactory outcomes after nasoseptal flap harvesting. Laryngoscope. 2013;123:1602-1606.
Hong SD, Nam DH, Park J, Kim HY, Chung SK, Dhong HJ. Olfactory outcomes after endoscopic pituitary surgery with nasoseptal “rescue” flaps: Electrocautery versus cold knife. Am J Rhinol Allergy. 2014;28:517-519.
Li P, Luo K, Zhang Q, Wang Z. Superior turbinate management and olfactory outcome after endoscopic endonasal transsphenoidal surgery for pituitary adenoma: A propensity score-matched cohort study. Int Forum Allergy Rhinol. 2020;10:1276-1284.
Orgain CA, Kuan EC, Alvarado R, et al. Smell preservation following unilateral endoscopic transnasal approach to resection of olfactory groove meningioma: A multi-institutional experience. J Neurol Surg B Skull Base. 2020;81:263-267.
Tajudeen BA, Adappa ND, Kuan EC, et al. Smell preservation following endoscopic unilateral resection of esthesioneuroblastoma: A multi-institutional experience. Int Forum Allergy Rhinol. 2016;6:1047-1050.
Desiato VM, Levy DA, Byun YJ, Nguyen SA, Soler ZM, Schlosser RJ. The prevalence of olfactory dysfunction in the general population: a systematic review and meta-analysis. Am J Rhinol Allergy. 2021;35:195-205.
Zhang C, Wang X. Initiation of the age-related decline of odor identification in humans: A meta-analysis. Ageing Res Rev. 2017;40:45-50.
Liu G, Zong G, Doty RL, Sun Q. Prevalence and risk factors of taste and smell impairment in a nationwide representative sample of the US population: A cross-sectional study. BMJ Open. 2016;6:8-11.
Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Olfactory impairment in older adults: Five-year incidence and risk factors. Laryngoscope. 2011;121:873-878.
Noel J, Habib AR, Thamboo A, Patel ZM. Variables associated with olfactory disorders in adults: A U.S. population-based analysis. World J Otorhinolaryngol Head Neck Surg. 2017;3:9-16.
Brämerson A, Johansson L, Ek L, Nordin S, Bende M. Prevalence of olfactory dysfunction: The Skövde population-based study. Laryngoscope. 2004;114:733-737.
Schubert CR, Cruickshanks KJ, Fischer ME, et al. Olfactory impairment in an adult population: The Beaver Dam Offspring Study. Chem Senses. 2012;37:325-334.
Doty RL, Kamath V. The influences of age on olfaction: A review. Front Psychol. 2014;5:1-20.
Lafreniere D, Mann N. Anosmia: Loss of smell in the elderly. Otolaryngol Clin North Am. 2009;42:123-131.
Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L. Smell identification ability: Changes with age. Science. 1984;226:1441-1443.
Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Prevalence of olfactory impairment in older adults. J Am Med Assoc. 2002;288:2307-2312.
Hoffman HJ, Rawal S, Li CM, Duffy VB. New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): First-year results for measured olfactory dysfunction. Rev Endocr Metab Disord. 2016;17:221-240.
Attems J, Walker L, Jellinger KA. Olfaction and aging: A mini-review. Gerontology. 2015;61:485-490.
Sulmont-Rossé C, Maître I, Amand M, et al. Evidence for different patterns of chemosensory alterations in the elderly population: Impact of age versus dependency. Chem Senses. 2015;40:153-164.
Kondo K, Kikuta S, Ueha R, Suzukawa K, Yamasoba T. Age-related olfactory dysfunction: Epidemiology, pathophysiology, and clinical management. Front Aging Neurosci. 2020;12:1-17.
Pinto JM, Schumm LP, Wroblewski KE, Kern DW, McClintock MK. Racial disparities in olfactory loss among older adults in the United States. J Gerontol A Biol Sci Med Sci. 2014;69:323-329.
Sorokowska A, Schriever VA, Gudziol V, et al. Changes of olfactory abilities in relation to age: Odor identification in more than 1400 people aged 4 to 80 years. Eur Arch Otorhinolaryngol. 2015;272:1937-1944.
Oleszkiewicz A, Schriever VA, Croy I, Hähner A, Hummel T. Updated Sniffin’ Sticks normative data based on an extended sample of 9139 subjects. Eur Arch Otorhinolaryngol. 2019;276:719-728.
Xu L, Liu J, Wroblewski KE, McClintock MK, Pinto JM. Odor sensitivity versus odor identification in older us adults: associations with cognition, age, gender, and race. Chem Senses. 2020;45:321-330.
Schubert CR, Fischer ME, Pinto AA, Klein BE, Klein R, Cruickshanks KJ. Odor detection thresholds in a population of older adults. Laryngoscope. 2017;127:1257-1262.
Hummel T, Bensafi M, Nikolaus J, Knecht M, Laing DG, Schaal B. Olfactory function in children assessed with psychophysical and electrophysiological techniques. Behav Brain Res. 2007;180:133-138.
Mullol J, Alobid I, Mariño-Sánchez F, et al. Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: A population-based survey (OLFACAT study). BMJ Open. 2012;2: e001256.
Schlosser RJ, Desiato VM, Storck KA, et al. A community-based study on the prevalence of olfactory dysfunction. Am J Rhinol Allergy. 2020;34:661-670.
Masala C, Saba L, Cecchini MP, Solla P, Loy F. Olfactory function and age: A sniffin’ sticks extended test study performed in Sardinia. Chemosens Percept. 2018;11:19-26.
Larsson M, Finkel D, Pedersen NL. Odor identification: Influences of age, gender, cognition, and personality. J Gerontol B Psychol Sci Soc Sci. 2000;55:304-310.
Kern DW, Wroblewski KE, Schumm LP, Pinto JM, Chen RC, McClintock MK. Olfactory function in wave 2 of the National Social Life, Health, and Aging Project. J Gerontol B Psychol Sci Soc Sci. 2014;69:S134-S143.
Wilson RS, Yu L, Bennett DA. Odor identification and mortality in old age. Chem Senses. 2011;36:63-67.
Kalmey JK, Thewissen JG, Dluzen DE. Age-related size reduction of foramina in the cribriform plate. Anat Rec. 1998;251:326-329.
Rawson NE, Gomez G, Cowart BJ, Kriete A, Pribitkin E, Restrepo D. Age-associated loss of selectivity in human olfactory sensory neurons. Neurobiol Aging. 2012;33:1913-1919.
Doty RL. Age-related deficits in taste and smell. Otolaryngol Clin North Am. 2018;51:815-825.
Sama-ul-Haq, Tahir M, Lone KP. Age and gender-related differences in mitral cells of olfactory bulb. J Coll Physicians Surg Pakistan. 2008;18:669-673.
Yousem DM, Geckle RJ, Bilker WB, Doty RL. olfactory bulb and tract and temporal lobe volumes: Normative data across decades. Ann New York Acad Sci. 1998;855:546-555.
Segura B, Baggio HC, Solana E, et al. Neuroanatomical correlates of olfactory loss in normal aged subjects. Behav Brain Res. 2013;246:148-153.
Trimmer C, Keller A, Murphy NR, et al. Genetic variation across the human olfactory receptor repertoire alters odor perception. Proc Natl Acad Sci U S A. 2019;116:9475-9480.
Adams DR, Wroblewski KE, et al. Factors associated with inaccurate self-reporting of olfactory dysfunction in older us adults. Chem Senses. 2017;42:223-231.
Boesveldt S, Postma EM, Boak D, Welge-Luessen A, Schöpf V, Mainland JD, et al. Anosmia-A clinical review. Chem Senses. 2017;42:513-523.
Rawal S, Hoffman HJ, Bainbridge KE, Huedo-Medina TB, Duffy VB. Prevalence and risk factors of self-reported smell and taste alterations: Results from the 2011-2012 US National Health and Nutrition Examination Survey (NHANES). Chem Senses. 2016;41:69-76.
Waldton S. Clinical observations of impaired cranial nerve function in senile dementia. Acta Psychiatrica Scandinavica 1974;50:539-47
Serby M, Corwin J, Novatt A, Conrad P, Rotrosen J. Olfaction in dementia. J Neurol Neurosurg Psychiatry 1985;48(8):848-49
Peabody CA, Tinklenberg JR. Olfactory deficits and primary degenerative dementia. Am J Psychiatry 1985;142:524-25
Knupfer L, Spiegel R. Differences in olfactory test performance between normal aged, Alzheimer and vascular type dementia individuals. Int J Geriat Psychiat 1986;1:3-14
Warner MD, Peabody CA, Flattery JJ, Tinklenberg JR. Olfactory deficits and Alzheimer's disease. Biological Psychiatry 1986;21(1):116-18
Doty RL, Reyes PF, Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Research Bulletin 1987;18(5):597-600
Koss E, Weiffenbach JM, Haxby JV, Friedland RP. Olfactory detection and recognition in Alzheimer's disease [letter]. Lancet 1987;1(8533):622
Moberg PJ, Pearlson GD, Speedie LJ, et al. Olfactory recognition: differential impairments in early and late Huntington's and Alzheimer's diseases. J. Clin. Exp. Neuropsychol 1987;9(6):650-64
Rezek DL. Olfactory deficits as a neurologic sign in dementia of the Alzheimer type. Archives of Neurology 1987;44:1030-32
Kesslak JP, Cotman CW, Chui HC, et al. Olfactory tests as possible probes for detecting and monitoring Alzheimer's disease. Neurobiol Aging 1988;9:399-403
Koss E, Weiffenbach JM, Haxby JV, Friedland RP. Olfactory detection and identification performance are dissociated in early Alzheimer's disease. Neurology 1988;38(8):1228-32
Murphy C, Gilmore MM, Seery CS, Salmon DP, Lasker BR. Olfactory thresholds are associated with degree of dementia in Alzheimer's disease. Neurobiology of Aging 1990;11(4):465-69
Schiffman SS, Clark CM, Warwick ZS. Gustatory and olfactory dysfunction in dementia: not specific to Alzheimer's disease. Neurobiology of Aging 1990;11(6):597-600
Buchsbaum MS, Kesslak JP, Lynch G, et al. Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls. Preliminary studies. Archives of General Psychiatry 1991;48(9):840-47
Doty RL, Perl DP, Steele JC, et al. Olfactory dysfunction in three neurodegenerative diseases. Geriatrics 1991;46 Suppl 1:47-51
Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease [see comments]. Neurology 1991;41(1):51-54
Serby M, Larson P, Kalkstein D. The nature and course of olfactory deficits in Alzheimer's disease. Am. J. Psychiatry 1991;148(3):357-60 https://doi.org/10.1176/ajp.148.3.357 [doi][published Online First: Epub Date]|.
Perl E, Shay U, Hamburger R, Steiner JE. Taste- and odor-reactivity in elderly demented patients. Chemical Senses 1992;17:779-94
Solomon GS. Anosmia in Alzheimer disease. Percept Motor Skills 1994;1994;79(3 Pt 1):1249-1250
Morgan CD, Nordin S, Murphy C. Odor identification as an early marker for Alzheimer's disease: impact of lexical functioning and detection sensitivity. Journal of Clinical & Experimental Neuropsychology 1995;17(5):793-803
Nordin S, Monsch AU, Murphy C. Unawareness of smell loss in normal aging and Alzheimer's disease: discrepancy between self-reported and diagnosed smell sensitivity. Journals of Gerontology 1995;50(4):187-92
Nordin S, Murphy C. Impaired sensory and cognitive olfactory function in questionable Alzheimer's disease. Neuropsychology 1996;10:113-19
Lehrner JP, Brucke T, Dal-Bianco P, Gatterer G, Kryspin-Exner I. Olfactory functions in Parkinson's disease and Alzheimer's disease. Chem Senses 1997;22(1):105-10
Moberg PJ, Doty RL, Mahr RN, et al. Olfactory identification in elderly schizophrenia and Alzheimer's disease. Neurobiology of Aging 1997;18(2):163-67
Nordin S, Almkvist O, Berglund B, Wahlund LO. Olfactory dysfunction for pyridine and dementia progression in Alzheimer disease. Archives of Neurology 1997;1997 Aug;54(8):993-98
Ahlskog JE, Waring SC, Petersen RC, et al. Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia. Neurology 1998;51(6):1672-77
Bacon AW, Bondi MW, Salmon DP, Murphy C. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction. Annals of the New York Academy of Sciences 1998;855:723-31
Hawkes CH, Shephard BC. Olfactory evoked responses and identification tests in neurological disease. Annals of the New York Academy of Sciences 1998;855:608-15
Solomon GS, Petrie WM, Hart JR, Brackin HB, Jr. Olfactory dysfunction discriminates Alzheimer's dementia from major depression. Journal of Neuropsychiatry & Clinical Neurosciences 1998;1998 Winter;10(1):64-67
Bacon-Moore AS, Paulsen JS, Murphy C. A test of odor fluency in patients with Alzheimer's and Huntington's disease. Journal of Clinical & Experimental Neuropsychology 1999;21(3):341-51
Larsson M, Semb H, Winblad B, Amberla K, Wahlund LO, Backman L. Odor identification in normal aging and early Alzheimer's disease: effects of retrieval support. Neuropsychology 1999;13(1):47-53
Niccoli-Waller CA, Harvey J, Nordin S, Murphy C. Remote odor memory in Alzheimer's disease: deficits as measured by familiarity. Journal of Adult Development 1999;6:131-36
McCaffrey RJ, Duff K, Solomon GS. Olfactory dysfunction discriminates probable Alzheimer's dementia from major depression: a cross-validation and extension. J Neuropsychiatry Clin. Neurosci 2000;12(1):29-33 https://doi.org/10.1176/jnp.12.1.29 [doi][published Online First: Epub Date]|.
Gray AJ, Staples V, Murren K, Dhariwal A, Bentham P. Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type. International Journal of Geriatric Psychiatry 2001;16(5):513-17
Kareken DA, Doty RL, Moberg PJ, et al. Olfactory-evoked regional cerebral blood flow in Alzheimer's disease. Neuropsychology 2001;15(1):18-29
McShane RH, Nagy Z, Esiri MM, et al. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. Journal of Neurology, Neurosurgery & Psychiatry 2001;70(6):739-43
Royet JP, Croisile B, Williamson-Vasta R, Hibert O, Serclerat D, Guerin J. Rating of different olfactory judgements in Alzheimer's disease. Chem. Senses 2001;26(4):409-17
Chan A, Tam J, Murphy C, Chiu H, Lam L. Utility of olfactory identification test for diagnosing Chinese patients with Alzheimer's disease. J. Clin. Exp. Neuropsychol 2002;24(2):251-59 https://doi.org/10.1076/jcen.24.2.251.992 [doi][published Online First: Epub Date]|.
Duff K, McCaffrey RJ, Solomon GS. The Pocket Smell Test: successfully discriminating probable Alzheimer's dementia from vascular dementia and major depression. Journal of Neuropsychiatry & Clinical Neurosciences 2002;14(2):197-201
Lange R, Donathan CL, Hughes LF. Assessing olfactory abilities with the University of Pennsylvania smell identification test: a Rasch scaling approach. Journal of Alzheimer's Disease 2002;4(2):77-91
Morgan CD, Murphy C. Olfactory event-related potentials in Alzheimer's disease. Journal of the International Neuropsychological Society 2002;2002 Sep;8(6):753-63
Wang QS, Tian L, Huang YL, Qin S, He LQ, Zhou JN. Olfactory identification and apolipoprotein E epsilon 4 allele in mild cognitive impairment. Brain Research 2002;2002 Sep 27;951(1):77-81
Murphy C, Jernigan TL, Fennema-Notestine C. Left hippocampal volume loss in Alzheimer's disease is reflected in performance on odor identification: a structural MRI study. Journal of the International Neuropsychological Society 2003;2003 Mar;9(3):459-71
Getchell ML, Shah DS, Buch SK, Davis DG, Getchell TV. 3-Nitrotyrosine immunoreactivity in olfactory receptor neurons of patients with Alzheimer's disease: implications for impaired odor sensitivity. Neurobiology of Aging 2003;2003 Sep;24(5):663-73
Peters JM, Hummel T, Kratzsch T, Lotsch J, Skarke C, Frolich L. Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques. American Journal of Psychiatry 2003;2003 Nov;160(11):1995-2002
Westervelt HJ, Stern RA, Tremont G. Odor identification deficits in diffuse lewy body disease. Cognitive & Behavioral Neurology 2003;16:93-99
Gilbert PE, Barr PJ, Murphy C. Differences in olfactory and visual memory in patients with pathologically confirmed Alzheimer's disease and the Lewy body variant of Alzheimer's disease. Journal of the International Neuropsychological Society 2004;10(6):835-42
Gilbert PE, Murphy C. The effect of the ApoE epsilon4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer's disease, probable Alzheimer's disease, and healthy elderly controls. Journal of Clinical & Experimental Neuropsychology 2004;26(6):779-94
Suzuki Y, Yamamoto S, Umegaki H, et al. Smell identification test as an indicator for cognitive impairment in Alzheimer's disease. International Journal of Geriatric Psychiatry 2004;19(8):727-33
Eibenstein A, Fioretti AB, Simaskou MN, et al. Olfactory screening test in mild cognitive impairment. Neurological Sciences 2005;26(3):156-60
Sparks DL, Petanceska S, Sabbagh M, et al. Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT).[see comment]. Current Alzheimer Research 2005;2(5):527-39
Tabert MH, Liu X, Doty RL, et al. A 10-item smell identification scale related to risk for Alzheimer's disease. Ann Neurol 2005;58(1):155-60
Motomura N, Tomota Y. Olfactory dysfuntion in dementia of Alzheimer's type and vascualr dementia. Psychogeriatrics 2006;6:19-20
Kjelvik G, Sando SB, Aasly J, Engedal KA, White LR. Use of the Brief Smell Identification Test for olfactory deficit in a Norwegian population with Alzheimer's disease. Int J Geriatr. Psychiatry 2007;22(10):1020-24
Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L, Ralph MAL. Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia 2007;45(8):1823-31
Pentzek M, Grass-Kapanke B, Ihl R. Odor identification in Alzheimer's disease and depression. Aging Clin Exp Res 2007;19(3):255-58
Sundermann EE, Gilbert PE, Murphy C. Apolipoprotein E epsilon4 genotype and gender: effects on memory. Am. J Geriatr. Psychiatry 2007;15(10):869-78 doi: 15/10/869 [pii];10.1097/JGP.0b013e318065415f [doi][published Online First: Epub Date]|.
Wilson RS, Schneider JA, Arnold SE, Tang Y, Boyle PA, Bennett DA. Olfactory identification and incidence of mild cognitive impairment in older age. Archives of General Psychiatry 2007;64:802-08
Devanand DP, Liu X, Tabert MH, et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol. Psychiatry 2008;64(10):871-79
Djordjevic J, Jones-Gotman M, De SK, Chertkow H. Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2008;29(5):693-706
McLaughlin NC, Westervelt HJ. Odor identification deficits in frontotemporal dementia: a preliminary study. Arch Clin Neuropsychol 2008;23(1):119-23
Westervelt HJ, Bruce JM, Coon WG, Tremont G. Odor identification in mild cognitive impairment subtypes. J Clin Exp Neuropsychol 2008;30(2):151-56
Jungwirth S, Zehetmayer S, Bauer P, Weissgram S, Tragl KH, Fischer P. Screening for Alzheimer's dementia at age 78 with short psychometric instruments. Int. Psychogeriatr 2009;21(3):548-59
Laakso MP, Tervo S, Hanninen T, Vanhanen M, Hallikainen M, Soininen H. Olfactory identification in non-demented elderly population and in mild cognitive impairment: a comparison of performance in clinical odor identification versus Boston Naming Test. J. Neural Transm 2009;116(7):891-95 https://doi.org/10.1007/s00702-009-0235-8 [doi][published Online First: Epub Date]|.
Lehrner J, Pusswald G, Gleiss A, Auff E, Dal-Bianco P. Odor identification and self-reported olfactory functioning in patients with subtypes of mild cognitive impairment. Clin. Neuropsychol 2009;23(5):818-30
Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett DA. Olfactory impairment in presymptomatic Alzheimer's disease. Ann. N. Y. Acad. Sci 2009;1170:730-35
Devanand DP, Tabert MH, Cuasay K, et al. Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiol Aging 2010;31(9):1593-600 doi: S0197-4580(08)00331-X [pii];10.1016/j.neurobiolaging.2008.09.008 [doi][published Online First: Epub Date]|.
Devanand DP, Van Heertum RL, Kegeles LS, et al. (99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease. Am J Geriatr. Psychiatry 2010;18(11):959-72 https://doi.org/10.1097/JGP.0b013e3181ec8696 [doi][published Online First: Epub Date]|.
Williams SS, Williams J, Combrinck M, Christie S, Smith AD, McShane R. Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. J. Neurol. Neurosurg. Psychiatry 2009;80(6):667-70 doi: 80/6/667 [pii];10.1136/jnnp.2008.155895 [doi][published Online First: Epub Date]|.
Forster S, Vaitl A, Teipel SJ, et al. Functional representation of olfactory impairment in early Alzheimer's disease. J Alzheimers. Dis 2010;22(2):581-91 doi: 0V7336M176512780 [pii];10.3233/JAD-2010-091549 [doi][published Online First: Epub Date]|.
Fusetti M, Fioretti AB, Silvagni F, et al. Smell and preclinical Alzheimer disease: study of 29 patients with amnesic mild cognitive impairment. J. Otolaryngol. Head Neck Surg 2010;39(2):175-81
Li W, Howard JD, Gottfried JA. Disruption of odour quality coding in piriform cortex mediates olfactory deficits in Alzheimer's disease. Brain 2010 doi: awq209 [pii];10.1093/brain/awq209 [doi][published Online First: Epub Date]|.
Razani J, Chan A, Nordin S, Murphy C. Semantic networks for odors and colors in Alzheimer's disease. Neuropsychology 2010;24(3):291-99 doi: 2010-07896-002 [pii];10.1037/a0018269 [doi][published Online First: Epub Date]|.
Steinbach S, Hundt W, Vaitl A, et al. Taste in mild cognitive impairment and Alzheimer's disease. J. Neurol 2010;257(2):238-46
Wang J, Eslinger PJ, Doty RL, et al. Olfactory deficit detected by fMRI in early Alzheimer's disease. Brain Res 2010;1357:184-94 doi: S0006-8993(10)01765-8 [pii];10.1016/j.brainres.2010.08.018 [doi][published Online First: Epub Date]|.
Bahar-Fuchs A, Moss S, Rowe C, Savage G. Awareness of olfactory deficits in healthy aging, amnestic mild cognitive impairment and Alzheimer's disease. Int. Psychogeriatr 2011;23(7):1097-106 doi: S1041610210002371 [pii];10.1017/S1041610210002371 [doi][published Online First: Epub Date]|.
Hidalgo J, Chopard G, Galmiche J, Jacquot L, Brand G. Just noticeable difference in olfaction: a discriminative tool between healthy elderly and patients with cognitive disorders associated with dementia. Rhinology 2011;49(5):513-18 doi: 1036 [pii];10.4193/Rhin [doi][published Online First: Epub Date]|.
Jimbo D, Inoue M, Taniguchi M, Urakami K. Specific feature of olfactory dysfunction with Alzheimer's disease inspected by the Odor Stick Identification Test. Psychogeriatrics 2011;11(4):196-204 https://doi.org/10.1111/j.1479-8301.2011.00387.x [doi][published Online First: Epub Date]|.
Makowska I, Kloszewska I, Grabowska A, Szatkowska I, Rymarczyk K. Olfactory deficits in normal aging and Alzheimer's disease in the polish elderly population. Arch. Clin Neuropsychol 2011;26(3):270-79 doi: acr011 [pii];10.1093/arclin/acr011 [doi][published Online First: Epub Date]|.
Schofield PW, Ebrahimi H, Jones AL, Bateman GA, Murray SR. An olfactory ‘stress test’ may detect preclinical Alzheimer's disease. BMC. Neurol 2012;12:24 doi: 1471-2377-12-24 [pii];10.1186/1471-2377-12-24 [doi][published Online First: Epub Date]|.
Sohrabi HR, Bates KA, Weinborn MG, et al. Olfactory discrimination predicts cognitive decline among community-dwelling older adults. Transl. Psychiatry 2012;2:e118 doi: tp201243 [pii];10.1038/tp.2012.43 [doi][published Online First: Epub Date]|.
Conti MZ, Vicini-Chilovi B, Riva M, et al. Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer's disease. Arch. Clin. Neuropsychol 2013;28(5):391-99 doi: act032 [pii];10.1093/arclin/act032 [doi][published Online First: Epub Date]|.
Seligman SC, Kamath V, Giovannetti T, Arnold SE, Moberg PJ. Olfaction and apathy in Alzheimer's disease, mild cognitive impairment, and healthy older adults. Aging Ment. Health 2013;17(5):564-70 https://doi.org/10.1080/13607863.2013.768208 [doi][published Online First: Epub Date]|.
Stamps JJ, Bartoshuk LM, Heilman KM. A brief olfactory test for Alzheimer's disease. J. Neurol. Sci 2013 doi: S0022-510X(13)00311-0 [pii];10.1016/j.jns.2013.06.033 [doi][published Online First: Epub Date]|.
Velayudhan L, Pritchard M, Powell JF, Proitsi P, Lovestone S. Smell identification function as a severity and progression marker in Alzheimer's disease. Int. Psychogeriatr 2013;25(7):1157-66 doi: S1041610213000446 [pii];10.1017/S1041610213000446 [doi][published Online First: Epub Date]|.
Doty RL, Bayona EA, Leon-Ariza DS, et al. The lateralized smell test for detecting Alzheimer's disease: failure to replicate. J. Neurol. Sci 2014;340(1-2):170-73 doi: S0022-510X(14)00166-X [pii];10.1016/j.jns.2014.03.022 [doi][published Online First: Epub Date]|.
Kjelvik G, Saltvedt I, White LR, et al. The brain structural and cognitive basis of odor identification deficits in mild cognitive impairment and Alzheimer's disease. BMC. Neurol 2014;14(1):168 doi: s12883-014-0168-1 [pii];10.1186/s12883-014-0168-1 [doi][published Online First: Epub Date]|.
Marigliano V, Gualdi G, Servello A, et al. Olfactory deficit and hippocampal volume loss for early diagnosis of Alzheimer disease: a pilot study. Alzheimer Dis. Assoc. Disord 2014;28(2):194-97 https://doi.org/10.1097/WAD.0b013e31827bdb9f [doi][published Online First: Epub Date]|.
Stanciu I, Larsson M, Nordin S, Adolfsson R, Nilsson LG, Olofsson JK. Olfactory impairment and subjective olfactory complaints independently predict conversion to dementia: a longitudinal, population-based study. J Int Neuropsychol Soc 2014;20(2):209-17 https://doi.org/10.1017/S1355617713001409[published Online First: Epub Date]|.
Devanand DP, Lee S, Manly J, et al. Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community. Neurology 2015;84(2):182-89 doi: WNL.0000000000001132 [pii];10.1212/WNL.0000000000001132 [doi][published Online First: Epub Date]|.
Hori Y, Matsuda O, Ichikawa S. Olfactory function in elderly people and patients with Alzheimer's disease. Psychogeriatrics 2015;15(3):179-85 https://doi.org/10.1111/psyg.12092 [doi][published Online First: Epub Date]|.
Servello A, Fioretti A, Gualdi G, et al. Olfactory Dysfunction, Olfactory Bulb Volume and Alzheimer's Disease: Is There a Correlation? A Pilot Study1. J. Alzheimers. Dis 2015;48(2):395-402 doi: JAD150232 [pii];10.3233/JAD-150232 [doi][published Online First: Epub Date]|.
Velayudhan L, Gasper A, Pritchard M, Baillon S, Messer C, Proitsi P. Pattern of Smell Identification Impairment in Alzheimer's Disease. J. Alzheimers. Dis 2015;46:381-87 doi: 987N114718T25G20 [pii];10.3233/JAD-142838 [doi][published Online First: Epub Date]|.
Hagemeier J, Woodward MR, Rafique UA, et al. Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy. Psychiatry. Res 2016;255:87-93 doi: S0925-4927(16)30066-X [pii];10.1016/j.pscychresns.2016.08.003 [doi][published Online First: Epub Date]|.
Roberts RO, Christianson TJ, Kremers WK, et al. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia. JAMA. Neurol 2016;73(1):93-101 doi: 2469511 [pii];10.1001/jamaneurol.2015.2952 [doi][published Online First: Epub Date]|.
Christensen IT, Larsson EM, Holm IE, Nielsen OBF, Andersen S. Olfactory testing in consecutive patients referred with suspected dementia. BMC. Geriatr 2017;17(1):129 https://doi.org/10.1186/s12877-017-0516-2 [doi];10.1186/s12877-017-0516-2 [pii][published Online First: Epub Date]|.
Devanand DP, Lentz C, Chunga RE, et al. Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment. J. Alzheimers. Dis 2017;60(4):1525-31 doi: JAD170497 [pii];10.3233/JAD-170497 [doi][published Online First: Epub Date]|.
Lafaille-Magnan ME, Poirier J, Etienne P, et al. Odor identification as a biomarker of preclinical AD in older adults at risk. Neurology 2017 doi: WNL.0000000000004159 [pii];10.1212/WNL.0000000000004159 [doi][published Online First: Epub Date]|.
Passler JS, Doty RL, Dolske MC, et al. Olfactory ability in normal pressure hydrocephalus as compared with Alzheimer's disease and healthy controls. J. Neurol. Sci 2017;372:217-19 doi: S0022-510X(16)30751-1 [pii];10.1016/j.jns.2016.11.049 [doi][published Online First: Epub Date]|.
Quarmley M, Moberg PJ, Mechanic-Hamilton D, et al. Odor Identification Screening Improves Diagnostic Classification in Incipient Alzheimer's Disease. J. Alzheimers. Dis 2017;55(4):1497-507 doi: JAD160842 [pii];10.3233/JAD-160842 [doi][published Online First: Epub Date]|.
Reijs BLR, Ramakers IHGB, Elias-Sonnenschein L, et al. Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition. J. Alzheimers. Dis 2017;60(3):1025-34 doi: JAD170564 [pii];10.3233/JAD-170564 [doi][published Online First: Epub Date]|.
Risacher SL, Tallman EF, West JD, et al. Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography. Alzheimers. Dement. (Amst.) 2017;9:57-66 https://doi.org/10.1016/j.dadm.2017.09.001 [doi];S2352-8729(17)30053-2 [pii][published Online First: Epub Date]|.
Roalf DR, Moberg MJ, Turetsky BI, et al. A quantitative meta-analysis of olfactory dysfunction in mild cognitive impairment. J. Neurol. Neurosurg. Psychiatry 2017;88(3):226-32 doi: jnnp-2016-314638 [pii];10.1136/jnnp-2016-314638 [doi][published Online First: Epub Date]|.
Woodward MR, Amrutkar CV, Shah HC, et al. Validation of olfactory deficit as a biomarker of Alzheimer disease. Neurol. Clin. Pract 2017;7(1):5-14 https://doi.org/10.1212/CPJ.0000000000000293 [doi];NEURCLINPRACT2016015255 [pii][published Online First: Epub Date]|.
Kreisl WC, Jin P, Lee S, et al. Odor Identification Ability Predicts PET Amyloid Status and Memory Decline in Older Adults. J. Alzheimers. Dis 2018;62(4):1759-66 doi: JAD170960 [pii];10.3233/JAD-170960 [doi][published Online First: Epub Date]|.
Palta P, Chen H, Deal JA, et al. Olfactory function and neurocognitive outcomes in old age: The Atherosclerosis Risk in Communities Neurocognitive Study. Alzheimers Dement 2018;14(8):1015-21 https://doi.org/10.1016/j.jalz.2018.02.019[published Online First: Epub Date]|.
Park SJ, Lee JE, Lee KS, Kim JS. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia. Neurol Sci 2018;39(3):557-64 https://doi.org/10.1007/s10072-018-3261-1[published Online First: Epub Date]|.
Woodward MR, Hafeez MU, Qi Q, et al. Odorant Item Specific Olfactory Identification Deficit May Differentiate Alzheimer Disease From Aging. Am J Geriatr Psychiatry 2018;26(8):835-46 https://doi.org/10.1016/j.jagp.2018.02.008[published Online First: Epub Date]|.
Yu Q, Guo P, Li D, et al. Olfactory Dysfunction and Its Relationship with Clinical Symptoms of Alzheimer Disease. Aging Dis 2018;9(6):1084-95 doi: 10.14336/AD.2018.0819[published Online First: Epub Date]|.
Lian TH, Zhu WL, Li SW, et al. Clinical, Structural, and Neuropathological Features of Olfactory Dysfunction in Patients with Alzheimer's Disease. J Alzheimers Dis 2019;70(2):413-23 https://doi.org/10.3233/JAD-181217[published Online First: Epub Date]|.
Lu J, Yang QX, Zhang H, et al. Disruptions of the olfactory and default mode networks in Alzheimer's disease. Brain Behav 2019;9(7):e01296 https://doi.org/10.1002/brb3.1296[published Online First: Epub Date]|.
Velayudhan L, Wilson-Morkeh F, Penney E, Jesu AJM, Baillon S, Brugha T. Smell identification function in early-onset alzheimer's disease and mild cognitive impairment. Int Psychogeriatr 2019;31(7):1065-70 https://doi.org/10.1017/s1041610218001503[published Online First: Epub Date]|.
Yoshii F, Onaka H, Kohara S, Ryo M, Takahashi W. Association of Smell Identification Deficit with Alzheimer's Disease Assessment Scale-Cognitive Subscale, Japanese Version Scores and Brain Atrophy in Patients with Dementia. Eur Neurol 2019;81(3-4):145-51 https://doi.org/10.1159/000501311[published Online First: Epub Date]|.
Yahiaoui-Doktor M, Luck T, Riedel-Heller SG, Loeffler M, Wirkner K, Engel C. Olfactory function is associated with cognitive performance: results from the population-based LIFE-Adult-Study. Alzheimers Res Ther 2019;11(1):43 https://doi.org/10.1186/s13195-019-0494-z[published Online First: Epub Date]|.
Yu HL, Chen ZJ, Zhao JW, Duan SR, Zhao JK. Olfactory Impairment and Hippocampal Volume in a Chinese MCI Clinical Sample. Alzheimer Dis Assoc Disord 2019;33(2):124-28 https://doi.org/10.1097/WAD.0000000000000305[published Online First: Epub Date]|.
Wu X, Geng Z, Zhou S, et al. Brain Structural Correlates of Odor Identification in Mild Cognitive Impairment and Alzheimer's Disease Revealed by Magnetic Resonance Imaging and a Chinese Olfactory Identification Test. Front Neurosci 2019;13:842 https://doi.org/10.3389/fnins.2019.00842[published Online First: Epub Date]|.
Baek MS, Cho H, Lee HS, Lee JH, Ryu YH, Lyoo CH. Effect of A/T/N imaging biomarkers on impaired odor identification in Alzheimer's disease. Sci Rep 2020;10(1):11556 https://doi.org/10.1038/s41598-020-68504-2[published Online First: Epub Date]|.
Beach TG, Adler CH, Zhang N, et al. Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia. PloS One 2020;15(4):e0231720 https://doi.org/10.1371/journal.pone.0231720[published Online First: Epub Date]|.
Devanand DP, Lee S, Luchsinger JA, et al. Intact global cognitive and olfactory ability predicts lack of transition to dementia. Alzheimers Dement 2020;16(2):326-34 https://doi.org/10.1016/j.jalz.2019.08.200[published Online First: Epub Date]|.
Devanand DP, Liu X, Chunga RE, et al. Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment. J Alzheimers Dis 2020;75(3):845-54 https://doi.org/10.3233/JAD-200021[published Online First: Epub Date]|.
Doorduijn AS, de van der Schueren MAE, van de Rest O, et al. Olfactory and gustatory functioning and food preferences of patients with Alzheimer's disease and mild cognitive impairment compared with controls: the NUDAD project. J Neurol 2020;267(1):144-52 https://doi.org/10.1007/s00415-019-09561-0[published Online First: Epub Date]|.
Olofsson JK, Larsson M, Roa C, Wilson DA, Jonsson Laukka E. Interaction Between Odor Identification Deficit and APOE4 Predicts 6-Year Cognitive Decline in Elderly Individuals. Behav Genet 2020;50(1):3-13 https://doi.org/10.1007/s10519-019-09980-9[published Online First: Epub Date]|.
Zhao A, Li Y, Yan Y, et al. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia. Transl Neurodegener 2020;9(1):30 https://doi.org/10.1186/s40035-020-00210-5[published Online First: Epub Date]|.
Dong Y, Wang Y, Liu K, et al. Olfactory Impairment Among Rural-Dwelling Chinese Older Adults: Prevalence and Associations With Demographic, Lifestyle, and Clinical Factors. Front Aging Neurosci 2021;13:621619 https://doi.org/10.3389/fnagi.2021.621619[published Online First: Epub Date]|.
Jobin B, Zahal R, Bussieres EL, Frasnelli J, Boller B. Olfactory Identification in Subjective Cognitive Decline: A Meta-Analysis. J Alzheimers Dis 2021;79(4):1497-507 https://doi.org/10.3233/JAD-201022[published Online First: Epub Date]|.
Klein J, Yan X, Johnson A, et al. Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer's Disease. J Alzheimers Dis 2021;80(3):1051-65 https://doi.org/10.3233/JAD-201149[published Online First: Epub Date]|.
Li J, Bur AM, Villwock MR, et al. Olfactory Phenotypes Differentiate Cognitively Unimpaired Seniors from Alzheimer's Disease and Mild Cognitive Impairment: A Combined Machine Learning and Traditional Statistical Approach. J Alzheimers Dis 2021;81(2):641-50 https://doi.org/10.3233/JAD-210175[published Online First: Epub Date]|.
Motter JN, Liu X, Qian M, Cohen HR, Devanand DP. Odor identification impairment and cholinesterase inhibitor treatment in Alzheimer's disease. Alzheimers Dement (Amst) 2021;13(1):e12158 https://doi.org/10.1002/dad2.12158[published Online First: Epub Date]|.
Sundermann EE, Fields A, Saloner R, et al. The utility of olfactory function in distinguishing early-stage Alzheimer's disease from HIV-associated neurocognitive disorders. AIDS 2021;35(3):429-37 https://doi.org/10.1097/QAD.0000000000002761[published Online First: Epub Date]|.
Wang Q, Chen B, Zhong X, et al. Olfactory Dysfunction Is Already Present with Subjective Cognitive Decline and Deepens with Disease Severity in the Alzheimer's Disease Spectrum. J Alzheimers Dis 2021;79(2):585-95 https://doi.org/10.3233/JAD-201168[published Online First: Epub Date]|.
Elian M. Olfactory impairment in motor neuron disease: a pilot study. Journal of Neurology, Neurosurgery & Psychiatry 1991;54(10):927-28
Sajjadian A, Doty RL, Gutnick DN, Chirurgi RJ, Sivak M, Perl D. Olfactory dysfunction in amyotrophic lateral sclerosis. Neurodegeneration 1994;3:153-57
Hawkes CH, Shephard BC, Geddes JF, Body GD, Martin JE. Olfactory disorder in motor neuron disease. Experimental Neurology 1998;150(2):248-53
Lang CJ, Schwandner K, Hecht M. Do patients with motor neuron disease suffer from disorders of taste or smell? Amyotroph. Lateral. Scler 2011;12(5):368-71 https://doi.org/10.3109/17482968.2011.579133 [doi][published Online First: Epub Date]|.
Takeda T, Iijima M, Uchihara T, et al. TDP-43 Pathology Progression Along the Olfactory Pathway as a Possible Substrate for Olfactory Impairment in Amyotrophic Lateral Sclerosis. J Neuropathol. Exp. Neurol 2015;74(6):547-56 https://doi.org/10.1097/NEN.0000000000000198 [doi][published Online First: Epub Date]|.
Pilotto A, Rossi F, Rinaldi F, et al. Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study. Neurodegener Dis 2016;16(5-6):411-6 https://doi.org/10.1159/000446802[published Online First: Epub Date]|.
Viguera C, Wang J, Mosmiller E, Cerezo A, Maragakis NJ. Olfactory dysfunction in amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol 2018;5(8):976-81 https://doi.org/10.1002/acn3.594 Ii];ACN3594 [pii][published Online First: Epub Date]|.
Masuda M, Watanabe H, Ogura A, et al. Clinicoradiological features in amyotrophic lateral sclerosis patients with olfactory dysfunction. Amyotroph Lateral Scler Frontotemporal Degener 2021;22(3-4):260-66 https://doi.org/10.1080/21678421.2020.1859544[published Online First: Epub Date]|.
Ansari KA. Olfaction in multiple sclerosis. With a note on the discrepancy between optic and olfactory involvement. European Neurology 1976;14(2):138-45
Pinching AJ. Clinical testing of olfaction reassessed. Brain 1977;100:377-88
Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiology & Behavior 1984;32:489-502
Doty RL, Li C, Mannon LJ, Yousem DM. Olfactory dysfunction in multiple sclerosis. New England Journal of Medicine 1997;336(26):1918-19
Hawkes CH, Shephard BC, Kobal G. Assessment of olfaction in multiple sclerosis: evidence of dysfunction by olfactory evoked response and identification tests. Journal of Neurology, Neurosurgery & Psychiatry 1997;63(2):145-51
Doty RL, Li C, Mannon LJ, Yousem DM. Olfactory dysfunction in multiple sclerosis: relation to longitudinal changes in plaque numbers in central olfactory structures. Neurology 1999;53(4):880-82
Zivadinov R, Zorzon M, Monti BL, Pagliaro G, Cazzato G. Olfactory loss in multiple sclerosis. Journal of the Neurological Sciences 1999;168(2):127-30
Zorzon M, Ukmar M, Bragadin LM, et al. Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis: a clinical and MR study. Multiple Sclerosis 2000;6(6):386-90
Fleiner F, Dahlslett SB, Schmidt F, Harms L, Goektas O. Olfactory and gustatory function in patients with multiple sclerosis. Am. J. Rhinol. Allergy 2010;24(5):e93-e97 https://doi.org/10.2500/ajra.2010.24.3506 [doi][published Online First: Epub Date]|.
Goektas O, Schmidt F, Bohner G, et al. Olfactory bulb volume and olfactory function in patients with multiple sclerosis. Rhinology 2011;49(2):221-26 https://doi.org/10.4193/Rhin [doi][published Online First: Epub Date]|.
Lutterotti A, Vedovello M, Reindl M, et al. Olfactory threshold is impaired in early, active multiple sclerosis. Mult. Scler 2011;17(8):964-69 doi: 1352458511399798 [pii];10.1177/1352458511399798 [doi][published Online First: Epub Date]|.
Dahlslett SB, Goektas O, Schmidt F, Harms L, Olze H, Fleiner F. Psychophysiological and electrophysiological testing of olfactory and gustatory function in patients with multiple sclerosis. Eur. Arch. Otorhinolaryngol 2012;269(4):1163-69 https://doi.org/10.1007/s00405-011-1812-7 [doi][published Online First: Epub Date]|.
Erb K, Bohner G, Harms L, et al. Olfactory function in patients with multiple sclerosis: a diffusion tensor imaging study. J. Neurol. Sci 2012;316(1-2):56-60 doi: S0022-510X(12)00055-X [pii];10.1016/j.jns.2012.01.031 [doi][published Online First: Epub Date]|.
Silva AM, Santos E, Moreira I, et al. Olfactory dysfunction in multiple sclerosis: association with secondary progression. Mult. Scler 2012;18(5):616-21 doi: 1352458511427156 [pii];10.1177/1352458511427156 [doi][published Online First: Epub Date]|.
Rolet A, Magnin E, Millot JL, et al. Olfactory dysfunction in multiple sclerosis: evidence of a decrease in different aspects of olfactory function. Eur. Neurol 2013;69(3):166-70 doi: 000345482 [pii];10.1159/000345482 [doi][published Online First: Epub Date]|.
Erb-Eigner K, Bohner G, Goektas O, et al. Tract-based spatial statistics of the olfactory brain in patients with multiple sclerosis. J. Neurol. Sci 2014;346(1-2):235-40 doi: S0022-510X(14)00571-1 [pii];10.1016/j.jns.2014.08.039 [doi][published Online First: Epub Date]|.
Holinski F, Schmidt F, Dahlslett SB, Harms L, Bohner G, Olze H. MRI study: objective olfactory function and CNS pathologies in patients with multiple sclerosis. Eur. Neurol 2014;72(3-4):157-62 doi: 000362165 [pii];10.1159/000362165 [doi][published Online First: Epub Date]|.
Batur Caglayan HZ, Irkec C, Nazliel B, Akyol GA, Capraz I. Olfactory functioning in early multiple sclerosis: Sniffin’ Sticks Test study. Neuropsychiatr. Dis. Treat 2016;12:2143-47 https://doi.org/10.2147/NDT.S116195 [doi];ndt-12-2143 [pii][published Online First: Epub Date]|.
Jordy SS, Starzewski AJ, Macedo FA, Manica GR, Tilbery CP, Carabetta EG. Olfactory alterations in patients with multiple sclerosis. Arq. Neuropsiquiatr 2016;74(9):697-700 doi: S0004-282 × 2016000900697 [pii];10.1590/0004-282 × 20160128 [doi][published Online First: Epub Date]|.
Kandemir S, Muluk NB, Melikoglu B, Dag E, Inal M, Sarin O. Smell functions in patients with multiple sclerosis: a prospective case-control study. B. -ENT 2016;12(4):323-31
Li LM, Yang LN, Zhang LJ, et al. Olfactory dysfunction in patients with multiple sclerosis. J Neurol. Sci 2016;365:34-39 doi: S0022-510X(16)30177-0 [pii];10.1016/j.jns.2016.03.045 [doi][published Online First: Epub Date]|.
Good KP, Tourbier IA, Moberg P, et al. Unilateral olfactory sensitivity in multiple sclerosis. Physiol. Behav 2017;168:24-30 doi: S0031-9384(16)30952-0 [pii];10.1016/j.physbeh.2016.10.017 [doi][published Online First: Epub Date]|.
Uecker FC, Olze H, Kunte H, et al. Longitudinal Testing of Olfactory and Gustatory Function in Patients with Multiple Sclerosis. PloS. One 2017;12(1):e0170492 https://doi.org/10.1371/journal.pone.0170492 [doi];PONE-D-16-29737 [pii][published Online First: Epub Date]|.
Atalar AC, Erdal Y, Tekin B, Yildiz M, Akdogan O, Emre U. Olfactory dysfunction in multiple sclerosis. Mult. Scler. Relat Disord 2018;21:92-96 doi: S2211-0348(18)30084-1 [pii];10.1016/j.msard.2018.02.032 [doi][published Online First: Epub Date]|.
Li LM, Guo HY, Zhao N, et al. Comparison of olfactory function between neuromyelitis optica and multiple sclerosis. Int. J Neurosci 2018;128(8):772-77 https://doi.org/10.1080/00207454.2018.1424152 [doi][published Online First: Epub Date]|.
Bsteh G, Hegen H, Ladstatter F, et al. Change of olfactory function as a marker of inflammatory activity and disability progression in MS. Mult Scler 2019;25(2):267-74 https://doi.org/10.1177/1352458517745724[published Online First: Epub Date]|.
Carotenuto A, Costabile T, Moccia M, et al. Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosis. Mult. Scler. Relat Disord 2019;27:1-6 doi: S2211-0348(18)30336-5 [pii];10.1016/j.msard.2018.09.024 [doi][published Online First: Epub Date]|.
Bsteh G, Berek K, Hegen H, et al. Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegeneration. Mult Scler 2020;26(1):57-68 https://doi.org/10.1177/1352458518814113[published Online First: Epub Date]|.
Bsteh G, Steiger R, Tuovinen N, et al. Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MS. Mult Scler 2020;26(6):706-15 https://doi.org/10.1177/1352458519838205[published Online First: Epub Date]|.
da Silva AM, Torres C, Ferreira I, et al. Prognostic value of odor identification impairment in multiple sclerosis: 10-Years follow-up. Mult Scler Relat Disord 2020;46:102486 https://doi.org/10.1016/j.msard.2020.102486[published Online First: Epub Date]|.
Goverover Y, Chen MH, Costa SL, Chiaravalloti ND, DeLuca J. Smell as a clinical-marker for functional limitations in multiple sclerosis: A pilot study. Mult Scler Relat Disord 2020;46:102508 https://doi.org/10.1016/j.msard.2020.102508[published Online First: Epub Date]|.
Okada K, Kakeda S, Tahara M. Olfactory identification associates with cognitive function and the third ventricle width in patients with relapsing-remitting multiple sclerosis. Mult Scler Relat Disord 2020;38:101507 https://doi.org/10.1016/j.msard.2019.101507[published Online First: Epub Date]|.
OuYang Q, Wang Y, Zhang YW, Yu M, Wang X. Change in Functional Brain Activation Patterns Induced by Olfactory Stimulation in Multiple Sclerosis. Neuropsychiatr Dis Treat 2020;16:1451-58 https://doi.org/10.2147/NDT.S252933[published Online First: Epub Date]|.
Almasi M, Sahraian MA, Haji Akhoundi F, Ezzati HR, Rohani M. The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis. Basic Clin Neurosci 2021;12(1):89-94 doi: 10.32598/bcn.12.1.1368.1[published Online First: Epub Date]|.
Ansari KA, Johnson A. Olfactory function in patients with Parkinson's disease. J. Chronic. Dis 1975;28(9):493-97
Ward Cd, Hess WA, Calne DB. Olfactory impairment in Parkinson's disease. Neurology 1983;33:943-46
Serby M, Corwin J, Conrad P, Rotrosen J. Olfactory dysfunction in Alzheimer's disease and Parkinson's disease. Amer J Psychiat 1985;142:781-82
Quinn NP, Rossor MN, Marsden CD. Olfactory threshold in Parkinson's disease. J Neurol Neurosurg Psychiat 1987;50:88-89
Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988;38(8):1237-44
Doty RL, Riklan M, Deems DA, Reynolds C, Stellar S. The olfactory and cognitive deficits of Parkinson's disease: evidence for independence. Ann Neurol 1989;25(2):166-71
Bostantjopoulou S, Katsarou Z, Mentenopoulos G, Logothetis J. Olfactory disturbances in patients with Parkinson's disease. Neurol. Psychiatr. (Bucur.) 1991;12:13-15
Murofushi T, Mizuno M, Osanai R, Hayashida T. Olfactory dysfunction in Parkinson's disease. ORL 1991;Journal of Oto-Rhino-Laryngology & its Related Specialties;1991;53(3):143-46
Zucco GM, Zaglis D, Wambsganss CS. Olfactory deficits in elderly subjects and Parkinson patients. Perceptual & Motor Skills 1991;73(3 Pt 1):895-98
Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiat 1992;55(2):138-42
Doty RL, Singh A, Tetrud J, Langston JW. Lack of Major Olfactory Dysfunction in MPTP-Induced Parkinsonism. Annals of Neurology 1992;32(1):97-100
Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM, Crawford D. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology 1993;43(5):962-65
Hawkes CH, Shephard BC. Selective anosmia in Parkinson's disease?. Lancet 1993;341(8842):435-36
Stern MB, Doty RL, Dotti M, et al. Olfactory function in Parkinson's disease subtypes. Neurology 1994;44(2):266-68
Doty RL, Bromley SM, Stern MB. Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. Neurodegeneration 1995;4(1):93-97
Lehrner J, Brucke T, Kryspin-Exner I, Asenbaum S, Podreka I. Impaired olfactory function in Parkinson's disease. Lancet 1995;345(8956):1054-55
Wenning GK. “Olfactory function in atypical parkinsonian syndromes”: Erratum. Acta Neurologica Scandinavica 1996;92(5)
Barz S, Hummel T, Pauli E, Majer M, Lang CJ, Kobal G. Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson's disease. Neurology 1997;49(5):1424-31
Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry 1997;62(5):436-46
Daum RF, Sekinger B, Kobal G, Lang CJ. Riechprufung mit “sniffin’ sticks” zur klinischen Diagnostik des Morbus Parkinson. Nervenarzt 2000;71(8):643-50
Montgomery EB, Jr., Koller WC, LaMantia TJ, et al. Early detection of probable idiopathic Parkinson's disease: I. Development of a diagnostic test battery. Mov. Disord 2000;15(3):467-73
Sobel N, Thomason ME, Stappen I, et al. An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A 2001;98(7):4154-59 https://doi.org/10.1073/pnas.071061598 [doi];071061598 [pii][published Online First: Epub Date]|.
Tissingh G, Berendse HW, Bergmans P, et al. Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Movement Disorders 2001;16:41-46
Zucco G, Zeni MT, Perrone A, Piccolo I. Olfactory sensitivity in early-stage Parkinson patients affected by more marked unilateral disorder. Perceptual & Motor Skills 2001;2001 Jun;92(3 Pt 1):894-98
Muller A, Reichmann H, Livermore A, Hummel T. Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients. Journal of Neural Transmission 2002;109(5-6):805-11
Double KL, Rowe DB, Hayes M, et al. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Archives of Neurology 2003;60(4):545-49
Hudry J, Thobois S, Broussolle E, Adeleine P, Royet JP. Evidence for deficiencies in perceptual and semantic olfactory processes in Parkinson's disease. Chemical Senses 2003;28(6):537-43
Katzenschlager R, Zijlmans J, Evans A, Watt H, Lees AJ. Olfactory function distinguishes vascular parkinsonism from Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry 2004;75(12):1749-52
Khan NL, Katzenschlager R, Watt H, et al. Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease. Neurology 2004;62(7):1224-26
Hummel T, Jahnke U, Sommer U, Reichmann H, Muller A. Olfactory function in patients with idiopathic Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleus. Journal of Neural Transmission 2005;112(5):669-76
Ondo WG, Lai D. Olfaction testing in patients with tremor-dominant Parkinson's disease: is this a distinct condition? Movement Disorders 2005;20(4):471-75
Marras C, Goldman S, Smith A, et al. Smell identification ability in twin pairs discordant for Parkinson's disease. Movement Disorders 2005;20(6):687-93
Siderowf A, Newberg A, Chou KL, et al. [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology 2005;64(10):1716-20 doi: 64/10/1716 [pii];10.1212/01.WNL.0000161874.52302.5D [doi][published Online First: Epub Date]|.
Lee PH, Yeo SH, Kim HJ, Youm HY. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy. Movement Disorders 2006;21(11):1975-77
Ross GW, Abbott RD, Petrovitch H, et al. Association of olfactory dysfunction with incidental Lewy bodies. Movement Disorders 2006;21(12):2062-67
Bohnen NI, Gedela S, Kuwabara H, et al. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease. Journal of Neurology 2007;254(1):84-90
Ferreira JJ, Guedes LC, Rosa MM, et al. High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal. Mov Disord 2007;22(8):1194-201
Kim JY, Lee WY, Chung EJ, Dhong HJ. Analysis of olfactory function and the depth of olfactory sulcus in patients with Parkinson's disease. Movement Disorders 2007;22(11):1563-66
Lee PH, Yeo SH, Yong SW, Kim YJ. Odour identification test and its relation to cardiac I-123-metaiodobenzylguanidine in patients with drug induced parkinsonism. Journal of Neurology Neurosurgery and Psychiatry 2007;78(11):1250-52
Quagliato LB, Viana MA, Quagliato EMAB, Simis S. Olfactory dysfunction in Parkinson's disease. Arquivos de Neuro-Psiquiatria 2007;65(3A):647-52
Boesveldt S, Verbaan D, Knol DL, et al. A comparative study of odor identification and odor discrimination deficits in Parkinson's disease. Mov Disord 2008;23(14):1984-90
Goldstein DS, Holmes C, Bentho O, et al. Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. Parkinsonism. Relat Disord 2008;14(8):600-07
Guo X, Gao G, Wang X, et al. Effects of bilateral deep brain stimulation of the subthalamic nucleus on olfactory function in Parkinson's disease patients. Stereotact. Funct. Neurosurg 2008;86(4):237-44
Herting B, Schulze S, Reichmann H, Haehner A, Hummel T. A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease. Journal of Neurology 2008;255(3):367-70
Iijima M, Kobayakawa T, Saito S, et al. Smell identification in Japanese Parkinson's disease patients: using the odor stick identification test for Japanese subjects. Intern. Med 2008;47(21):1887-92
Lotsch J, Reichmann H, Hummel T. Different odor tests contribute differently to the evaluation of olfactory loss. Chemical Senses 2008;33(1):17-21
Louis ED, Marder K, Tabert MH, Devanand DP. Mild parkinsonian signs are associated with lower olfactory test scores in the community-dwelling elderly. Movement Disorders 2008;23(4):524-30
Ross GW, Petrovitch H, Abbott RD, et al. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008;63(2):167-73 https://doi.org/10.1002/ana.21291[published Online First: Epub Date]|.
Shah M, Muhammed N, Findley LJ, Hawkes CH. Olfactory tests in the diagnosis of essential tremor. Parkinsonism. Relat Disord 2008;14(7):563-68 doi: S1353-8020(08)00028-X [pii];10.1016/j.parkreldis.2007.12.006 [doi][published Online First: Epub Date]|.
Silveira-Moriyama L, Guedes LC, Kingsbury A, et al. Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology 2008;71(13):1021-26
Verbaan D, Boesveldt S, van Rooden SM, et al. Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics? Neurology 2008;71(23):1877-82
Wilson RS, Arnold SE, Buchman AS, Tang Y, Bennett DA. Odor identification and progression of parkinsonian signs in older persons. Exp. Aging Res 2008;34(3):173-87 doi: 793974424 [pii];10.1080/03610730802070001 [doi][published Online First: Epub Date]|.
Boesveldt S, de Muinck Keizer RJ, Wolters EC, Berendse HW. Odor recognition memory is not independently impaired in Parkinson's disease. J. Neural Transm 2009;116(5):575-78
Boesveldt S, de Muinck Keizer RJ, Knol DL, Wolters EC, Berendse HW. Extended testing across, not within, tasks raises diagnostic accuracy of smell testing in Parkinson's disease. Mov Disord 2009;24(1):85-90
Chou KL, Bohnen NI. Performance on an Alzheimer-selective odor identification test in patients with Parkinson's disease and its relationship with cerebral dopamine transporter activity. Parkinsonism. Relat Disord 2009;15(9):640-43 doi: S1353-8020(09)00066-2 [pii];10.1016/j.parkreldis.2009.03.004 [doi][published Online First: Epub Date]|.
Ferraris A, Ialongo T, Passali GC, et al. Olfactory dysfunction in Parkinsonism caused by PINK1 mutations. Mov Disord 2009;24(16):2350-57 https://doi.org/10.1002/mds.22816 [doi][published Online First: Epub Date]|.
Haehner A, Boesveldt S, Berendse HW, et al. Prevalence of smell loss in Parkinson's disease-a multicenter study. Parkinsonism. Relat Disord 2009;15(7):490-94
Landis BN, Cao VH, Guinand N, et al. Retronasal olfactory function in Parkinson's disease. Laryngoscope 2009;119(11):2280-83 https://doi.org/10.1002/lary.20547 [doi][published Online First: Epub Date]|.
Miyamoto T, Miyamoto M, Iwanami M, Suzuki K, Inoue Y, Hirata K. Odor identification test as an indicator of idiopathic REM sleep behavior disorder. Mov Disord 2009;24(2):268-73 https://doi.org/10.1002/mds.22361 [doi][published Online First: Epub Date]|.
Postuma RB, Gagnon JF, Vendette M, Montplaisir JY. Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease. Brain 2009;132(Pt 12):3298-307
Shah M, Deeb J, Fernando M, et al. Abnormality of taste and smell in Parkinson's disease. Parkinsonism Relat Disord 2009;15(3):232-7 https://doi.org/10.1016/j.parkreldis.2008.05.008[published Online First: Epub Date]|.
Silveira-Moriyama L, Mathias C, Mason L, Best C, Quinn NP, Lees AJ. Hyposmia in pure autonomic failure. Neurology 2009;72(19):1677-81
Wattendorf E, Welge-Lussen A, Fiedler K, et al. Olfactory impairment predicts brain atrophy in Parkinson's disease. J. Neurosci 2009;29(49):15410-13
Bohnen NI, Muller ML, Kotagal V, et al. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain 2010;133(Pt 6):1747-54 doi: awq079 [pii];10.1093/brain/awq079 [doi][published Online First: Epub Date]|.
Bovi T, Antonini A, Ottaviani S, et al. The status of olfactory function and the striatal dopaminergic system in drug-induced parkinsonism. J Neurol 2010;257(11):1882-89 https://doi.org/10.1007/s00415-010-5631-3 [doi][published Online First: Epub Date]|.
Cramer CK, Friedman JH, Amick MM. Olfaction and apathy in Parkinson's disease. Parkinsonism. Relat Disord 2010;16(2):124-26
Deeb J, Shah M, Muhammed N, et al. A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson's disease. Quarterly Journal of Medicine 2010;103(12):941-52 doi: hcq142 [pii];10.1093/qjmed/hcq142 [doi][published Online First: Epub Date]|.
Hummel T, Fliessbach K, Abele M, et al. Olfactory FMRI in patients with Parkinson's disease. Front Integr. Neurosci 2010;4:125. https://doi.org/10.3389/fnint.2010.00125 https://doi.org/10.3389/fnint.2010.00125 [doi][published Online First: Epub Date]|.
Kertelge L, Bruggemann N, Schmidt A, et al. Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson's disease. Mov Disord 2010;25(15):2665-69 https://doi.org/10.1002/mds.23272 [doi][published Online First: Epub Date]|.
McKinnon J, Evidente V, Driver-Dunckley E, et al. Olfaction in the elderly: a cross-sectional analysis comparing Parkinson's disease with controls and other disorders. Int. J Neurosci 2010;120(1):36-39 https://doi.org/10.3109/00207450903428954 [doi][published Online First: Epub Date]|.
Meusel T, Westermann B, Fuhr P, Hummel T, Welge-Lussen A. The course of olfactory deficits in patients with Parkinson's disease-a study based on psychophysical and electrophysiological measures. Neurosci Lett 2010;486(3):166-70 doi: S0304-3940(10)01261-9 [pii];10.1016/j.neulet.2010.09.044 [doi][published Online First: Epub Date]|.
Oka H, Toyoda C, Yogo M, Mochio S. Olfactory dysfunction and cardiovascular dysautonomia in Parkinson's disease. J Neurol 2010;257(6):969-76 https://doi.org/10.1007/s00415-009-5447-1 [doi][published Online First: Epub Date]|.
Ramjit AL, Sedig L, Leibner J, et al. The relationship between anosmia, constipation, and orthostasis and Parkinson's disease duration: results of a pilot study. Int. J. Neurosci 2010;120(1):67-70
Santin R, Fonseca VF, Bleil CB, Rieder CR, Hilbig A. Olfactory function and Parkinson's disease in Southern Brazil. Arq Neuropsiquiatr 2010;68(2):252-57 doi: S0004-282 × 2010000200019 [pii][published Online First: Epub Date]|.
Sedig L, Leibner J, Ramjit AL, et al. Is rhinorrhea an under-recognized intrinsic symptom of Parkinson disease? A prospective pilot study. Int. J. Neurosci 2010;120(4):258-60
Silveira-Moriyama L, Hughes G, Church A, et al. Hyposmia in progressive supranuclear palsy. Mov Disord 2010;25(5):570-77 https://doi.org/10.1002/mds.22688 [doi][published Online First: Epub Date]|.
Silveira-Moriyama L, Munhoz RP, de JC, et al. Olfactory heterogeneity in LRRK2 related Parkinsonism. Mov Disord 2010;25(16):2879-83 https://doi.org/10.1002/mds.23325 [doi][published Online First: Epub Date]|.
Aden E, Carlsson M, Poortvliet E, et al. Dietary intake and olfactory function in patients with newly diagnosed Parkinson's disease: a case-control study. Nutr. Neurosci 2011;14(1):25-31 https://doi.org/10.1179/174313211 × 12966635733312 [doi][published Online First: Epub Date]|.
Alcalay RN, Siderowf A, Ottman R, et al. Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology 2011;76(4):319-26 doi: WNL.0b013e31820882aa [pii];10.1212/WNL.0b013e31820882aa [doi][published Online First: Epub Date]|.
Berendse HW, Roos DS, Raijmakers P, Doty RL. Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease. J. Neurol. Sci 2011;310(1-2):21-24 doi: S0022-510X(11)00332-7 [pii];10.1016/j.jns.2011.06.020 [doi][published Online First: Epub Date]|.
Damholdt MF, Borghammer P, Larsen L, Ostergaard K. Odor identification deficits identify Parkinson's disease patients with poor cognitive performance. Mov Disord 2011;26(11):2045-50 https://doi.org/10.1002/mds.23782 [doi][published Online First: Epub Date]|.
Iijima M, Kobayakawa T, Saito S, et al. Differences in odor identification among clinical subtypes of Parkinson's disease. Eur. J. Neurol 2010 doi: ENE3167 [pii];10.1111/j.1468-1331.2010.03167.x [doi][published Online First: Epub Date]|.
Kim HJ, Jeon BS, Lee JY, Cho YJ, Hong KS, Cho JY. Taste function in patients with Parkinson disease. J Neurol 2011;258(6):1076-79 https://doi.org/10.1007/s00415-010-5884-x [doi][published Online First: Epub Date]|.
Moessnang C, Frank G, Bogdahn U, Winkler J, Greenlee MW, Klucken J. Altered activation patterns within the olfactory network in Parkinson's disease. Cereb. Cortex 2011;21(6):1246-53 doi: bhq202 [pii];10.1093/cercor/bhq202 [doi][published Online First: Epub Date]|.
Rodriguez-Violante M, Lees AJ, Cervantes-Arriaga A, Corona T, Silveira-Moriyama L. Use of smell test identification in Parkinson's disease in Mexico: a matched case-control study. Mov Disord 2011;26(1):173-76 https://doi.org/10.1002/mds.23354 [doi][published Online First: Epub Date]|.
Rolheiser TM, Fulton HG, Good KP, et al. Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease. J Neurol 2011;258(7):1254-60 https://doi.org/10.1007/s00415-011-5915-2 [doi][published Online First: Epub Date]|.
Ruiz-Martinez J, Gorostidi A, Goyenechea E, et al. Olfactory deficits and cardiac (123) I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations. Mov Disord 2011 https://doi.org/10.1002/mds.23773 [doi][published Online First: Epub Date]|.
Saunders-Pullman R, Stanley K, Wang C, et al. Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology 2011;77(4):319-24 doi: WNL.0b013e318227041c [pii];10.1212/WNL.0b013e318227041c [doi][published Online First: Epub Date]|.
Suzuki M, Hashimoto M, Yoshioka M, Murakami M, Kawasaki K, Urashima M. The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy. BMC. Neurol 2011;11(1):157 doi: 1471-2377-11-157 [pii];10.1186/1471-2377-11-157 [doi][published Online First: Epub Date]|.
Valldeoriola F, Gaig C, Muxi A, et al. (123)I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations. J Neurol 2011;258(6):1126-32 https://doi.org/10.1007/s00415-010-5896-6 [doi][published Online First: Epub Date]|.
Wang J, You H, Liu JF, Ni DF, Zhang ZX, Guan J. Association of olfactory bulb volume and olfactory sulcus depth with olfactory function in patients with Parkinson disease. AJNR Am J Neuroradiol 2011;32(4):677-81 doi: ajnr.A2350 [pii];10.3174/ajnr.A2350 [doi][published Online First: Epub Date]|.
Wu X, Yu C, Fan F, et al. Correlation between progressive changes in piriform cortex and olfactory performance in early Parkinson's disease. Eur. Neurol 2011;66(2):98-105 doi: 000329371 [pii];10.1159/000329371 [doi][published Online First: Epub Date]|.
Yoritaka A, Shimo Y, Shimo Y, Inoue Y, Yoshino H, Hattori N. Nonmotor Symptoms in Patients with PARK2 Mutations. Parkinsons. Dis 2011;2011:473640 https://doi.org/10.4061/2011/473640 [doi][published Online First: Epub Date]|.
Zhang K, Yu C, Zhang Y, et al. Voxel-based analysis of diffusion tensor indices in the brain in patients with Parkinson's disease. Eur. J. Radiol 2011;77(2):269-73 doi: S0720-048X(09)00468-9 [pii];10.1016/j.ejrad.2009.07.032 [doi][published Online First: Epub Date]|.
Baba T, Kikuchi A, Hirayama K, et al. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study. Brain 2012;135(Pt 1):161-69 doi: awr321 [pii];10.1093/brain/awr321 [doi][published Online First: Epub Date]|.
Busse K, Heilmann R, Kleinschmidt S, et al. Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2012;83(4):441-47 doi: jnnp-2011-301719 [pii];10.1136/jnnp-2011-301719 [doi][published Online First: Epub Date]|.
Chen W, Chen S, Kang WY, et al. Application of odor identification test in Parkinson's disease in China: a matched case-control study. J. Neurol. Sci 2012;316(1-2):47-50 doi: S0022-510X(12)00057-3 [pii];10.1016/j.jns.2012.01.033 [doi][published Online First: Epub Date]|.
Kang P, Kloke J, Jain S. Olfactory dysfunction and parasympathetic dysautonomia in Parkinson's disease. Clin Auton. Res 2012 https://doi.org/10.1007/s10286-012-0158-6 [doi][published Online First: Epub Date]|.
Kang SH, Lee HM, Seo WK, Kim JH, Koh SB. The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease. J Neurol Sci 2016;368:374-8 https://doi.org/10.1016/j.jns.2016.07.057[published Online First: Epub Date]|.
Maremmani C, Rossi G, Tambasco N, et al. The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson's disease patients. Parkinsonism. Relat Disord 2012;18(6):788-93 doi: S1353-8020(12)00125-3 [pii];10.1016/j.parkreldis.2012.03.021 [doi][published Online First: Epub Date]|.
Parrao T, Chana P, Venegas P, Behrens MI, Aylwin ML. Olfactory Deficits and Cognitive Dysfunction in Parkinson's Disease. Neurodegener. Dis 2012;10:179-82
Rahayel S, Frasnelli J, Joubert S. The effect of Alzheimer's disease and Parkinson's disease on olfaction: a meta-analysis. Behav. Brain Res 2012;231(1):60-74 doi: S0166-4328(12)00176-3 [pii];10.1016/j.bbr.2012.02.047 [doi][published Online First: Epub Date]|.
Siderowf A, Jennings D, Eberly S, et al. Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome study. Mov Disord 2012;27(3):406-12
Casjens S, Eckert A, Woitalla D, et al. Diagnostic value of the impairment of olfaction in Parkinson's disease. Plos One 2013;8(5):e64735 https://doi.org/10.1371/journal.pone.0064735 [doi];PONE-D-13-03933 [pii][published Online First: Epub Date]|.
Hakyemez HA, Veyseller B, Ozer F, et al. Relationship of olfactory function with olfactory bulbus volume, disease duration and Unified Parkinson's disease rating scale scores in patients with early stage of idiopathic Parkinson's disease. J. Clin. Neurosci 2013;20(10):1469-70 doi: S0967-5868(13)00109-4 [pii];10.1016/j.jocn.2012.11.017 [doi][published Online First: Epub Date]|.
Sierra M, Sanchez-Juan P, Martinez-Rodriguez MI, et al. Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease. Neurology 2013;80(7):621-26 doi: WNL.0b013e31828250d6 [pii];10.1212/WNL.0b013e31828250d6 [doi][published Online First: Epub Date]|.
Antsov E, Silveira-Moriyama L, Kilk S, et al. Adapting the Sniffin’ Sticks olfactory test to diagnose Parkinson's disease in Estonia. Parkinsonism. Relat Disord 2014;20(8):830-33 doi: S1353-8020(14)00153-9 [pii];10.1016/j.parkreldis.2014.04.012 [doi][published Online First: Epub Date]|.
Cecchini MP, Osculati F, Ottaviani S, Boschi F, Fasano A, Tinazzi M. Taste performance in Parkinson's disease. J. Neural Transm 2014;121(2):119-22 https://doi.org/10.1007/s00702-013-1089-7 [doi][published Online First: Epub Date]|.
Driver-Dunckley E, Adler CH, Hentz JG, et al. Olfactory dysfunction in incidental Lewy body disease and Parkinson's disease. Parkinsonism. Relat Disord 2014;20(11):1260-62 doi: S1353-8020(14)00304-6 [pii];10.1016/j.parkreldis.2014.08.006 [doi][published Online First: Epub Date]|.
Gaig C, Vilas D, Infante J, et al. Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson's Disease. PloS. One 2014;9(10):e108982 https://doi.org/10.1371/journal.pone.0108982 [doi];PONE-D-14-12783 [pii][published Online First: Epub Date]|.
Picillo M, Pellecchia MT, Erro R, et al. The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. Neurol. Sci 2014;35(3):379-83 https://doi.org/10.1007/s10072-013-1522-6 [doi][published Online First: Epub Date]|.
Johansen KK, Waro BJ, Aasly JO. Olfactory dysfunction in sporadic Parkinson's Disease and LRRK2 carriers. Acta Neurol Scand 2014;129(5):300-6 https://doi.org/10.1111/ane.12172[published Online First: Epub Date]|.
Rodriguez-Violante M, Gonzalez-Latapi P, Camacho-Ordonez A, Martinez-Ramirez D, Morales-Briceno H, Cervantes-Arriaga A. Comparing the accuracy of different smell identification tests in Parkinson's disease: relevance of cultural aspects. Clin Neurol Neurosurg 2014;123:9-14 https://doi.org/10.1016/j.clineuro.2014.04.030[published Online First: Epub Date]|.
Navarro-Otano J, Gaig C, Muxi A, et al. (123)I-MIBG cardiac uptake, smell identification and (123)I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease. Parkinsonism Relat Disord 2014;20(2):192-97 doi: S1353-8020(13)00388-X [pii];10.1016/j.parkreldis.2013.10.025 [doi][published Online First: Epub Date]|.
Wolz M, Hähner A, Meixner L, et al. Accurate detection of Parkinson's disease in tremor syndromes using olfactory testing. Eur Neurol 2014;72(1-2):1-6 https://doi.org/10.1159/000358054[published Online First: Epub Date]|.
Guducu C, Taslica S, Cakmur R, Ozgoren M, Ikiz AO, Oniz A. Assessing Olfactory Function in Parkinson's Disease via Entropy Analysis of Chemosensory Event Related Potentials. Tohoku J Exp Med 2015;237(2):111-6 https://doi.org/10.1620/tjem.237.111[published Online First: Epub Date]|.
Mahlknecht P, Iranzo A, Hogl B, et al. Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD. Neurology 2015;84(7):654-58 doi: WNL.0000000000001265 [pii];10.1212/WNL.0000000000001265 [doi][published Online First: Epub Date]|.
Lopez Hernandez N, Garcia Escriva A, Shalabi Benavent M. Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson's disease. Neurologia 2015;30(8):496-501 https://doi.org/10.1016/j.nrl.2014.03.010[published Online First: Epub Date]|.
Paschen L, Schmidt N, Wolff S, et al. The olfactory bulb volume in patients with idiopathic Parkinson's disease. Eur J Neurol 2015;22(7):1068-73 https://doi.org/10.1111/ene.12709[published Online First: Epub Date]|.
Rossi M, Perez-Lloret S, Millar VP, et al. Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease. Mov. Disord 2015;30(9):1275-79 https://doi.org/10.1002/mds.26276 [doi][published Online First: Epub Date]|.
Shill HA, Hentz JG, Caviness JN, et al. Unawareness of Hyposmia in Elderly People With and Without Parkinson's Disease. Mov Disord Clin Pract 2016;3(1):43-47 https://doi.org/10.1002/mdc3.12220[published Online First: Epub Date]|.
Evans AH, Chai CH. Evaluation of Nonmotor Symptoms in Diagnosis of Parkinsonism and Tremor. Parkinsons. Dis 2016;2016:9182946 https://doi.org/10.1155/2016/9182946 [doi][published Online First: Epub Date]|.
Fullard ME, Tran B, Xie SX, et al. Olfactory impairment predicts cognitive decline in early Parkinson's disease. Parkinsonism. Relat Disord 2016;25:45-51 https://doi.org/10.1016/j.parkreldis.2016.02.013 [doi];S1353-8020(16)30041-4 [pii][published Online First: Epub Date]|.
Huang SF, Chen K, Wu JJ, et al. Odor Identification Test in Idiopathic REM-Behavior Disorder and Parkinson's Disease in China. PloS One 2016;11(8):e0160199 https://doi.org/10.1371/journal.pone.0160199[published Online First: Epub Date]|.
Mahlknecht P, Pechlaner R, Boesveldt S, et al. Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease. Mov Disord 2016;31(9):1408-13 https://doi.org/10.1002/mds.26637[published Online First: Epub Date]|.
Swallow DM, Lawton MA, Grosset KA, et al. Variation in Recent Onset Parkinson's Disease: Implications for Prodromal Detection. J Parkinsons. Dis 2016;6(2):289-300 doi: JPD150741 [pii];10.3233/JPD-150741 [doi][published Online First: Epub Date]|.
Barber TR, Lawton M, Rolinski M, et al. Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder. Sleep 2017;40(8) https://doi.org/10.1093/sleep/zsymptom071[published Online First: Epub Date]|.
Cozac VV, Auschra B, Chaturvedi M, et al. Among Early Appearing Non-Motor Signs of Parkinson's Disease, Alteration of Olfaction but Not Electroencephalographic Spectrum Correlates with Motor Function. Front Neurol 2017;8:545 https://doi.org/10.3389/fneur.2017.00545 [doi][published Online First: Epub Date]|.
Iannilli E, Stephan L, Hummel T, Reichmann H, Haehner A. Olfactory impairment in Parkinson's disease is a consequence of central nervous system decline. J. Neurol 2017;264(6):1236-46 https://doi.org/10.1007/s00415-017-8521-0 [doi];10.1007/s00415-017-8521-0 [pii][published Online First: Epub Date]|.
Krismer F, Pinter B, Mueller C, et al. Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism. Parkinsonism Relat Disord 2017;35:36-41 https://doi.org/10.1016/j.parkreldis.2016.11.010[published Online First: Epub Date]|.
Passali GC, Bove F, Vargiu L, et al. New olfactometric findings in Parkinson's disease. Clin. Otolaryngol 2017;42(4):837-43 https://doi.org/10.1111/coa.12816 [doi][published Online First: Epub Date]|.
Terroba Chambi C, Rossi M, Bril A, et al. Diagnostic Value of Combined Acute Levodopa Challenge and Olfactory Testing to Predict Parkinson's Disease. Mov Disord Clin Pract 2017;4(6):824-28 https://doi.org/10.1002/mdc3.12517[published Online First: Epub Date]|.
Wang Y, Wu JJ, Liu FT, et al. Olfaction in Parkin carriers in Chinese patients with Parkinson disease. Brain Behav 2017;7(5):e00680 https://doi.org/10.1002/brb3.680[published Online First: Epub Date]|.
Camargo CHF, Jobbins VA, Serpa RA, Berbetz FA, Sabatini JS, Teive HAG. Association between olfactory loss and cognitive deficits in Parkinson's disease. Clin. Neurol. Neurosurg 2018;173:120-23 doi: S0303-8467(18)30335-4 [pii];10.1016/j.clineuro.2018.08.018 [doi][published Online First: Epub Date]|.
Dolatshahi M, Pourmirbabaei S, Kamalian A, Ashraf-Ganjouei A, Yaseri M, Aarabi MH. Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease. Front Neurol 2018;9:560 https://doi.org/10.3389/fneur.2018.00560[published Online First: Epub Date]|.
Lee HR, Park JH, Han SW, Baik JS. Cognition, Olfaction and Uric Acid in Early de novo Parkinson's Disease. J Mov. Disord 2018;11(3):139-44 doi: jmd.18037 [pii];10.14802/jmd.18037 [doi][published Online First: Epub Date]|.
Li DK, Liu FT, Chen K, et al. Depressive Symptoms Are Associated With Color Vision but not Olfactory Function in Patients With Parkinson's Disease. J Neuropsychiatry Clin Neurosci 2018;30(2):122-29 https://doi.org/10.1176/appi.neurospych.17030063[published Online First: Epub Date]|.
Masala C, Solla P, Liscia A, et al. Correlation among olfactory function, motors’ symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease. J Neurol 2018;265(8):1764-71 https://doi.org/10.1007/s00415-018-8913-9 [doi];10.1007/s00415-018-8913-9 [pii][published Online First: Epub Date]|.
Park JW, Kwon DY, Choi JH, Park MH, Yoon HK. Olfactory dysfunctions inI-I Parkinson's disease with mild cognitive impairment. Parkinsonism Relat Disord 2018;46:69-73 https://doi.org/10.1016/j.parkreldis.2017.11.334[published Online First: Epub Date]|.
Roos DS, Oranje OJM, Freriksen AFD, Berendse HW, Boesveldt S. Flavor perception and the risk of malnutrition in patients with Parkinson's disease. J Neural. Transm. (Vienna.) 2018;125(6):925-30 https://doi.org/10.1007/s00702-018-1862-8 [doi];10.1007/s00702-018-1862-8 [pii][published Online First: Epub Date]|.
Cecchini MP, Federico A, Zanini A, et al. Olfaction and taste in Parkinson's disease: the association with mild cognitive impairment and the single cognitive domain dysfunction. J Neural. Transm. (Vienna.) 2019 https://doi.org/10.1007/s00702-019-01996-z [doi];10.1007/s00702-019-01996-z [pii][published Online First: Epub Date]|.
Leonhardt B, Tahmasebi R, Jagsch R, Pirker W, Lehrner J. Awareness of olfactory dysfunction in Parkinson's disease. Neuropsychology 2019 doi: 2019-18122-001 [pii];10.1037/neu0000544 [doi][published Online First: Epub Date]|.
Lin YQ, Cui SS, Du JJ, et al. N1 and P1 Components Associate With Visuospatial-Executive and Language Functions in Normosmic Parkinson's Disease: An Event-Related Potential Study. Front Aging Neurosci 2019;11:18 https://doi.org/10.3389/fnagi.2019.00018[published Online First: Epub Date]|.
Melis M, Sollai G, Masala C, et al. Odor identification performance in Idiopathic Parkinson's disease is associated with gender and the genetic variability of the olfactory binding-protein (OBPIIa). Chem. Senses 2019 doi: 5427164 [pii];10.1093/chemse/bjz020 [doi][published Online First: Epub Date]|.
Pekel NB, Yildiz D, Taymur I, et al. Associations Between Olfactory Impairment and Cognitive Functions in Patients with Parkinson Disease. Noro Psikiyatr Ars 2020;57(3):216-21 doi: 10.29399/npa.23070[published Online First: Epub Date]|.
Pinkhardt EH, Liu H, Ma D, et al. Olfactory screening of Parkinson's Disease patients and healthy subjects in China and Germany: A study of cross-cultural adaptation of the Sn'ffin' Sticks 12-identification test. PLoS One 2019;14(11):e0224331 https://doi.org/10.1371/journal.pone.0224331[published Online First: Epub Date]|.
Saatci O, Yilmaz NH, Zirh A, Yulug B. The therapeutic effect of deep brain stimulation on olfactory functions and clinical scores in Parkinson's disease. J Clin. Neurosci 2019;68:55-61 doi: S0967-5868(19)30800-8 [pii];10.1016/j.jocn.2019.07.055 [doi][published Online First: Epub Date]|.
Sanjari MH, Dolatshahi M, Salardini E, Aarabi MH. Association of olfaction dysfunction with brain microstructure in prodromal Parkinson disease. Neurol. Sci 2019;40(2):283-91 https://doi.org/10.1007/s10072-018-3629-2 [doi];10.1007/s10072-018-3629-2 [pii][published Online First: Epub Date]|.
Sobhani S, Rahmani F, Aarabi MH, Sadr AV. Exploring white matter microstructure and olfaction dysfunction in early parkinson disease: diffusion MRI reveals new insight. Brain Imaging Behav 2019;13(1):210-19 https://doi.org/10.1007/s11682-017-9781-0 [doi];10.1007/s11682-017-9781-0 [pii][published Online First: Epub Date]|.
Sui X, Zhou C, Li J, Chen L, Yang X, Li F. Hyposmia as a Predictive Marker of Parkinson's Disease: A Systematic Review and Meta-Analysis. Biomed Res Int 2019;2019:3753786 https://doi.org/10.1155/2019/3753786[published Online First: Epub Date]|.
Wang XY, Han YY, Li G, Zhang B. Association between autonomic dysfunction and olfactory dysfunction in Parkinson's disease in southern Chinese. BMC Neurol 2019;19(1):17 https://doi.org/10.1186/s12883-019-1243-4[published Online First: Epub Date]|.
Guo P, Wang RD, Lian TH, et al. Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease. Front Aging Neurosci 2020;12:594324 https://doi.org/10.3389/fnagi.2020.594324[published Online First: Epub Date]|.
He R, Zhao Y, He Y, et al. Olfactory Dysfunction Predicts Disease Progression in Parkinson's Disease: A Longitudinal Study. Front Neurosci 2020;14:569777 https://doi.org/10.3389/fnins.2020.569777[published Online First: Epub Date]|.
Lohle M, Wolz M, Beuthien-Baumann B, et al. Olfactory dysfunction correlates with putaminal dopamine turnover in early de novo Parkinson's disease. J Neural Transm (Vienna) 2020;127(1):9-16 https://doi.org/10.1007/s00702-019-02122-9[published Online First: Epub Date]|.
Schmidt N, Paschen L, Witt K. Invalid Self-Assessment of Olfactory Functioning in Parkinson's Disease Patients May Mislead the Neurologist. Parkinsons Dis 2020;2020:7548394 https://doi.org/10.1155/2020/7548394[published Online First: Epub Date]|.
Solla P, Masala C, Liscia A, et al. Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson's disease. J Neurol 2020;267(1):57-63 https://doi.org/10.1007/s00415-019-09551-2[published Online First: Epub Date]|.
Yoo HS, Chung SJ, Lee YH, Ye BS, Sohn YH, Lee PH. Association between Olfactory Deficit and Motor and Cognitive Function in Parkinson's Disease. J Mov Disord 2020;13(2):133-41 doi: 10.14802/jmd.19082[published Online First: Epub Date]|.
Zhao Y, He Y, He R, et al. The Discriminative Power of Different Olfactory Domains in Parkinson's Disease. Front Neurol 2020;11:420 https://doi.org/10.3389/fneur.2020.00420[published Online First: Epub Date]|.
Silva MM, Viveiros CP, Kotsifas NJ, et al. Olfactory impairment in frontotemporal dementia: A systematic review and meta-analysis. Dement Neuropsychol. 2019;13:154-161.
Doty RL. Olfactory dysfunction in neurodegenerative diseases: Is there a common pathological substrate? Lancet Neurol. 2017;16:478-488.
Martzke JS, Kopala LC, Good KP. Olfactory dysfunction in neuropsychiatric disorders: Review and methodological considerations. Biol Psychiatry. 1997;42:721-732.
Schecklmann M, Schwenck C, Taurines R, et al. A systematic review on olfaction in child and adolescent psychiatric disorders. J Neural Transm. 2013;120:121-130.
Turetsky BI, Crutchley P, Walker J, Gur RE, Moberg PJ. Depth of the olfactory sulcus: A marker of early embryonic disruption in schizophrenia? Schizophr Res. 2009;115:8-11.
Turetsky BI, Moberg PJ, Arnold SE, Doty RL, Gur RE. Low olfactory bulb volume in first-degree relatives of patients with schizophrenia. Am J Psychiatry. 2003;160:703-708.
Moberg PJ, Kamath V, Marchetto DM, et al. Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis. Schizophr Bull. 2013;40:50-59.
Irani F, Seligman S, Kamath V, Kohler C, Gur RC. A meta-analysis of emotion perception and functional outcomes in schizophrenia. Schizophr Res. 2012;137:203-211.
Kamath V, Moberg PJ, Kohler CG, Gur RE, Turetsky BI. Odor hedonic capacity and anhedonia in schizophrenia and unaffected first-degree relatives of schizophrenia patients. Schizophr Bull. 2011;39:59-67.
Turetsky BI, Hahn C-G, Borgmann-Winter K, Moberg PJ. Scents and nonsense: Olfactory dysfunction in schizophrenia. Schizophr Bull. 2009;35:1117-1131.
Turetsky BI, Moberg PJ. An odor-specific threshold deficit implicates abnormal intracellular cyclic AMP signaling in schizophrenia. Am J Psychiatry. 2009;166:226-233.
Turetsky BI, Kohler CG, Gur RE, Moberg PJ. Olfactory physiological impairment in first-degree relatives of schizophrenia patients. Schizophr Res. 2008;102:220-229.
Roalf DR, Turetsky BI, Owzar K, et al. Unirhinal olfactory function in schizophrenia patients and first-degree relatives. J Neuropsychiatry Clin Neurosci. 2006;18:389-396.
Moberg PJ, Arnold SE, Doty RL, Kohler C, Kanes S, Seigel S, Gur RE, Turetsky BI. Impairment of odor hedonics in men with schizophrenia. Am J Psychiatry. 2003;160:1784-1789.
Turetsky BI, Moberg PJ, Roalf DR, Arnold SE, Gur RE. Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia. Arch Gen Psychiatry. 2003;60:1193-1200.
Gur RE, Turetsky BI, Cowell PE, et al. Temporolimbic volume reductions in schizophrenia. Arch Gen Psychiatry. 2000;57:769-775.
Kamath V, Turetsky BI, Calkins ME, et al. Olfactory processing in schizophrenia, non-ill first-degree family members, and young people at-risk for psychosis. World J Biol Psychiatry. 2014;15:209-218.
Turetsky BI, Moberg PJ, Quarmley M, et al. Structural anomalies of the peripheral olfactory system in psychosis high-risk subjects. Schizophr Res. 2018;195:197-205.
Roalf DR, Quarmley M, Calkins ME, et al. Temporal Lobe Volume Decrements in Psychosis Spectrum Youths. Schizophr Bull. 2017;43:601-610.
Kamath V, Moberg PJ, Gur RE, Doty RL, Turetsky BI. Effects of the val (158) met catechol-o-methyltransferase gene polymorphism on olfactory processing in schizophrenia. Behav Neurosci. 2012;126:209.
Kazour F, Richa S, Desmidt T, Lemaire M, Atanasova B, El Hage W. Olfactory and gustatory functions in bipolar disorders: A systematic review. Neurosci Biobehav Rev. 2017;80:69-79.
Islam MA, Fagundo AB, Arcelus J, et al. Olfaction in eating disorders and abnormal eating behavior: a systematic review. Front Psychol. 2015;6:1431.
Croy I, Hummel T. Olfaction as a marker for depression. J Neurol. 2017;264:631-638.
Kohli P, Soler ZM, Nguyen SA, Muus JS, Schlosser RJ. The association between olfaction and depression: a systematic review. Chem Senses. 2016;41:479-486.
Burón E, Bulbena A. Olfaction in affective and anxiety disorders: A review of the literature. Psychopathology. 2013;46:63-74.
Larsson M, Tirado C, Wiens S. A meta-analysis of odor thresholds and odor identification in autism spectrum disorders. Front Psychol. 2017;8:679.
Tonacci A, Billeci L, Tartarisco G, et al. Olfaction in autism spectrum disorders: A systematic review. Child Neuropsychol. 2017;23:1-25.
Moberg PJ, Agrin R, Gur RE, Gur RC, Turetsky BI, Doty RL. Olfactory dysfunction in schizophrenia: a qualitative and quantitative review. Neuropsychopharmacology. 1999;21:325-340.
Nguyen AD, Shenton ME, Levitt JJ. Olfactory dysfunction in schizophrenia: a review of neuroanatomy and psychophysiological measurements. Harv Rev Psychiatry. 2010;18:279-292.
Moberg PJ, Kamath V, Marchetto DM, et al. Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis. Schizophr Bull. 2014;40:50-59.
Crow AJ, Janssen JM, Vickers KL, Parish-Morris J, Moberg PJ, Roalf DR. Olfactory dysfunction in neurodevelopmental disorders: A meta-analytic review of autism spectrum disorders, attention deficit/hyperactivity disorder and obsessive-compulsive disorder. J Autism Dev Disord. 2020;50:2685-2697.
Khurshid K, Crow AJ, Rupert PE, et al. A quantitative meta-analysis of olfactory dysfunction in epilepsy. Neuropsychol Rev. 2019;29:328-337.
Hwang BY, Mampre D, Penn R, Anderson WS, Kang J, Kamath V. Olfactory testing in temporal lobe epilepsy: A systematic review. Curr Neurol Neurosci Rep. 2020;20:65.
Chen C, Shih YH, Yen DJ, et al. Olfactory auras in patients with temporal lobe epilepsy. Epilepsia. 2003;44(2):257-260’.
O'Brien TJ, Kilpatrick C, Murrie V, Vogrin S, Morris K, Cook MJ. Temporal lobe epilepsy caused by mesial temporal sclerosis and temporal neocortical lesions. A clinical and electroencephalographic study of 46 pathologically proven cases. Brain. 1996;119 (Pt 6):2133-2141.
Anderson AK, Christoff K, Stappen I, et al. Dissociated neural representations of intensity and valence in human olfaction. Nature neuroscience. 2003;6(2):196-202.
Sarnat HB, Flores-Sarnat L. Might the olfactory bulb be an origin of olfactory auras in focal epilepsy? Epileptic disorders: international epilepsy journal with videotape. 2016;18(4):344-355.
Haehner A, Henkel S, Hopp P, et al. Olfactory function in patients with and without temporal lobe resection. Epilepsy Behav. 2012;25(4):477-480.
Eskenazi B, Cain WS, Novelly RA, Mattson R. Odor perception in temporal lobe epilepsy patients with and without temporal lobectomy. Neuropsychologia. 1986;24(4):553-562.
Stankewitz A, May A. Increased limbic and brainstem activity during migraine attacks following olfactory stimulation. Neurology. 2011;77(5):476-482.
Demarquay G, Royet JP, Mick G, Ryvlin P. Olfactory hypersensitivity in migraineurs: a H(2)(15)O-PET study. Cephalalgia. 2008;28(10):1069-1080.
Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 2004;113(10):1447-1455.
Liu HY, Chou KH, Lee PL, et al. Hippocampus and amygdala volume in relation to migraine frequency and prognosis. Cephalalgia. 2017;37(14):1329-1336.
Schaefer ML, Böttger B, Silver WL, Finger TE. Trigeminal collaterals in the nasal epithelium and olfactory bulb: a potential route for direct modulation of olfactory information by trigeminal stimuli. J Comp Neurol. 2002;444(3):221-226.
Doğan A, Bayar Muluk N, Şahan MH, Asal N, Inal M, Ergün U. Olfactory bulbus volume and olfactory sulcus depth in migraine patients: an MRI evaluation. European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2018;275(8):2005-2011.
Marmura MJ, Monteith TS, Anjum W, Doty RL, Hegarty SE, Keith SW. Olfactory function in migraine both during and between attacks. Cephalalgia. 2014.
Saisu A, Tatsumoto M, Hoshiyama E, Aiba S, Hirata K. Evaluation of olfaction in patients with migraine using an odour stick identification test. Cephalalgia. 2011;31(9):1023-1028.
Hirsch AR. Olfaction in migraine. Cephalalgia. 1998;18:360-360.
(IHS) HCCotIHS. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):627-808.
Kelman L. The aura: a tertiary care study of 952 migraine patients. Cephalalgia. 2004;24(9):728-734.
De Carlo D, Toldo I, Dal Zotto L, et al. Osmophobia as an early marker of migraine: a follow-up study in juvenile patients. Cephalalgia. 2012;32(5):401-406.
Zanchin G, Dainese F, Trucco M, Mainardi F, Mampreso E, Maggioni F. Osmophobia in migraine and tension-type headache and its clinical features in patients with migraine. Cephalalgia. 2007;27(9):1061-1068.
Raiele V, Pandolfi E, La Vecchia M. The prevalence of allodynia, osmophobia, and red ear syndrome in the juvenile headache: preliminary data. J Headache Pain. 2005;6:271-271.
Terrin A, Mainardi F, Lisotto C, et al. A prospective study on osmophobia in migraine versus tension-type headache in a large series of attacks. Cephalalgia. 2020;40:337-346.
Kelman L. Osmophobia and taste abnormality in migraineurs: a tertiary care study. Headache. 2004;44:1019-1023.
Corletto E, Dal ZL, Resos A, et al. Osmophobia in juvenile primary headaches. Cephalalgia. 2008;28(8):825-831.
Demarquay G, Royet JP, Giraud P, Chazot G, Valade D, Ryvlin P. Rating of olfactory judgements in migraine patients. Cephalalgia. 2006;26(9):1123-1130.
Chakravarty A. How triggers trigger acute migraine attacks: a hypothesis. Medical hypotheses. 2010;74(4):750-753.
Sasannejad P, Saeedi M, Shoeibi A, Gorji A, Abbasi M, Foroughipour M. Lavender essential oil in the treatment of migraine headache: a placebo-controlled clinical trial. Eur Neurol. 2012;67(5):288-291.
Niazi M, Hashempur MH, Taghizadeh M, Heydari M, Shariat A. Efficacy of topical Rose (Rosa damascena Mill.) oil for migraine headache: A randomized double-blinded placebo-controlled cross-over trial. Complementary therapies in medicine. 2017;34:35-41.
Taga A, Russo M, Manzoni GC, Torelli P. Cluster Headache With Accompanying Migraine-Like Features: A Possible Clinical Phenotype. Headache. 2017;57(2):290-297.
Whiting AC, Marmura MJ, Hegarty SE, Keith SW. Olfactory acuity in chronic migraine: a cross-sectional study. Headache. 2015;55(1):71-75.
Aktürk T, Tanık N, Serin Hİ, Saçmacı H, İnan LE. Olfactory bulb atrophy in migraine patients. Neurol Sci. 2019;40:127-132.
Coleman ER, Grosberg BM, Robbins MS. Olfactory hallucinations in primary headache disorders: case series and literature review. Cephalalgia. 2011;31(14):1477-1489.
Bellamio M, Mainardi F, Toldo G, Zanchin G, Maggioni F. P051. Olfactory migrainous hallucinations: a typical aura manifestation? J Headache Pain. 2015;16(Suppl 1):A80.
Karstensen HG, Tommerup N. Isolated and syndromic forms of congenital anosmia. Clin Genet. 2012;81:210-215.
Nordin S, Brämerson A. Complaints of olfactory disorders: Epidemiology, assessment and clinical implications. Curr Opin Allergy Clin Immunol. 2008;8:10-15.
Schriever VA, Hummel T. Etiologies of olfactory dysfunction in a pediatric population: based on a retrospective analysis of data from an outpatient clinic. Eur Arch Otorhinolaryngol. 2020;277:3213-3216.
Croy I, Negoias S, Novakova L, Landis BN, Hummel T. Learning about the functions of the olfactory system from people without a sense of smell. PLoS One. 2012;7: e33365.
Harris R, Davidson TM, Murphy C, Gilbert PE, Chen M. Clinical evaluation and symptoms of chemosensory impairment: One thousand consecutive cases from the Nasal Dysfunction Clinic in San Diego. Am J Rhinol. 2006;20:101-108.
Keller A, Zhuang H, Chi Q, Vosshall LB, Matsunami H. Genetic variation in a human odorant receptor alters odour perception. Nature. 2007;449:468-472.
Fonteyn S, Huart C, Deggouj N, Collet S, Eloy P, Rombaux P. Non-sinonasal-related olfactory dysfunction: A cohort of 496 patients. Eur Ann Otorhinolaryngol Head Neck Dis. 2014;131:87-91.
Yousem DM, Geckle RJ, Bilker WB, Doty RL. Olfactory bulb and tract and temporal lobe volumes: Normative data across decades. Ann New York Acad Sci. 1998;855:546-555.
Abolmaali ND, Hietschold V, Vogl TJ, Hüttenbrink KB, Hummel T. MR evaluation in patients with isolated anosmia since birth or early childhood. Am J Neuroradiol. 2002;-3:157-163.
Louis DN, Arriagada P V., Hyman BT, Hedley-Whyte ET. Olfactory dysgenesis or hypoplasia: A variant in the arhinencephaly spectrum? Neurology. 1992;42:179-182.
Karstensen HG, Vestergaard M, Baaré WF, et al. Congenital olfactory impairment is linked to cortical changes in prefrontal and limbic brain regions. Brain Imaging Behav. 2018;12:1569-1582.
Peter MG, Mårtensson G, Postma EM, et al. Morphological changes in secondary, but not primary, sensory cortex in individuals with life-long olfactory sensory deprivation. Neuroimage. 2020;218: 117005.
Leopold DA, Hornung DE, Schwob JE. Congenital lack of olfactory ability. Ann Otol Rhinol Laryngol. 1992;101:229-236.
Feldmesser E, Bercovich D, Avidan N, et al. Mutations in olfactory signal transduction genes are not a major cause of human congenital general anosmia. Chem Senses. 2007;32:21-30.
Karstensen HG, Mang Y, Fark T, Hummel T, Tommerup N. The first mutation in CNGA2 in two brothers with anosmia. Clin Genet. 2015;88:293-296.
Alkelai A, Olender T, Haffner-Krausz R, et al. A role for TENM1 mutations in congenital general anosmia. Clin Genet. 2016;90:211-219.
Sailani MR, Jingga I, Mirmazlomi SH, et al. Isolated congenital anosmia and CNGA2 mutation. Sci Rep. 2017;7:2667.
Bianco SD, Kaiser UB. The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev Endocrinol. 2009;5:569-576.
Sanlaville D, Etchevers HC, Gonzales M, et al. Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J Med Genet. 2006;43:211-217.
Weiss J, Pyrski M, Jacobi E, et al. Loss-of-function mutations in sodium channel Na v 1.7 cause anosmia. Nature. 2011;472:186-192.
McEwen DP, Koenekoop RK, Khanna H, et al. Hypomorphic CEP290/NPHP6 mutations result in anosmia caused by the selective loss of G proteins in cilia of olfactory sensory neurons. Proc Natl Acad Sci U S A. 2007;104:15917-15922.
Kulaga HM, Leitch CC, Eichers ER, et al. Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse. Nat Genet. 2004;36:994-998.
Dahmer-Heath M, Schriever V, Kollmann S, et al. Systematic evaluation of olfaction in patients with hereditary cystic kidney diseases/renal ciliopathies. J Med Genet. 2020; jmedgenet-2020-107192.
Hauser LJ, Jensen EL, Mirsky DM, Chan KH. Pediatric anosmia: A case series. Int J Pediatr Otorhinolaryngol. 2018;110:135-139.
Powell J, Zammit-Maempel I, Carrie S. Congenital anosmia: our experience of eleven patients with aplasia or hypoplasia of the olfactory tract. Clin Otolaryngol. 2017;42:1038-1040.
Aiba T, Inoue Y, Matsumoto K, Shakudo M, Hashimoto K, Yamane H. Magnetic resonance imaging for diagnosis of congenital anosmia. Acta Otolaryngol Suppl. 2004;554:50-54.
Qu Q, Liu J, Ni D, et al. Diagnosis and clinical characteristics of congenital anosmia: Case series report. J Otolaryngol Head Neck Surg. 2010;39:723-731.
Cui L, Evans WJ. Olfactory event-related potentials to amyl acetate in congenital anosmia. Electroencephalogr Clin Neurophysiol. 1997;102(4):303-306.
Kim DH, Kim SW, Hwang SH, et al. Prognosis of Olfactory Dysfunction according to Etiology and Timing of Treatment. Otolaryngol Head Neck Surg. 2017;156(2):371-377.
Henkin RI, Abdelmeguid M, Knöppel AB. Initiation of smell function in patients with congenital hyposmia. Am J Otolaryngol. 2016;37:175-181.
Shushan S, Yeshurun Y, Arzi A, Roth Y, Sobel N. Olfactory brain responses in congenital anosmia. Chem Senses. 2015;40:291-291.
Mai Y, Zhang X, Li Z, et al. olfaction is a marker of severity but not diagnosis in anorexia nervosa: A systematic review and meta-analysis. Neuropsychol Rev. 2020;30:251-266.
Islam MA, Fagundo AB, Arcelus J, et al. Olfaction in eating disorders and abnormal eating behavior: a systematic review. Front Psychol. 2015;6:1431.
Roessner V, Bleich S, Banaschewski T, Rothenberger A. Olfactory deficits in anorexia nervosa. Eur Arch Psychiatry Clin Neurosci. 2005;255:6-9.
Schreder T, Albrecht J, Kleemann AM, et al. Olfactory performance of patients with anorexia nervosa and healthy subjects in hunger and satiety. Rhinology. 2008;46:175-183.
Kinnaird E, Stewart C, Tchanturia K. The relationship of autistic traits to taste and olfactory processing in anorexia nervosa. Mol Autism. 2020;11:1-10.
Smoliner C, Fischedick A, Sieber CC, Wirth R. Olfactory function and malnutrition in geriatric patients. J Gerontol A Biol Sci Med Sci. 2013;68:1582-1588.
Aschenbrenner K, Scholze N, Joraschky P, Hummel T. Gustatory and olfactory sensitivity in patients with anorexia and bulimia in the course of treatment. J Psychiatr Res. 2008;43:129-137.
Rapps N, Giel KE, Söhngen E, et al. Olfactory deficits in patients with anorexia nervosa. Eur Eat Disord Rev. 2010;18:385-389.
Schecklmann M, Pfannstiel C, Fallgatter AJ, Warnke A, Gerlach M, Romanos M. Olfaction in child and adolescent anorexia nervosa. J Neural Transm. 2012;119:721-728.
Dazzi F, De Nitto S, Zambetti G, Loriedo C, Ciofalo A. Alterations of the olfactory-gustatory functions in patients with eating disorders. Eur Eat Disord Rev. 2013;21:382-385.
Fernández-Aranda F, Agüera Z, Fernández-García JC, et al. Smell-taste dysfunctions in extreme weight/eating conditions: analysis of hormonal and psychological interactions. Endocrine. 2016;51:256-267.
Bentz M, Guldberg J, Vangkilde S, Pedersen T, Plessen KJ, Jepsen JR. Heightened olfactory sensitivity in young females with recent-onset anorexia nervosa and recovered individuals. PLoS One. 2017;12:1-17.
Fernandez-Garcia JC, Alcaide J, Santiago-Fernandez C, et al. An increase in visceral fat is associated with a decrease in the taste and olfactory capacity. PLoS One. 2017;12:1-14.
Tonacci A, Calderoni S, Billeci L, et al. Autistic traits impact on olfactory processing in adolescent girls with Anorexia Nervosa restricting type. Psychiatry Res. 2019;274:20-26.
Fedoroff IC, Stoner SA, Andersen AE, Doty RL, Rolls BJ. Olfactory dysfunction in anorexia and bulimia nervosa. Int J Eat Disord. 1995;18:71-77.
Kopala LC, Good K, Goldner EM, Birmingham CL. Olfactory identification ability in anorexia nervosa. J Psychiatry Neurosci. 1995;20:283-286.
Lombion-Pouthier S, Vandel P, Nezelof S, Haffen E, Millot JL. Odor perception in patients with mood disorders. J Affect Disord. 2006;90:187-191.
Stein D, Gross-Isseroff R, Besserglick R, et al. Olfactory function and alternation learning in eating disorders. Eur Neuropsychopharmacol. 2012;22:615-624.
Peng M, Coutts D, Wang T, Cakmak YO. Systematic review of olfactory shifts related to obesity. Obes Rev. 2019;20:325-338.
Skrandies W, Zschieschang R. Olfactory and gustatory functions and its relation to body weight. Physiol Behav. 2015;142:1-4.
Fernández-Aranda F, Agüera Z, Fernández-García JC, et al. Smell-taste dysfunctions in extreme weight/eating conditions: Analysis of hormonal and psychological interactions. Endocrine. 2016;51:256-267.
Pastor A, Fernández-Aranda F, Fitó M, et al. A lower olfactory capacity is related to higher circulating concentrations of endocannabinoid 2-arachidonoylglycerol and higher body mass index in women. PLoS One. 2016;11: e0148734.
Herz RS, Van Reen E, Gredvig-Ardito CA, Carskadon MA. Insights into smell and taste sensitivity in normal weight and overweight-obese adolescents. Physiol Behav. 2020;221: 112897.
Poessel M, Freiherr J, Wiencke K, Villringer A, Horstmann A. Insulin resistance is associated with reduced food odor sensitivity across a wide range of body weights. Nutrients. 2020;12:2201.
Fernandez-Garcia JC, Alcaide J, Santiago-Fernandez C, et al. An increase in visceral fat is associated with a decrease in the taste and olfactory capacity. PLoS One. 2017;12: e0171204.
Besser G, Erlacher B, Aydinkoc-Tuzcu K, et al. Body-mass-index associated differences in ortho- and retronasal olfactory function and the individual significance of olfaction in health and disease. J Clin Med. 2020;9:366.
Richardson BE, Vander Woude EA, Sudan R, Thompson JS, Leopold DA. Altered olfactory acuity in the morbidly obese. Obes Surg. 2004;14:967-969.
Uygun B, Kiyici S, Ozmen S, Gul Z, Sigirli D, Cavun S. The association between olfaction and taste functions with serum ghrelin and leptin levels in obese women. Metab Syndr Relat Disord. 2019;17:452-457.
Zhang Z, Zhang B, Wang X, et al. Olfactory dysfunction mediates adiposity in cognitive impairment of type 2 diabetes: Insights from clinical and functional neuroimaging studies. Diabetes Care. 2019;42:1274-1283.
Nettore IC, Maione L, Palatucci G, et al. Flavor identification inversely correlates with body mass index (BMI). Nutr Metab Cardiovasc Dis. 2020;30:1299-1305.
Poessel M, Breuer N, Joshi A, et al. Reduced olfactory bulb volume in obesity and its relation to metabolic health status. Front Hum Neurosci. 2020;14: 586998.
Guild AA. Olfactory acuity in normal and obese human subjects: diurnal variations and the effect of d-amphetamine sulphate. J Laryngol Otol. 1956;70:408-414.
Trellakis S, Tagay S, Fischer C, et al. Ghrelin, leptin and adiponectin as possible predictors of the hedonic value of odors. Regul Pept. 2011;167:112-117.
Zijlstra N, Bukman AJ, Mars M, Stafleu A, Ruijschop RMAJ, de Graaf C. Eating behaviour and retro-nasal aroma release in normal-weight and overweight adults: A pilot study. Br J Nutr. 2011;106:297-306.
Simchen U, Koebnick C, Hoyer S, Issanchou S, Zunft HJ. Odour and taste sensitivity is associated with body weight and extent of misreporting of body weight. Eur J Clin Nutr. 2006;60:698-705.
Stafford LD, Whittle A. Obese individuals have higher preference and sensitivity to odor of chocolate. Chem Senses. 2015;40:279-284.
Herz RS, Van Reen E, Gredvig-Ardito CA, Carskadon MA. Insights into smell and taste sensitivity in normal weight and overweight-obese adolescents. Physiol Behav. 2020;221: 112897.
Boesveldt S, Lindau ST, McClintock MK, Hummel T, Lundstrom JN. Gustatory and olfactory dysfunction in older adults: a national probability study. Rhinology. 2011;49:324-330.
Liu B, Luo Z, Pinto JM, et al. Relationship between poor olfaction and mortality among community-dwelling older adults: A cohort study. Ann Intern Med. 2019;170:673-681.
Campolo J, Corradi E, Rizzardi A, et al. Correlates of olfactory impairment in middle-aged non-diabetic Caucasian subjects with stage I-II obesity. Eur Arch Otorhinolaryngology. 2021;278:2047-2054.
Obrebowski A, Obrebowska-Karsznia Z, Gawliński M. Smell and taste in children with simple obesity. Int J Pediatr Otorhinolaryngol. 2000;55:191-196.
Jurowich CF, Seyfried F, Miras AD, et al. Does bariatric surgery change olfactory perception? Results of the early postoperative course. Int J Colorectal Dis. 2014;29:253-260.
Holinski F, Menenakos C, Haber G, Olze H, Ordemann J. Olfactory and gustatory function after bariatric surgery. Obes Surg. 2015;25:2314-2320.
Zerrweck C, Gallardo VC, Calleja C, Sepúlveda E, Guilber L. Gross olfaction before and after laparoscopic gastric bypass. Obes Surg. 2017;27:2988-2992.
Melis M, Pintus S, Mastinu M, et al. Changes of taste, smell and eating behavior in patients undergoing bariatric surgery: Associations with prop phenotypes and polymorphisms in the odorant-binding protein obpiia and cd36 receptor genes. Nutrients. 2021;13:250.
Hancı D, Altun H, Altun H, Batman B, Karip AB, Serin KR. Laparoscopic Sleeve Gastrectomy Improves Olfaction Sensitivity in Morbidly Obese Patients. Obes Surg. 2016;26(3):558-562.
Campolo J, Corradi E, Rizzardi A, et al. Correlates of olfactory impairment in middle-aged non-diabetic Caucasian subjects with stage I-II obesity. Eur Arch Otorhinolaryngol. 2020;278:2047-2054.
Richardson BE, Vander Woude EA, Sudan R, Thompson JS, Leopold DA. Altered olfactory acuity in the morbidly obese. Obes Surg. 2004;14:967-969.
Enck P, Rieber N, Sauer H, et al. Almost nothing - not even bariatric surgery for obesity - changes olfactory sensitivity. J Res Obes. 2014;2014:1-13.
Ajmani GS, Suh HH, Wroblewski KE, Pinto JM. Smoking and olfactory dysfunction: A systematic literature review and meta-analysis. Laryngoscope. 2017;127:1753-1761.
Dinc AS, Sengezer T, Cayonu M, Sahin MM. Smoking cessation improves olfactory functions. Laryngoscope. 2020;130:E35-E38
Ottaviano G, Marioni G, Giacomelli L, et al. Smoking and chronic rhinitis: Effects of nasal irrigations with sulfurous-arsenical-ferruginous thermal water: A prospective, randomized, double-blind study Am J Otolaryngol. 2012;33:657-662.
Danielides V, Katotomichelakis M, Balatsouras D, et al. Improvement of olfaction after endoscopic sinus surgery in smokers and nonsmokers. Ann Otol Rhinol Laryngol. 2009;118:13-20.
Etter JF, Ussher M, Hughes JR. A test of proposed new tobacco withdrawal symptoms. Addiction. 2013;108:50-59.
Siegel JK, Wroblewski KE, McClintock MK, Pinto JM. Olfactory dysfunction persists after smoking cessation and signals increased cardiovascular risk. Int Forum Allergy Rhinol. 2019;9:977-985.
Schubert CR, Cruickshanks KJ, Fischer ME, et al. Carotid intima media thickness, atherosclerosis, and 5-year decline in odor identification: the Beaver Dam Offspring study. J Gerontol A Biol Sci Med Sci. 2015;70:879-884.
Hoffman HJ, Rawal S, Li CM, Duffy VB. New chemosensory component in U.S. National Health and Nutrition Examination Survey (NHANES): First-year results for measured olfactory dysfunction. Rev Endocr Metab Disord. 2016;17:221-240.
Pinto JM, Schumm LP, Wroblewski KE, Kern DW, McClintock MK. Racial disparities in olfactory loss among older adults in the United States. J Gerontol A Biol Sci Med Sci. 2014;69:323-329.
Jalali MM, Habibi AF, Samin MG. Predictors of olfactory impairment among northern Iranian population. Iran J Otorhinolaryngol. 2020;32:271-279.
Fluitman KS, Nadar HJ, Roos DS, et al. The association of olfactory function with BMI, appetite, and prospective weight change in Dutch community-dwelling older adults. J Nutr Health Aging. 2019;23:746-752.
Khil L, Wellmann J, Berger K. Determinants of single and multiple sensory impairments in an urban population. Otolaryngol Head Neck Surg. 2015;153:364-371.
Schubert CR, Cruickshanks KJ, Fischer ME, et al. Olfactory impairment in an adult population: the Beaver Dam Offspring Study. Chem Senses. 2012;37:325-334.
Doty RL, Petersen I, Mensah N, Christensen K. Genetic and environmental influences on odor identification ability in the very old. Psychol Aging. 2011;26:864-871.
Ranft U, Schikowski T, Sugiri D, Krutmann J, Krämer U. Long-term exposure to traffic-related particulate matter impairs cognitive function in the elderly. Environ Res. 2009;109:1004-1011.
Vennemann MM, Hummel T, Berger K. The association between smoking and smell and taste impairment in the general population. J Neurol. 2008;255:1121-1126.
Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Prevalence of olfactory impairment in older adults. JAMA. 2002;288:2307-2312.
Veyseller B, Ozucer B, Karaaltin AB, et al. Connecticut (CCCRC) olfactory test: normative values in 426 healthy volunteers. Indian J Otolaryngol Head Neck Surg. 2014;66:31-34.
Liu HC, Wang SJ, Lin KP, Lin KN, Fuh JL, Teng EL. Performance on a smell screening test (the MODSIT): A study of 510 predominantly illiterate Chinese subjects. Physiol Behav. 1995;58:1251-1255.
Mackay-Sim A, Johnston AN, Owen C, Burne TH. Olfactory ability in the healthy population: Reassessing presbyosmia. Chem Senses. 2006;31:763-771.
Ishimaru T, Fujii M. Effects of smoking on odour identification in Japanese subjects. Rhinology. 2007;45:224-228.
Frye RE, Schwartz BS, Doty RL. Dose-related effects of cigarette smoking on olfactory function. JAMA. 1990;263:1233-1236.
Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: A standardized microencapsulated test of olfactory function. Physiol Behav. 1984;32:489-502.
Delgado-Losada ML, Delgado-Lima AH, Bouhaben J. Spanish validation for olfactory function testing ui'g the Sn'iffin' Sticks Olfactory Test: Threshold, discrimination, and identification. Brain Sci. 2020;10:943.
Nettore IC, Maione L, Desiderio S, et al. Influences of age, sex and smoking habit on flavor recognition in healthy population. Int J Environ Res Public Health. 2020;17:959.
Duffy VB, Glennon SG, Larsen BA, Rawal S, Oncken C, Litt MD. Heightened olfactory dysfunction and oral irritation among chronic smokers and heightened propylthiouracil (PROP) bitterness among menthol smokers. Physiol Behav. 2019;201:111-122.
Katotomichelakis M, Balatsouras D, Tripsianis G, et al. The effect of smoking on the olfactory function. Rhinology. 2007;45:273-280.
Cardesín A, Alobid I, Benítez P, et al. Barcelona Smell-Test - 24 (BAST-24): Validation and smell characteristics in the healthy Spanish population. Rhinology. 2006;44:83-89.
Glennon SG, Huedo-Medina T, Rawal S, Hoffman HJ, Litt MD, Duffy VB. Chronic cigarette smoking associates directly and indirectly with self-reported olfactory alterations: Analy-s of the 2011-2014 National Health and Nutrition Examination Survey. Nicotine Tob Res. 2019;21:818-827.
Rawal S, Hoffman HJ, Bainbridge KE, Huedo-Medina TB, Duffy VB. Prevalence and risk factors of self-reported smell and taste alterations: result-from the 2011-2012 US National Health and Nutrition Examination Survey (NHANES). Chem Senses. 2016;41:69-76.
Lee WH, Hong SN, Kim HJ, et al. Effects of cigarette smoking on rhinologic diseases: Korean National Health and Nutrition Examinat-n Survey 2008-2011. Int Forum Allergy Rhinol. 2015;5:937-943.
Huang Z, Huang S, Cong H, et al. Smell and taste dysfunction is associated with higher serum total cholesterol concentrations in Chinese. Adults J Nutr. 2017;147:1546-1551.
Collins MM, Hawthorne M, el-Hmd K, Gray J. The subjective effects of smoking on nasal symptoms. Clin Otolaryngol Allied Sci. 1999;24:324-327.
Fjaeldstad AW, Ovesen T, Hummel T. The association between smoking on olfactory dysfunction in 3,900 patients with olfactory loss. Laryngoscope. 2021;131:E8-E13.
Erdem K, Ucaroglu ER, Sehitogullari A, et al. Effects of coronary artery bypass grafting surgery on olfactory and taste functions. Heart Surg Forum. 2019;22:E416-E422.
Sharer JD, Leon-Sarmiento FE, Morley JF, Weintraub D, Doty RL. Olfactory dysfunction in Park'inson's disease: Positive effect of cigarette smoking. Mov Disord. 2015;30:859-862.
Siderowf A, Jennings D, Connolly J, Doty RL, Marek K, Stern MB. Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Park'inson's disease. Mov Disord. 2007;22:2249-2255.
Mori E, Matsuwaki Y, Mitsuyama C, Okushi T, Nakajima T, Moriyama H. Risk factors for olfactory dysfunction in chronic rhinosinusitis. Auris Nasus Larynx. 2013;40:465-469.
Litvack JR, Fong K, Mace J, James KE, Smith TL. Predictors of olfactory dysfunction in patients with chronic rhinosinusitis. Laryngoscope. 2008;118:2225-2230.
Sugiyama K, Matsuda T, Kondo H, et al. Postoperative olfaction in chronic sinusitis: Smokers versus nonsmokers. Ann Otol Rhinol Laryngol. 2002;111:1054-1058.
Şanlı A, Bekmez E, Yıldız G, Erdoğan BA, Yılmaz HB, Altın G. Relationship between smoking and otorhinolaryngological symptoms. Kulak Burun Bogaz Ihtis Derg. 2016;26:28-33.
Pepino MY, Mennella JA. Cigarette smoking and obesity are associated with decreased fat perception in women. Obesity (Silver Spring). 2014;22:1050-1055.
Santos KW, Echeveste SS, Vidor DC. Influence of gustatory and olfactory perception in the oral phase of swallowing in smokers. Codas. 2014;26:68-75.
Schriever VA, Reither N, Gerber J, Iannilli E, Hummel T. Olfactory bulb volume in smokers. Exp Brain Res. 2013;225:153-157.
Hayes JE, Jinks AL. Evaluation of smoking on olfactory thresholds of phenyl ethyl alcohol and n-butanol. Physiol Behav. 2012;107:177-180.
Rosenblatt MR, Olmstead RE, Iwamoto-Schaap PN, Jarvik ME. Olfactory thresholds for nicotine and menthol in smokers (abstinent and nonabstinent) and nonsmokers. Physiol Behav. 1998;65:575-579.
Ahlström R, Berglund B, Berglund U, Engen T, Lindvall T. A comparison of odor perception in smokers, nonsmokers, and passive smokers. Am J Otolaryngol. 1987;8:1-6.
Cometto-Muñiz JE, Cain WS. Perception of nasal pungency in smokers and nonsmokers. Physiol Behav. 1982;29:727-731.
Fonteyn S, Huart C, Deggouj N, Collet S, Eloy P, Rombaux P. Non-sinonasal-related OD: A cohort of 496 patients. Eur Ann Otorhinolaryngol Head Neck Dis. 2014;131:87-91.
Hald MO, Fjaeldstad A, Kjaer S, Ovesen T. Characterisation of patients with idiopathic olfactory dysfunction and plan for clinical follow-up. Dan Med J. 2020;67: A06200421.
Hoekman PK, Houlton JJ, Seiden AM. The utility of magnetic resonance imaging in the diagnostic evaluation of idiopathic olfactory loss. Laryngoscope. 2014;124:365-368.
Haehner A, Masala C, Walter S, Reichmann H, Hummel T. Incidence of Parkinson's disease in a large patient cohort with idiopathic smell and taste loss. J Neurol. 2018;266:339-345.
Seubert J, Freiherr J, Frasnelli J, Hummel T, Lundström J. Orbitofrontal cortex and olfactory bulb volume predict distinct aspects of olfactory performance in healthy subjects. Cereb Cortex. 2013;23:2448-2456.
Frasnelli J, Lundström JN, Boyle JA, Djordjevic J, Zatorre RJ, Jones-Gotman M. Neuroanatomical correlates of olfactory performance. Exp Brain Res. 2010;201:1-11.
Bitter T, Gudziol H, Burmeister HP, Mentzel HJ, Guntinas-Lichius O, Gaser C. Anosmia leads to a loss of gray matter in cortical brain areas. Chem Senses. 2010;35:407-415.
Yao L, Pinto JM, Yi X, Li L, Peng P, Wei Y. Gray matter volume reduction of olfactory cortices in patients with idiopathic olfactory loss. Chem Senses. 2014;39:755-760.
Hummel T, Urbig A, Huart C, Duprez T, Rombaux P. Volume of olfactory bulb and depth of olfactory sulcus in 378 consecutive patients with olfactory loss. J Neurol. 2015;262:1046-1051.
Rombaux P, Mouraux A, Bertrand B, Nicolas G, Duprez T, Hummel T. olfactory function and olfactory bulb volume in patients with postinfectious olfactory loss. Laryngoscope. 2006;116:436-439.
Liu J, Pinto JM, Yang L, Yao L, Miao X, Wei Y. Evaluation of idiopathic olfactory loss with chemosensory event-related potentials and magnetic resonance imaging. Int Forum Allergy Rhinol. 2018;8:1315-1322.
Deems DA, Doty RL, Settle RG, et al. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg. 1991;117:519-528.
Temmel AF, Quint C, Schickinger-Fischer B, Klimek L, Stoller E, Hummel T. Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg. 2002;128:635-641.
Landis BN, Konnerth CG, Hummel T. A study on the frequency of olfactory dysfunction. Laryngoscope. 2004;114:1764-1769.
Frasnelli J, Landis BN, Heilmann S, et al. Clinical presentation of qualitative olfactory dysfunction. Eur Arch Otorhinolaryngol. 2004;261:411-415.
Harris R, Davidson TM, Murphy C, Gilbert PE, Chen M. Clinical evaluation and symptoms of chemosensory impairment: one thousand consecutive cases from the Nasal Dysfunction Clinic in San Diego. Am J Rhinol. 2006;20:101-108.
Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54:1-30.
Miwa T, Ikeda K, Ishibashi T, et al. Clinical practice guidelines for the management of olfacto-y dysfunction - secondary publication. Auris Nasus Larynx. 2019;46:653-662.
Seiden AM, Duncan HJ. The diagnosis of a conductive olfactory loss. Laryngoscope. 2001;111:9-14.
Welge-Lussen A, Wille C, Renner B, Kobal G. Anesthesia affects olfaction and chemosensory event-related potentials. Clin Neurophysiol. 2004;115:1384-1391.
Stuck BA, Beule A, Damm M, et al. [Position paper “Chemosensory testing for expert opinion in smell disorders”]. Laryngorhinootologie. 2014;93:327-329.
Whitcroft KL, Hummel T. Clinical Diagnosis and current management strategies for olfactory dysfunction: A review. JAMA Otolaryngol Head Neck Surg. 2019;145:846-853.
Stuck BA, Hummel T. Olfaction in allergic rhinitis: A systematic review. J Allergy Clin Immunol. 2015;136:1460-1470.
Kohli P, Naik AN, Harruff EE, Nguyen SA, Schlosser RJ, Soler ZM. The prevalence of olfactory dysfunction in chronic rhinosinusitis. Laryngoscope. 2017;127:309-320.
Schofield PW, Moore TM, Gardner A. Traumatic brain injury and olfaction: a systematic review. Front Neurol. 2014;5:5.
Bakker K, Catroppa C, Anderson V. Olfactory dysfunction in pediatric traumatic brain injury: a systematic review. J Neurotrauma. 2014;31:308-314.
Bramerson A, Nordin S, Bende M. Clinical experience with patients with olfactory complaints, and their quality of life. Acta Otolaryngol. 2007;127:167-174.
Schriever VA, Gupta N, Pade J, Szewczynska M, Hummel T. Olfactory function following nasal surgery: a 1-year follow-up. Eur Arch Otorhinolaryngol. 2013;270:107-111.
Pade J, Hummel T. Olfactory function following nasal surgery. Laryngoscope. 2008;118:1260-1264.
Ajmani GS, Suh HH, Wroblewski KE, Pinto JM. Smoking and olfactory dysfunction: A systematic literature review and meta-analysis. Laryngoscope. 2017;127:1753-1761.
Brion M, de Timary P, Vander Stappen C, et al. Chemosensory dysfunction in alcohol-related disorders: A joint exploration of olfaction and taste. Chem Senses. 2015;40:605-608.
Silva MM, Mercer PB, Witt MC, Pessoa RR. Olfactory dysfunction in Alzheimer's disease Systematic review and meta-analysis. Dement Neuropsychol. 2018;12:123-132.
Kohli P, Soler ZM, Nguyen SA, Muus JS, Schlosser RJ. The association between olfaction and depression: A systematic review. Chem Senses. 2016;41:479-486.
Carnemolla SE, Hsieh JW, Sipione R, et al. Olfactory dysfunction in frontotemporal dementia and psychiatric disorders: A systematic review. Neurosci Biobehav Rev. 2020;118:588-611.
Choi JS, Hur K, Chow M, Shen J, Wrobel B. Olfactory dysfunction and cognition among older adults in the United States. Int Forum Allergy Rhinol. 2018;8:648-654.
Doty RL, Perl DP, Steele JC, et al. Olfactory dysfunction in three neurodegenerative diseases. Geriatrics. 1991;46 suppl 1: 47-51.
Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol. 1998;55:84-90.
Fullard ME, Morley JF, Duda JE. Olfactory dysfunction as an early biomarker in Parkinson's disease. Neurosci Bull. 2017;33:515-525.
Zou YM, Lu D, Liu LP, Zhang HH, Zhou YY. Olfactory dysfunction in Alzheimer's disease. Neuropsychiatr Dis Treat. 2016;12:869-875.
Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters E, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol. 2004;56:173-181.
Kohli P, Schlosser RJ, Storck K, Soler ZM. Olfactory cleft computed tomography analysis and olfaction in chronic rhinosinusitis. Am J Rhinol Allergy. 2016;30:402-406.
Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg. 1997;117(3 pt 2): S35-40.
Soler ZM, Hyer JM, Karnezis TT, Schlosser RJ. The Olfactory Cleft Endoscopy Scale correlates with olfactory metrics in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol. 2016;6:293-298.
Armstrong JE, Laing DG, Wilkes FJ, Laing ON. Olfactory function in Australian aboriginal children and chronic otitis media. Chem Senses. 2008;33:503-507.
Coelho DH, Costanzo RM. Posttraumatic olfactory dysfunction. Auris Nasus Larynx. 2016;43:137-143.
Yildirim D, Altundag A, Tekcan Sanli DE, et al. A new perspective on imaging of olfactory dysfunction: Does size matter? Eur J Radiol. 2020;132: 109290.
Kandemirli SG, Altundag A, Yildirim D, Tekcan Sanli DE, Saatci O. Olfactory bulb MRI and paranasal sinus CT findings in persistent COVID-19 anosmia. Acad Radiol. 2021;28:28-35.
Biacabe B, Faulcon P, Amanou L, Bonfils P. Olfactory cleft disease: an analysis of 13 cases. Otolaryngol Head Neck Surg. 2004;130:202-208.
Mueller C, Temmel AF, Toth J, Quint C, Herneth A, Hummel T. Computed tomography scans in the evaluation of patients with olfactory dysfunction. Am J Rhinol. 2006;20:109-112.
Fokkens W, Lund VJ, Hopkins C, et al. European position paper on rhinosinustis and nasal polyps 2020. Rhinology. 2020;58(suppl S29): 1-164.
Liu J, Pinto JM, Yang L, Yao L, Miao X, Wei Y. Evaluation of idiopathic olfactory loss with chemosensory event-related potentials and magnetic resonance imaging. Int Forum Allergy Rhinol. 2018;8:1315-1322.
Yao L, Yi X, Pinto JM, et al. Olfactory cortex and olfactory bulb volume alterations in patients with post-infectious olfactory loss. Brain Imaging Behav. 2018;12:1355-1362.
Lötsch J, Reither N, Bogdanov V, et al. A brain-lesion pattern based algorithm for the diagnosis of posttraumatic olfactory loss. Rhinology. 2015;53:365-370.
Ottaviano G’ Cantone’ E, D'Errico A, ’t al. Sn'iffin' Sticks and olfactory system imaging in patients with Kallmann syndrome. Int Forum Allergy Rhinol. 2015;5:855-861.
Huart C, Meusel T, Gerber J, Duprez T, Rombaux P, Hummel T. The depth of the olfactory sulcus is an indicator of congenital anosmia. AJNR Am J Neuroradiol. 2011;32:1911-1914.
Rombaux P, Potier H, Markessis E, Duprez T, Hummel T. Olfactory bulb volume and depth of olfactory sulcus in patients with idiopathic olfactory loss. Eur Arch Otorhinolaryngol. 2010;267:1551-1556.
Atighechi S, Salari H, Baradarantar MH, Jafari R, Karimi G, Mirjali M. A comparative study of brain perfusion single-photon emission computed tomography and magnetic resonance imaging in patients with post-traumatic anosmia. Am J Rhinol Allergy. 2009;23:409-412.
Goektas O, Fleiner F, Sedlmaier B, Bauknecht C. Correlation of olfactory dysfunction of different etiologies in MRI and comparison with subjective and objective olfactometry. Eur J Radiol. 2009;71:469-473.
Haehner A, Rodewald A, Gerber JC, Hummel T. Correlation of olfactory function with changes in the volume of the human olfactory bulb. Arch Otolaryngol Head Neck Surg. 2008;134:621-624.
Mueller A, Rodewald A, Reden J, Gerber J, von Kummer R, Hummel T. Reduced olfactory bulb volume in post-traumatic and post-infectious olfactory dysfunction. Neuroreport. 2005;16:475-478.
Abolmaali ND, Hietschold V, Vogl TJ, Huttenbrink KB, Hummel T. MR evaluation in patients with isolated anosmia since birth or early childhood. AJNR Am J Neuroradiol. 2002;23:157-164.
AbdelBari Mattar M, El Adle H. Prognostic factors for olfactory dysfunction in adult mild head trauma. World Neurosurg. 2020;141:e545-e52.
Langdon C, Lehrer E, Berenguer J, et al. Olfactory training in post-traumatic smell impairment: mild improvement in threshold performances: Results from a randomized controlled trial. J Neurotrauma. 2018;35:2641-2652.
Chung MS, Choi WR, Jeong HY, Lee JH, Kim JH. MR imaging-based evaluations of olfactory bulb atrophy in patients with olfactory dysfunction. AJNR Am J Neuroradiol. 2018;39:532-537.
Shiga H, Taki J, Okuda K, et al. Prognostic value of olfactory nerve damage measured with thallium-based olfactory imaging in patients with idiopathic olfactory dysfunction. Sci Rep. 2017;7:3581.
Lötsch J, Ultsch A, Eckhardt M, Huart C, Rombaux P, Hummel T. Brain lesion-pattern analysis in patients with olfactory dysfunctions following head trauma. Neuroimage Clin. 2016;11:99-105.
Miao X, Yang L, Gu H, et al. Evaluation of post-traumatic anosmia with MRI and chemosensory ERPs. Eur Arch Otorhinolaryngol. 2015;272:1945-1953.
Hummel T, Urbig A, Huart C, Duprez T, Rombaux P. Volume of olfactory bulb and depth of olfactory sulcus in 378 consecutive patients with olfactory loss. J Neurol. 2015;262:1046-1051.
Hoekman PK, Houlton JJ, Seiden AM. The utility of magnetic resonance imaging in the diagnostic evaluation of idiopathic olfactory loss. Laryngoscope. 2014;124:365-368.
Levy LM, Degnan AJ, Sethi I, Henkin RI. Anatomic olfactory structural abnormalities in congenital smell loss: magnetic resonance imaging evaluation of olfactory bulb, groove, sulcal, and hippocampal morphology. J Comput Assist Tomogr. 2013;37:650-657.
Atighechi S, Zolfaghari A, Baradaranfar M, Dadgarnia M. Estimation of sensitivity and specificity of brain magnetic resonance imaging and single photon emission computed tomography in the diagnosis of olfactory dysfunction after head traumas. Am J Rhinol Allergy. 2013;27:403-406.
Rombaux P, Huart C, Deggouj N, Duprez T, Hummel T. Prognostic value of olfactory bulb volume measurement for recovery in postinfectious and posttraumatic olfactory loss. Otolaryngol Head Neck Surg. 2012;147:1136-1141.
Rombaux P, Martinage S, Huart C, Collet S. Post-infectious olfactory loss: a cohort study and update. B-ENT. 2009; 5 suppl 13: 89-95.
Rombaux P, Mouraux A, Bertrand B, Nicolas G, Duprez T, Hummel T. Retronasal and orthonasal olfactory function in relation to olfactory bulb volume in patients with posttraumatic loss of smell. Laryngoscope. 2006;116:901-905.
Rombaux P, Mouraux A, Bertrand B, Nicolas G, Duprez T, Hummel T. Olfactory function and olfactory bulb volume in patients with postinfectious olfactory loss. Laryngoscope. 2006;116:436-439.
Aiba T, Inoue Y, Matsumoto K, Shakudo M, Hashimoto K, Yamane H. Magnetic resonance imaging for diagnosis of congenital anosmia. Acta Otolaryngol Suppl. 2004:(554): 50-54.
Yousem DM, Geckle RJ, Bilker WB, Kroger H, Doty RL. Posttraumatic smell loss: relationship of psychophysical tests and volumes of the olfactory bulbs and tracts and the temporal lobes. Acad Radiol. 1999;6:264-272.
Doty RL, Yousem DM, Pham LT, Kreshak AA, Geckle R, Lee WW. Olfactory dysfunction in patients with head trauma. Arch Neurol. 1997;54:1131-1140.
Yousem DM, Geckle RJ, Bilker WB, McKeown DA, Doty RL. Posttraumatic olfactory dysfunction: MR and clinical evaluation. AJNR Am J Neuroradiol. 1996;17:1171-1179.
Yousem DM, Geckle RJ, Bilker W, McKeown DA, Doty RL. MR evaluation of patients with congenital hyposmia or anosmia. AJR Am J Roentgenol. 1996;166:439-443.
Moon WJ, Park M, Hwang M, Kim JK. Functional MRI as an objective measure of olfaction deficit in patients with traumatic anosmia. AJNR Am J Neuroradiol. 2018;39:2320-2325.
Han P, Winkler N, Hummel C, Hahner A, Gerber J, Hummel T. Impaired brain response to odors in patients with varied severity of olfactory loss after traumatic brain injury. J Neurol. 2018;265:2322-2332.
Reichert JL, Postma EM, Smeets PAM, et al. Severity of olfactory deficits is reflected in functional brain networks-An fMRI study. Hum Brain Mapp. 2018;39:3166-3177.
Pellegrino R, Hahner A, Bojanowski V, Hummel C, Gerber J, Hummel T. Olfactory function in patients with hyposmia compared with he-lthy sub-ects - An fMRI study. Rhinology. 2016;54:374-381.
Kollndorfer K, Fischmeister FP, Kowalczyk K, et al. Olfactory training induces changes in regional functional connectivity in patients with long-term smell loss. Neuroimage Clin. 2015;9:401-410.
Yunpeng Z, Han P, Joshi A, Hummel T. Individual variability of olfactory fMRI in normosmia and olfactory dysfunction. Eur Arch Otorhinolaryngol. 2021;278:379-387.
Peter MG, Fransson P, Martensson G, et al. Normal olfactory functional connectivity despite lifelong absence of olfactory experiences. Cereb Cortex. 2021;31:159-168.
Park M, Chung J, Kim JK, Jeong Y, Moon WJ. Altered functional brain networks in patients with traumatic anosmia: Resting-state functional MRI based on graph theoretical analysis. Korean J Radiol. 2019;20:1536-1545.
Peter MG, Martensson G, Postma EM, et al. Morphological changes in secondary, but not primary, sensory cortex in individuals with life-long olfactory sensory deprivation. Neuroimage. 2020;218: 117005.
Frasnelli J, Fark T, Lehmann J, Gerber J, Hummel T. Brain structure is changed in congenital anosmia. Neuroimage. 2013;83:1074-1080.
Gellrich J, Han P, Manesse C, et al. Brain volume changes in hyposmic patients before and after olfactory training. Laryngoscope. 2018;128:1531-1536.
Yao L, Pinto JM, Yi X, Li L, Peng P, Wei Y. Gray matter volume reduction of olfactory cortices in patients with idiopathic olfactory loss. Chem Senses. 2014;39:755-760.
Peng P, Gu H, Xiao W, et al. A voxel-based morphometry study of anosmic patients. Br J Radiol. 2013;86: 20130207.
Bitter T, Bruderle J, Gudziol H, Burmeister HP, Gaser C, Guntinas-Lichius O. Gray and white matter reduction in hyposmic subjects-a voxel-based morphometry study. Brain Res. 2010;1347:42-47.
Bitter T, Gudziol H, Burmeister HP, Mentzel HJ, Guntinas-Lichius O, Gaser C. Anosmia leads to a loss of gray matter in cortical brain areas. Chem Senses. 2010;35:407-415.
Bitter T, Siegert F, Gudziol H, et al. Gray matter alterations in parosmia. Neuroscience. 2011;177:177-182.
Tremblay C, Mei J, Frasnelli J. Olfactory bulb surroundings can help to distinguish Park'inson's disease from non-parkinsonian olfactory dysfunction. Neuroimage Clin. 2020;28: 102457.
Chen B, Akshita J, Han P, Thaploo D, Kitzler HH, Hummel T. Aberrancies of brain network structures in patients with anosmia. Brain Topogr. 2020;33:403-411.
Haehner A, Schöpf V, Loureiro A, et al. Substancia nigra fractional anisotropy changes confirm the PD at-risk status of patients with idiopathic smell loss. Parkinsonism Relat Disord. 2018;50:113-116
Micarelli A, Chiaravalloti A, Danieli R, Schillaci O, Alessandrini M. Cerebral metabolic changes related to clinical parameters in idiopathic anosmic patients during olfactory stimulation: a pilot investigation. Eur Arch Otorhinolaryngol. 2017;274:2649-2655.
Shiga H, Taki J, Washiyama K, et al. Assessment of olfactory nerve by SPECT-MRI image with nasal thallium-201 administration in patients with olfactory impairments in comparison to healthy volunteers. PLoS One. 2013;8: e57671.
Gerami H, Nemati S, Abbaspour F, Banan R. Brain single photon emission computed tomography in anosmic subjects after closed head trauma. Acta Med Iran. 2011;49:13-17.
Moein ST, Hashemian SM, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty RL. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020;10:944-950.
Nordin S, Monsch AU, Murphy C. Unawareness of smell loss in normal aging and Alzheimer's disease: discrepancy between self-reported and diagnosed smell sensitivity. J Gerontol. 1995;50:187-192.
Wehling E, Nordin S, Espeseth T, Reinvang I, Lundervold AJ. Unawareness of olfactory dysfunction and its association with cognitive functioning in middle aged and old adults. Arch Clin Neuropsychol. 2011;26:260-269.
Callahan CD, Hinkebein JH. Assessment of anosmia after traumatic brain injury: performance characteristics of the University of Pennsylvania Smell Identification Test. J Head Trauma Rehabil. 2002;17:251-256.
Doty RL, Yousem DM, Pham LT, Kreshak AA, Geckle R, Lee WW. Olfactory dysfunction in patients with head trauma. Arch Neurol. 1997;54:1131-1140.
Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. 1988;38:1237-1244.
Doty RL, Reyes PF, Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull. 1987;18:597-600.
Drummond M, Douglas J, Olver J. ‘If I haven't got'any smeIll … I'm out of work’: Consequences of olfactory impairment following traumatic brain injury. Brain Injury. 2013;27:332-345.
Gudziol V, Hoenck I, Landis B, Podlesek D, Bayn M, Hummel T. The impact and prospect of traumatic brain injury on olfactory function: a cross-sectional and prospective study. Eur Arch Otorhinolaryngol. 2014;271:1533-1540.
Howell J, Costanzo RM, Reiter ER. Head trauma and olfactory function. World J Otorhinolaryngol Head Neck Surg. 2018;4:39-45.
London B, Nabet B, Fisher AR, White B, Sammel MD, Doty RL. Predictors of prognosis in patients with olfactory disturbance. Ann Neurol. 2008;63:159-166.
Adams DR, Wroblewski KE, Kern DW, et al. Factors associated with inaccurate self-reporting of olfactory dysfunction in older US adults. Chem Senses. 2017;42:223-231.
B Osman A, Silas, J. Electrophysiological measurement of olfactory function. In: Doty RL, ed. Handbook of Olfaction and Gustation. 3rd ed. Hoboken, NJ: John Wiley & Sons; 2015: 261-277.
Kamath V, Turetsky BI, Seligman SC, Marchetto DM, Walker JB, Moberg PJ. The influence of semantic processing on odor identification ability in schizophrenia. Arch Clin Neuropsychol. 2013;28:254-261.
Engen T. Classical psychophysics: Humans as sensors. In: Meiselman HL, Rivlin RS, eds. Clinical Measurement of Taste and Smell. New York, NY: Macmillan Publishing Company; 1986: 39-49.
Hidalgo J, Chopard G, Galmiche J, Jacquot L, Brand G. Just noticeable difference in olfaction: a discriminative tool between healthy elderly and patients with cognitive disorders associated with dementia. Rhinology. 2011;49:513-518.
Peterson LR, Peterson MJ. Short-term retention of individual verbal items. J Exper Psychol. 1959;58:193-198.
Patel SJ, Bollhoefer AD, Doty RL. Influences of ethanol ingestion on olfactory function in humans. Psychopharmacology. 2004;171:429-434.
Doty RL, Smith R, McKeown DA, Raj J. Tests of human olfactory function: principal components analysis suggests that most measure a common source of variance. Percept Psychophys. 1994;56:701-707.
Lawless HT, Malone GT. A comparison of rating scales: sensitivity, replicates and relative measurement. J Sensory Stud. 1986;1:155-174.
Doty RL, Gregor TP, Settle RG. Influence of intertrial interval and sniff-bottle volume on phenyl ethyl alcohol odor detection thresholds. Chem Senses. 1986;11:259-264.
Kern DW, Wroblewski KE, Schumm LP, Pinto JM, McClintock MK. Field survey measures of olfaction: The olfactory function field exam (OFFE). Field Methods. 2014;26:421-434.
Martzke JS, Kopala LC, Good KP. Olfactory dysfunction in neuropsychiatric disorders: review and methodological considerations. Biol Psychiat. 1997;42:721-732.
Doty RL, Tourbier I, Ng V, et al. Influences of hormone replacement therapy on olfactory and cognitive function in postmenopausal women. Neurobiol Aging. 2015;36:2053-2059.
Good KP, Tourbier IA, Moberg P, et al. Unilateral olfactory sensitivity in multiple sclerosis. Physiol Behav. 2017;168:24-30.
Doty RL, Tourbier I, Neff JK, et al. Influences of temporal lobe epilepsy and temporal lobe resection on olfaction. J Neurol. 2018;265:1654-1665.
ASTM: Standard practice for determination of odor and taste thresholds by a forced-choice ascending concentration series method of limits (E679-97 & E679-04). Philadelphia, PA: American Society for Testing and Materials; 1997.
Cornsweet TN. The staircase-method in psychophysics. Am J Psychol. 1962;75:485-491.
Justesen DR, Adair ER, Stevens JC, Bruce-Wolfe V. A comparative study of human sensory thresholds: 2450-MHz microwaves vs far-infrared radiation. Bioelectromagnetics. 1982;3:117-125.
Clark B, Stewart JD. Comparison of three methods to determine thresholds for perception of angular acceleration. Am J Psychol. 1968;81:207-216.
Wise PM, Bien N, Wysocki CJ. Two rapid odor threshold methods compared with a modified method of constant stimuli. Chem Percept. 2008;1:16-23.
Doty RL, McKeown DA, Lee WW, Shaman P. A study of the test-retest reliability of ten olfactory tests. Chem Senses. 1995;20:645-656.
Doty RL, Laing DG. Psychophysical Measurement of Human Olfactory Function. In: Doty RL, ed. Handbook of Olfaction and Gustation. 3rd ed. New York, NY: Wiley-Liss; 2015: 229-261.
Hedner M, Larsson M, Arnold N, Zucco GM, Hummel T. Cognitive factors in odor detection, odor discrimination, and odor identification tasks. J Clin Exp Neuropsychol. 2010: 32:1-6.
Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. ‘’niffin’ sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses. 1997;22:39-52.
Evans LD. A two-score composite program for combining standard scores. Behav Res Methods Instrum Comput. 1996;28:209-213.
Lawless HT, Horne J, Spiers W. Contrast and range effects for category, magnitude and labeled magnitude scales in judgements of sweetness intensity. Chemical Senses. 2000;25(1): 85-92.
Foley ’J, Cross DV, O'Reilly JA. Pervasiveness and magnitude of context effects: evidence for the relativity of absolute magnitude estimation. Percept Psychophys. 1990;48:551-558.
Ko’ TY, Kim KO, O'Mahony M. Effects of forgetting on performance on various intensity scaling protocols: Magnitude estimation and labeled magnitude scale (green scale). J Sens Stud. 2002;17:177-192.
Rovee CK, Cohen RY, Shlapack W. Life-span stability in olfactory sensitivity. Dev Psychol. 1975;11:311-318.
Moberg PJ, Arnold SE, Doty RL, et al. Impairment of odor hedonics in men with schizophrenia. Am J Psychiat. 2003;160:1784-1789.
Green BG, Dalton P, Cowart B, Shaffer G, Rankin K, Higgins J. Evaluating the ‘Labeled Magnitude Scale’ for measuring sensations of taste and smell. Chem Senses. 1996;21:323-334.
Schifferstein HN. Labeled Magnitude Scales: A critical review. Food Qual Pref. 2012;26:151-158.
McMahon C, Scadding GK. Le Nez du Vin-a quick test of olfaction. Clin Otolaryngol Appl Sci. 1996;21:278-280.
Davidson TM, Murphy C. Rapid clinical evaluation of anosmia. The alcohol sniff test. Arch Otolaryngol Head Neck Surg. 1997;123:591-594.
Davidson TM, Freed C, Healy MP, Murphy C. Rapid clinical evaluation of anosmia in children: the Alcohol Sniff Test. Ann NY Acad Sci. 1998;855:787-792.
Kremer B, Klimek L, Mosges R. Clinical validation of a new olfactory test. Eur Arch Oto-Rhino-Laryngol. 1998;255:355-358.
Hummel T, Konnerth CG, Rosenheim K, Kobal G. Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol. 2001;110:976-981.
Duff K, McCaffrey RJ, Solomon GS. The Pocket Smell Test: successfully discriminating probable Alzheimer's dementia from vascular dementia and major depression. J Neuropsychiat Clin Neurosci. 2002;14:197-201.
Koskinen S, Vento S, Malmberg H, Tuorila H. Correspondence between three olfactory tests and suprathreshold odor intensity ratings. Acta Oto-Laryngologica. 2004;124:1072-1077.
Jackman AH, Doty RL. Utility of a three-item smell identification test in detecting olfactory dysfunction. Laryngoscope. 2005;115:2209-2212.
Mueller C, Renner B. A new procedure for the short screening of olfactory function using five items fr'm the “Sniffin' Sticks” identification test kit. Am J Rhinol. 2006;20:113-116.
Adams DR, Kern DW, Wroblewski KE, McClintock MK, Dale W, Pinto JM. Olfactory dysfunction predicts subsequent dementia in older U.S. adults. J Am Geriatr Soc. 2018;66:140-144.
Vodicka J, Pellant A, Chrobok V. Screening of olfactory function using odourized markers. Rhinology. 2007;45:164-168.
Green P, Iverson GL. Effects of injury severity and cognitive exaggeration on olfactory deficits in head injury compensation claims. NeuroRehabilitation. 2001;16:237-243.
Bohnen NI, Gedela S, Kuwabara H, et al. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease. J Neurol. 2007;254:84-90.
Toledano A, Ruiz C, Navas C, et al. Development of a short olfactory test based on the Connecticut Test (CCCRC). Rhinology. 2009;47:465-469.
Hummel T, Pfetzing U, Lötsch J. A short olfactory test based on the identification of three odors. J Neurol. 2010;257:1316-1321.
Mullol J, Alobid I, Marino-Sanchez F, et al. Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study). BMJ Open. 2012;2: e001256.
Dalton P, Doty RL, Murphy C, et al. Olfactory assessment using the NIH Toolbox. Neurology. 2013;80(11 suppl 3): S32-S36.
Rawal S, Hoffman HJ, Honda M, Heudo-Medina TB, Duffy VB. The taste and smell proto-l in the 2011-2014 US National Health and Nutrition Examination Survey (NHANES): Test-retest reliability and validity testing. Chem Percept. 2015;8:138-148.
Hoffman HJ, Rawal S, Li CM, Duffy VB. New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunction. Rev Endocr Meatol Disord. 2016;17:221-240.
Christensen IT, Larsson EM, Holm IE, Nielsen OB, Andersen S. Olfactory testing in consecutive patients referred with suspected dementia. BMC Geriatr. 2017;17:129.
Joseph T, Auger SD, Peress L, et al. Screening performance of abbreviated versions of the UPSIT® smell test. J Neurol. 2019;266:1897-1906.
Auger SD, Kanavou S, Lawton M, et al. Testing shortened versions of smell tests to screen for hyposmia in Parkinson's disease. Mov Disord Clin Pract. 2020;7:394-398.
Calvo-Henriquez C, Maldonado-Alvarado B, Chiesa-Estomba C, et al. Ethyl alcohol threshold test: a fast, reliable and affordable olfactory Assessment tool for COVID-19 patients. Eur Arch Oto-Rhino-Laryngol. 2020;277:2783-2792.
Elsberg CA, Levy I. The sense of smell: I. A new and simple method of quantitative olfactometry. Bull Neurol Institute NY. 1935;4:5-19.
Fordyce ID. Olfaction tests. Br J Ind Med. 1961;18:213-215.
Douek EE. Smell: recent theories and their clinical application. J Laryngol Otol. 1967;81:431-439.
Amoore JE. Specific anosmia: a clue to the olfactory code. Nature. 1967;214:1095-1098.
Amoore JE, Ollman BG. Practical test kits for quantitatively evaluating the sense of smell. Rhinology. 1983;21:49-54.
Eichenbaum H, Morton TH, Potter H, Corkin S. Selective olfactory deficits in case H.M. Brain. 1983;106(pt 2): 459-472.
Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: A standardized microencapsulated test of olfactory function. Physiol Behav. 1984;32:489-502.
Doty RL. The Smell Identification Test™ Administration Manual. 3rd ed. Haddon Heights, NJ: Sensonics International; 1995.
Corwin J. Olfactory identification in hemodialysis: acute and chronic effects on discrimination and response bias. Neuropsychologia. 1989;27:513-522.
Murphy C, Anderson JA, Markison S. Psychophysical assessment of chemosensory disorders in clinical populations. In: Kurihara K, Suzuki N, Ogawa H, eds. Olfaction and Taste XI. Tokyo: Springer-Verlag; 1994: 609-613.
Markison S, Nijjar R, Murphy C. Olfactory impairment in children detected by the children's odor identification test. Chem Senses. 1993;18:595-596.
Krantz EM, Schubert CR, Dalton DS, et al. Test-retest reliability of the San Diego Odor Identification Test and comparison with the brief smell identification test. Chem Senses. 2009;34:435-440.
Smith RS, Doty RL, Burlingame GK, McKeown DA. Smell and taste function in the visually impaired. Percept Psychophysics. 1993;54:649-655.
Doty RL, Marcus A, Lee WW. Development of the 12-item cross-cultural smell identification test (B-SIT®). Laryngoscope. 1996;106:353-356.
Nordin S, Bramerson A, Liden E, Bende M. The Scandinavian Odor-Identification Test: development, reliability, validity and normative data. Acta Otolaryngol. 1998;118:226-234.
Ikeda K, Tabata K, Oshima T, Nishikawa H, Hidaka H, Takasaka T. Unilateral examination of olfactory threshold using the Jet Stream Olfactometer. Auris Nasus Larynx. 1999;26:435-439.
Tsukatani T, Reiter ER, Miwa T, Costanzo RM. Comparison of diagnostic findings using different olfactory test methods. Laryngoscope. 2005;115:1114-1117.
Briner HR, Simmen D. Smell diskettes as screening test of olfaction. Rhinology. 1999;37:145-148.
Rydzewski B, Pruszewicz A, Sulkowski WJ. Assessment of smell and taste in patients with allergic rhinitis. Acta Otolaryngol. 2000;120:323-326.
Oberg C, Larsson M, Backman L. Differential sex effects in olfactory functioning: the role of verbal processing. J Internat Neuropsychol Soc. 2002;8:691-698.
Heilmann S, Strehle G, Rosenheim K, Damm M, Hummel T. Clinical assessment of retronasal olfactory function. Arch Otolaryngol Head Neck Surg. 2002;128:414-418.
Choudhury ES, Moberg P, Doty RL. Influences of age and sex on a microencapsulated odor memory test. Chem Senses. 2003;28:799-805.
Doty RL. The Odor Memory Test™ Administration Manual. 2nd ed. Haddon Heights, NJ: Sensonics International; 2003.
Good KP, Martzke JS, Daoud MA, Kopala LC. Unirhinal norms for the University of Pennsylvania Smell Identification Test. Clin Neuropsychol. 2003;17:226-234.
Saito S, Ayabe-Kanamura S, Takashima Y, et al. Development of a smell identification test using a novel stick-type odor presentation kit. Chem Senses. 2006;31:379-391.
Kobayashi M, Reiter ER, DiNardo LJ, Costanzo RM. A new clinical olfactory function test: cross-cultural influence. Arch Otolaryngol Head Neck Surg. 2007;133:331-336.
Ahmad AT, Jbara MA, Hiyasat D, Bateiha A, Ajlouni KM. The standard clinical smell testing protocol of the National Center for Diabetes, Endocrinology and Genetics in Amman, Jordan: JOR test. Am J Otolaryngol. 2007;28:388-391.
Zucco GM. Olfactory performance assessed via a new odour recognition test: Reliability and normative data. J Cogn Psychol. 2011;23:1-7.
Weierstall R, Pause BM. Development of a 15-item odour discrimination test (Dusseldorf Odour Discrimination Test). Perception. 2012;41:193-203.
Maremmani C, Rossi G, Tambasco N, et al. The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson's disease patients. Parkinsonism Relat Disord. 2012;18:788-793.
George J, Jose T, Behari M. Use of Indian smell identification test for evaluating olfaction in idiopathic Parkinson's disease patients in India. Neurol India. 2013;61:365-370.
Nehara HR, Sharma B, Kumar A, Saran S, Mangalhara NK, Mathur SK. Correlation of Olfactory Phenotype by Indian Smell Identification Test and Quantitative MRI of Olfactory Apparatus in Idiopathic Hypogonadotropic Hypogonadism. Indian J Endocrinol Metab. 2019;23:367-372.
Fox RS, Manly JJ, Slotkin J, Devin Peipert J, Gershon RC. Reliability and validity of the Spanish-Language version of the NIH Toolbox. Assessment. 2021: 28:457-471.
Okutani F, Hirose K, Kobayashi T, Kaba H, Hyodo M. Evaluation of “Open Essence” odor-identification test card by application to healthy volunteers. Auris Nasus Larynx. 2013;40:76-80.
Chaiyasate S, Roongrotwattanasiri K, Hanprasertpong N, Fooanant S. Normal smell identification score and N-butanol threshold in Thai adults. J Med Assoc Thai. 2013;96:324-328.
Kern DW, Schumm LP, Wroblewski KE, Pinto JM, Hummel T, McClintock MK. Olfactory thresholds of the U.S. Population of home-dwelling older adults: development and validation of a short, reliable measure. PLoS One. 2015;10: e0118589.
Croy I, Hoffmann H, Philpott C, et al. Retronasal testing of olfactory function: an investigation and comparison in seven countries. Eur Arch Otorhinolaryngol. 2014;271:1087-1095.
Jiang RS, Liang KL. A pilot study of the Self-Administered Computerized Olfactory Testing System. Am J Rhinol Allergy. 2015;29:e55-e58.
Croy I, Zehner C, Larsson M, Zucco GM, Hummel T. Test-retest reliability and validity'of the Sniffin' TOM odor memory test. Chem Senses. 2015;40:173-179.
Sorokowska A, Sabiniewicz A, Larsson M. TOM-32-An extended test for the assessment of olfactory memory. J Neurosci Methods. 2020;344: 108873.
Hsu NI, Lai JT, Shen PH. Development of Taiwan Smell Identification Test: a quick office-based smell screening test for Taiwanese. Am J Rhinol Allergy. 2015;29:e50-e54.
Doty RL, Wylie C, Potter M, Beston R, Cope B, Majam K. Clinical validation of the olfactory detection threshold module of the Snap & Sniff® olfactory test system. Int Forum Allergy Rhinol. 2019;9:986-992.
Doty RL. The Snap & Sniff® Olfactory Test System: Threshold Administration Manual. 3rd ed. Haddon Heights, NJ: Sensonics International; 2018.
Doty RL. The Snap & Sniff® Olfactory Test System: Odor Discrimination Administration Manual. Haddon Heights, NJ: Sensonics International; 2019.
Villwock JA, Li J, Moore C, Chiu AG, Sykes KJ. Affordable rapid olfaction measurement array: a novel, essential oil-based test strongly correlated with UPSIT® and subjective outcome measures. Ann Otol Rhinol Laryngol. 2020;129:39-45.
Yoshino A, Goektas G, Mahmut MK, et al. A new method for assessment of retronasal olfactory function. Laryngoscope. 2021;131:E324-E330.
Kasemsuk N, Thanaviratananich S, Piromchai P. A study of 30 odors panel smell identification test, smell detection threshold and University of Pennsylvania Smell Identification Test (UPSIT®) in Thailand. Auris Nasus Larynx. 2020;47:1003-1008.
Proetz AW. Exact olfactometry. Ann Otol Rhinol Laryngol. 1924;33:275-278.
Jones FN. The reliability of olfactory thresholds obtained by sniffing. Am J Psychol. 1955;68:289-290.
Henkin RI, Bartter FC. Studies on olfactory thresholds in normal man and in patients with adrenal cortical insufficiency: the role of adrenal cortical steroids and of serum sodium concentration. J Clin Invest. 1966;45:1631-1639.
Sherman AH, Amoore JE, Weigel V. The pyridine scale for clinical measurement of olfactory threshold: a quantitative reevaluation. Otolaryngol Head Neck Surg. 1979;87:717-733.
Engen T, Kuisma JE, Eimas PD. Short-term memory of odors. J Exp Psychol. 1973;99:222-225.
Rovee CK, HarrisSL, Yopp R. Olfactory thresholds and level of anxiety. Bull Psychonom Soc. 1973;2:76-78.
Toyota B, Kitamura T, Takagi SF. Olfactory disorders-olfactometry and therapy. Tokyo: Igaku-Shoin; 1978.
Takagi SF. Standardized olfactometries in Japan-a review over ten years. Chem Senses. 1989;14:25-46.
Takagi SF. A standardized olfactometer in Japan. A review over ten years. Ann N Y Acad Sci. 1987;510:113-118.
Koelega HS. Olfaction and sensory asymmetry. Chemical Senses. 1979;4:89-95.
Perry JD, Frisch S, Jafek B, Jafek M. Olfactory detection thresholds using pyridine, thiophene, and phenethyl alcohol. Otolaryngol Head Neck Surg (1979). 1980;88:778-782.
Potter H, Butters N. An assessment of olfactory deficits in patients with damage to prefrontal cortex. Neuropsychologia. 1980;18:621-628.
Fortier I, Ferraris J, Mergler D. Measurement precision of an olfactory perception threshold test for use in field studies. Am J Ind Med. 1991;20:495-504.
Cain WS, Gent J, Catalanotto FA, Goodspeed RB. Clinical evaluation of olfaction. Am J Otolaryngol. 1983;4:252-256.
Cain WS, Gent JF. Olfacto-y sensitivity - reliability, generality, and association with aging. J Exp Psychol Human Percept Perform. 1991;17:382-391.
Ghorbanian SN, Paradise JL, Doty RL. Odor perception in children in relation to nasal obstruction. Pediatrics. 1983;72:510-516.
Deems DA, Doty RL. Age-related changes in the phenyl ethyl alcohol odor detection threshold. Trans PA Acad Opthalmol Otolaryngol. 1987;39:646-650.
Doty RL. Intranasal trigeminal detection of chemical vapors by humans. Physiol Behav. 1975;14:855-859.
Wright HN. Characterization of olfactory dysfunction. Arch Otolaryngol Head Neck Surg. 1987;113:163-168.
Kurtz DB, Sheehe PR, Kent PF, White TL, Hornung DE, Wright HN. Odorant quality perception: a metric individual differences approach. Percept Psychophys. 2000;62:1121-1129.
Hendriks AP. Olfactory dysfunction. Rhinology. 1988;26:229-251.
Bromley SM, Doty RL. Odor recognition memory is better under bilateral than unilateral test conditions. Cortex. 1995;31:25-40.
Robson AK, Woollons AC, Ryan J, Horrocks C, Williams S, Dawes PJD. Validation of the combined olfactory test. Clin Otolaryngol. 1996;21:512-518.
Kobal G, Hummel T, Sekinger B, Barz S, Roscher S,’Wolf. “Sniffin' sticks”: screening of olfactory performance. Rhinology. 1996;34:222-226.
Oleszkiewicz A, Schriever VA, Croy I, Hahner A, Hummel T. ‘pdated Sniffin' Sticks normative data based on an extended sample of 9139 subjects. Eur Arch Otorhinolaryngol. 2019;276:719-728.
Albrecht J, Anzinger A, Kopietz R, et al. Test-retest reliability of the olfactory detection threshold test'of the Sniffin' sticks. Chem Senses. 2008;33:461-467.
Lehrner J, Deecke L. The Viennese olfactor- test battery - A new method for assessing human olfactory functions. Aktuelle Neurologie. 2000;27:170-177.
Kobal GP. A threshold-like measure for the assessment of olfactory sensitivity: the “random” procedure. Eur Arch Oto-Rhino-Laryngol. 2001;258:168-172.
Thomas-Danguin T, Rouby C, Sicard G, et al. Development of the ETOC: A European test of olfactory capabilities. Rhinology. 2003;41:142-151.
Bonfils P, Faulcon P, Avan P. Screening of olfactory function using the Biolfa olfactory test: investigations in patients with dysosmia. Acta Oto-Laryngologica. -04; 124:1063-1071.
Cardesin A, Alobid I, Benitez P, et al. Barcel-na Smell Test - 24 (BAST-24): validation and smell characteristics in the healthy Spanish population. Rhinology. 2006;44:83-89.
Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L, Ralph MAL. Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia. 2007;45:1823-1831.
Renner B, Mueller CA, Dreier J, Faulhaber S, Rascher W, Kobal G. The candy smell test: a new test for retronasal olfactory performance. Laryngoscope. 2009;119:487-495.
Haehner A, Mayer AM, Landis BN, et al. High test-retest reliability of the extended version ’f the “Sniffin' Sticks” test. Chem Senses. 2009;34:705-711.
Rouby C, Thomas-Danguin T, Vigouroux M, et al. The Lyon clinical olfactory test: validation and measurement of hyposmia and anosmia in healthy and diseased populations. Int J Otolaryngol. 2011; 2011: 203805.
Freiherr J, Gordon AR, Alden EC, et al. The 40-item Monell E'tended Sniffin' Sticks Identification Test (MONEX-40). J Neurosci Methods. 2012;205:10-16.
Hsieh JW, Keller A, Wong M, Jiang RS, Vosshall LB. SMELL-S and SMELL-R: Olfactory tests not influenced by odor-specific insensitivity or prior olfactory experience. Proc Natl Acad Sci U S A. 2017;114:11275-11284.
a. Philpott CMJA, Gaskin L, McClelland PC, Goodenough A, Clark A, Robinson GE. Murty. The Leicester semi-automated olfactory -hreshold test - a psychophysical olfactory test for the 21st century. Rhin-ogy 47-3:248-253, 2009
Richman RA, Wallace K, Sheehe PR. Assessment of an abbreviated odorant identification task for children: a rapid screening device for schools and clinics. Acta Paediatrica. 1995;84:434-437.
Richman RA, Sheehe PR, Wallace K, Hyde JM, Coplan J. Olfactory performance during childhood. II. Developing a discrimination task for children. J Pediatr. 1995;127:421-426.
Laing DG, Segovia C, Fark T, et al. Tests for screening olfactory and gustatory function in school-age children. Otolaryngol Head Neck Surg. 2008;139:74-82.
Dalton P, Mennella JA, Maute C, et al. Development of a test to evaluate olfactory function in a pediatric population. Laryngoscope. 2011;121:1843-1850.
Cameron EL, Doty RL. Odor identification testing in children and young adults using the smell wheel. Int J Pediatr Otorhinolaryngol. 2013;77:346-350.
Dżaman K, Zielnik-Jurkiewicz B, Jurkiewicz D, Molińska-Glura M. Test for screening olfactory function in children. Int J Pediatr Otorhinolaryngol. 2013;77:418-423.
Schriever VA, Agosin E, Altundag A, et al. Development of an international odor identification test for children: The Universal Sniff test. J Pediatr. 2018;198:265-272.
Mariño-Sánchez F, Valls-Mateus M, Fragola C, et al. Paediatric Barcelona Olfactory Test-6 (pBOT-6): Validation of a combined odour identification and threshold screening test in healthy Spanish children and adolescents. J Invest Allerg Clin Immunol. 2020: 30:439-447.
Concheiro-Guisan A, Fiel-Ozores A, Novoa-Carballal R, et al. Subtle olfactory dysfunction after SARS-CoV-2 virus infection in children. Int J Pediatr Otorhinolaryngol. 2021;140: 110539.
Stevens JC, Cain WS. Old-age deficits in the sense of smell as gauged by thresholds, magnitude matching, and odor identification. Psychol Aging. 1987;2:36-42.
Cain WS, Gent JF, Goodspeed RB, Leonard G. Evaluation of olfactory dysfunction in the Connecticut Chemosensory Clinical Research Center. Laryngoscope. 1988;98:83-88.
Cain WS, Rabin RD. Comparability of two tests of olfactory function. Chem Senses. 1989;14:479-485.
Hummel T, Cramer O, Mohammadian P, Geisslinger G, Pauli, Kobal G. Comparison of the antinociception produced by two oral formulations of ibuprofen: ibuprofen effervescent vs ibuprofen tablets. Eur J Clin Pharm. 1997;52:107-114.
Lehrner JP, Gluck J, Laska M. Odor identification, consistency of label use, olfactory threshold and their relationships to odor memory over the human lifespan. Chem Senses. 1999;24:337-346.
Seeliger M, Pfister M, Gendo K, et al. Comparative study of visual, auditory, and olfactory function in Usher syndrome. Graefes Arch Clin Exp Ophthalmol. 1999;237:301-307.
Tourbier IA, Doty RL. Sniff magnitude test: Relationship to odor identification, detection, and memory tests in a clinic population. Chem Senses. 2007;32:515-523.
Lotsch J, Reichmann H, Hummel T. Different odor tests contribute differently to the evaluation of olfactory loss. Chem Senses. 2008;33:17-21.
Hong SM, Park IH, Kim KM, Shin JM, Lee HM. Relationship between the Korean version'of the Sniffin' stick test and the T&T olfactometer in the Korean population. Clin Exp Otorhinolaryngol. 2011;4:184-187.
Mahmut MK, Stevenson RJ. Olfactory abilities and psychopathy: higher psychopathy scores are associated with poorer odor discrimination and identification. Chem Percept. 2012;5:300-307.
Soler ZM, Kohli P, Storck KA, Schlosser RJ. Olfactory impairment in chronic rhinosinusitis using threshold, discrimination, and identification scores. Chem Senses. 2016;41:713-719.
Aniteli MB, Marson FA, Cunha FR, Sakano E. Correlation and agreement of olfactory perception assessed by the Connecticut Chemosensory Clinical Research Center olfactory test and the Brief-Smell Identification Test†. Braz J Otorhinolaryngol. 2020; S1808-8694(20)30234-2.
Tian J, Pinto JM, Li, L, Zhang S, Sun Z, Wei Y. Identification of viruses in patients with postviral olfactory dysfunction by multiplex reverse-transcription polymerase chain reaction. Laryngoscope. 2021;131:158-164.
Kondo HK, Matsuda T, Hashiba M, Baba S. A study of the relationship between the T&T olfacometer and the University of Pennsylvania Smell Identification Test in a Japanese population. Am J Rhinol-1998;12:353-358.
Simopoulos E, Katotomichelakis M, Gouveris H, Tripsianis G, Livaditis M, Danielides V. Olfaction-associated quality of life in chronic rhinosinusitis: adaptation and validation of an olfaction-specific questionnaire. Laryngoscope. 2012;122:1450-1454.
Frasnelli J, Hummel T. Olfactory dysfunction and daily life. Eur Arch Otorhinolaryngol. 2005;262:231-235.
Pusswald G, Auff E, Johann L. Development of a brief self-report inventory to measure olfactory dysfunction and quality of life in patients with problems with the sense of smell. Chem Percept. 2012;5:292-299.
Nordin S, Bramerson A, Murphy C, Bende M. A Scandinavian adaptation of the Multi-Clinic Smell and Taste Questionnaire: evaluation of questions about olfaction. Acta Otolaryngol. 2003;123:536-542.
Miwa T, Furukawa M, Tsukatani T, Costanzo RM, DiNardo LJ, Reiter ER. Impact of olfactory impairment on quality of life and disability. Arch Otolaryngol Head Neck Surg. 2001;127:497-503.
Mattos JL, Schlosser RJ, Mace JC, Smith TL, Soler ZM. Establishing the minimal clinically important difference for the Questionnaire of Olfactory Disorders. Int Forum Allergy Rhinol. 2018;8:1041-1046.
Puccinell’ CL, Yin LX, O'Brien EK, et al. Long-term olfaction outcomes in transnasal endoscopic skull-base surgery: a prospective cohort study comparing electrocautery and cold knife upper septal limb incision techniques. Int Forum Allergy Rhinol. 2019;9:493-500.
Georgalas C, Detsis M, Geramas I, Terzakis D, Liodakis A. Quality of life outcomes in frontal sinus surgery. J Clin Med. 2020;9:2145.
Bachert C, Zinreich SJ, Hellings PW, et al. Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP. Rhinology. 2020;58:10-17.
Randhawa PS, Watson N, Lechner M, Ritchie L, Choudhury N, Andrews PJ. The outcome of septorhinoplasty surgery on olfactory function. Clin Otolaryngol. 2016;41:15-20.
Soler ZM, Smith TL, Alt JA, Ramakrishnan VR, Mace JC, Schlosser RJ. Olfactory-specific quality of life outcomes after endoscopic sinus surgery. Int Forum Allergy Rhinol. 2016;6:407-413.
Mattos JL, Schlosser RJ, Storck KA, Soler ZM. Understanding the relationship between olfactory-specific quality of life, objective olfactory loss, and patient factors in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017;7:734-740.
Thomas AJ, Mace JC, Ramakrishnan VR, et al. Quality-of-life and olfaction changes observed with short-term medical management of chronic rhinosinusitis. Int Forum Allergy Rhinol. 2020;10:656-664.
Hinz A, Luck T, Riedel-Heller SG, et al. Olfactory dysfunction: properties'of the Sniffin' Sticks Screening 12 test and associations with quality of life. Eur Arch Otorhinolaryngol. 2019;276:389-395.
Desiato VM, Soler ZM, Nguyen SA, et al. Evaluating the relationship between olfactory function and loneliness in community-dwelling individuals: A cross-sectional study. Am J Rhinol Allergy. 2021;35:334-340.
Zou LQ, Hummel T, Otte MS, et al. Association between olfactory function and quality of life in patients with olfactory disorders: a multicenter study in over 760 participants. Rhinology. 2021;59:164-172.
Katotomichelakis M, Simopoulos E, Tripsianis G, et al. Predictors of quality of life outcomes in chronic rhinosinusitis after sinus surgery. Eur Arch Otorhinolaryngol. 2014;271:733-741.
Schlosser RJ, Storck KA, Rudmik L, et al. Association of olfactory dysfunction in chronic rhinosinusitis with economic productivity and medication usage. Int Forum Allergy Rhinol. 2017;7:50-55.
Prajapati DP, Shahrvini B, MacDonald BV, et al. Association of subjective olfactory dysfunction and 12-item odor identification testing in ambulatory COVID-19 patients. Int Forum Allergy Rhinol. 2020 Sep 10. https://doi.org/10.1002/alr.22688. Online ahead of print.
Qiu C, Cui C, Hautefort C, et al. Olfactory and gustatory dysfunction as an early identifier of COVID-19 in adults and children: An international multicenter study. Otolaryngol Head Neck Surg. 2020;163:714-721.
Seo MY, Seok H, Hwang SJ, et al. Trend of olfactory and gustatory dysfunction in COVID-19 patients in a quarantine facility. J Korean Med Sci. 2020;35: e375.
Blomqvist EH, Bramerson A, Stjarne P, Nordin S. Consequences of olfactory loss and adopted coping strategies. Rhinology. 2004;42:189-194.
Erskine SE, Philpott CM. An unmet need: Patients with smell and taste disorders. Clin Otolaryngol. 2020;45:197-203.
Kern RC. Chronic sinusitis and anosmia: pathologic changes in the olfactory mucosa. Laryngoscope. 2000;110:1071-1077.
Lane AP, Turner J, May L, Reed R. A genetic model of chronic rhinosinusitis-associated olfactory inflammation reveals reversible functional impairment and dramatic neuroepithelial reorganization. J Neurosci. 2010;30:2324-2329.
Pozharskaya T, Liang J, Lane AP. Regulation of inflammation-associated olfactory neuronal death and regeneration by the type II tumor necrosis factor receptor. Int Forum Allergy Rhinol. 2013;3:740-747.
Sousa Garcia D, Chen M, Smith AK, Lazarini PR, Lane AP. Role of the type I tumor necrosis factor receptor in inflammation-associated olfactory dysfunction. Int Forum Allergy Rhinol. 2017;7:160-168.
Turner JH, Liang KL, May L, Lane AP. Tumor necrosis factor alpha inhibits olfactory regeneration in a transgenic model of chronic rhinosinusitis-associated olfactory loss. Am J Rhinol Allergy. 2010;24:336-340.
Turner JH, May L, Reed RR, Lane AP. Reversible loss of neuronal marker protein expression in a transgenic mouse model for sinusitis-associated olfactory dysfunction. Am J Rhinol Allergy. 2010;24:192-196.
Bryche B, Dewaele A, Saint-Albin A, Le Poupon Schlegel C, Congar P, Meunier N. IL-17c is involved in olfactory mucosa responses to Poly(I:C) mimicking virus presence. Brain Behav Immun. 2019;79:274-283.
Burkhardt AM, Perez-Lopez A, Ushach I, et al. CCL28 Is involved in mucosal IgA responses, olfaction, and resistance to enteric infections. J Interferon Cytokine Res. 2019;39:214-223.
Kalkonde YV, Shelton R, Villarreal M, et al. The CC chemokine receptor 5 regulates olfactory and social recognition in mice. Neuroscience. 2011;197:153-161.
Rouyar A, Classe M, Gorski R, et al. Type 2/Th2-driven inflammation impairs olfactory sensory neurogenesis in mouse chronic rhinosinusitis model. Allergy. 2019;74:549-559.
Schlosser RJ, Mulligan JK, Hyer JM, Karnezis TT, Gudis DA, Soler ZM. Mucous cytokine levels in chronic rhinosinusitis-associated olfactory loss. JAMA Otolaryngol Head Neck Surg. 2016;142:731-737.
Lavin J, Min JY, Lidder AK, et al. Superior turbinate eosinophilia correlates with olfactory deficit in chronic rhinosinusitis patients. Laryngoscope. 2017;127:2210-2218.
Wu J, Chandra RK, Li P, Hull BP, Turner JH. Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitis. Laryngoscope. 2018;128:E304-e310.
Morse JC, Shilts MH, Ely KA, et al. Patterns of olfactory dysfunction in chronic rhinosinusitis identified by hierarchical cluster analysis and machine learning algorithms. Int Forum Allergy Rhinol. 2019;9:255-264.
Soler ZM, Yoo F, Schlosser RJ, et al. Correlation of mucus inflammatory proteins and olfaction in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2020;10:343-355.
Han X, Wu D, Sun Z, et al. Type 1/type 2 inflammatory cytokines correlate with olfactory function in patients with chronic rhinosinusitis. Am J Otolaryngol. 2020;41: 102587.
Darnell EP, Wroblewski KE, Pagel KL, Kern DW, McClintock MK, Pinto JM. IL-1Rahigh-IL-4low-IL-13low: A novel Plasma cytokine signature associated with olfactory dysfunction in older US adults. Chem Senses. 2020;45:407-414.
Henkin RI, Schmidt L, Velicu I. Interleukin 6 in hyposmia. JAMA Otolaryngol Head Neck Surg. 2013;139:728-734.
Schubert CR, Cruickshanks KJ, Fischer ME, Klein BE, Klein R, Pinto AA. Inflammatory and vascular markers and olfactory impairment in older adults. Age Ageing. 2015;44:878-882.
Yoo F, Soler ZM, Mulligan JK, et al. Olfactory cleft mucus proteins associated with olfactory dysfunction in a cohort without chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019;9:1151-1158.
Ottoson D. Sustained potentials evoked by olfactory stimulation. Acta Physiol Scand. 1954;32:384-386.
Hosoya Y, Yoshida H. Über die bioelektrischen Erscheinungen an der Riechschleimhaut. J Med Sci III Biophysics. 1937;5:22.
Osterhammel P, Terkildsen K, Zilsdorff K. Electro-olfactograms in man. J Laryngol. 1969;83:731-733.
Kobal G. Elektrophysiologische Untersuchungen des Menschlichen Geruchssinns. Thieme Verlag. New York, NY: Stuttgart; 1981.
Knecht M, Hummel T. Recording of the human electro-olfactogram. Physiol Behav. 2004;83:13-19.
Lapid H, Seo HS, Schuster B, et al. Odorant concentration dependence in electroolfactograms recorded from the human olfactory epithelium. J Neurophysiol. 2009;102:2121-2130.
Lapid H, Shushan S, Plotkin A, et al. Neural activity at the human olfactory epithelium reflects olfactory perception. Nat Neurosci. 2011;14:1455-1461.
Hummel T, Mojet J, Kobal G. Electro-olfactograms are present when odorous stimuli have not been perceived. Neurosci Lett. 2006;397:224-228.
Wang L, Chen L, Jacob T. Evidence for peripheral plasticity in human odour response. J Physiol. 2004;554:236-244.
Hummel T, Knecht M, Kobal G. Peripherally obtained electrophysiological responses to olfactory stimulation in man: electro-olfactograms exhibit a smaller degree of desensitization compared with subjective intensity estimates. Brain Res. 1996;717:160-164.
Leopold DA, Hummel T, Schwob JE, Hong SC, Knecht M, Kobal G. Anterior distribution of human olfactory epithelium. Laryngoscope. 2000;110:417-421.
Poletti SC, Cavazzana A, Guducu C, Larsson M, Hummel T. Indistinguishable odour enantiomers: Differences between peripheral and central-nervous electrophysiological responses. Sci Rep. 2017;7:8978.
Spehr M, Schwane K, Heilmann S, Gisselmann G, Hummel T, Hatt H. Dual capacity of a human olfactory receptor. Curr Biol. 2004;14:R832-T833.
Cavazzana A, Poletti SC, Guducu C, Larsson M, Hummel T. Electro-olfactogram Responses Before and After Aversive Olfactory Conditioning in Humans. Neuroscience. 2018;373:199-206.
Hummel T, Seo HS, Pellegrino R, Heilmann S. Electro-olfactograms in humans in response to ortho-and retronasal chemosensory stimulation. Chemosens Perc. 2017;10:114-118.
Furukawa M, Kamide M, Ohkado T, Umeda R. Electro-olfactogram (EOG) in olfactometry. Auris Nasus Larynx. 1989;16:33-38.
Turetsky BI, Hahn CG, Arnold SE, Moberg PJ. Olfactory receptor neuron dysfunction in schizophrenia. Neuropsychopharmacology. 2009;34:767-774.
Hummel T, Stupka G, Haehner A, Poletti SC. Olfactory training changes electrophysiological responses at the level of the olfactory epithelium. Rhinology. 2018;56:330-335.
Lapid H, Hummel T. Recording odor-evoked response potentials at the human olfactory epithelium. Chem Sens-. 2013;38:3-17.
Ishimaru T, Scheibe M, Gudziol V, Negoias S. Recordings of the optical intrinsic signal from the middle turbinate in response to olfactory and trigeminal stimulation: a pilot study. Eur Arch Otorhinolaryngol. 2008;265:781-785.
Ishimaru T, Krone F, Scheibe M, Gudziol V, Negoias S, Hummel T. Intrinsic chemosensory signal recorded from the human nasal mucosa in patients with smell loss. Eur Arch Otorhinolaryngol. 2013;270:1335-1338.
Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54:1-30.
Derin S, Koseoglu S, Sahin C, Sahan M. Effect of vitamin B12 deficiency on olfactory function. Int Forum Allergy Rhinol. 2016;6:1051-1055.
Dhir S, Tarasenko M, Napoli E, Giulivi C. Neurological, psychiatric, and biochemical aspects of thiamine deficiency in children and adults. Front Psychiatry. 2019;10:207.
Heyneman CA. Zinc deficiency and taste disorders. Ann Pharmacother. 1996;30:186-187.
Alpers DH. Zinc and deficiencies of taste and smell. JAMA. 1994;272:1233-1234.
Van Wouwe JP. Clinical and laboratory assessment of zinc deficiency in Dutch children. A review. Biol Trace Elem Res. 1995;49:211-225.
Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol. 2006;20:3-18.
US Food and Drug Administration. Warnings on Three Zicam Intranasal Zinc Products. (2009). https://www.medicinenet.com/script/main/art.asp?articlekey=101218. Accessed June 10, 2021.
Dissaneevate P, Warne GL, Zacharin MR. Clinical evaluation in isolated hypogonadotrophic hypogonadism (Kallmann syndrome). J Pediatr Endocrinol Metab. 1998;11:631-638.
Young J. Approach to the male patient with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2012;97:707-718.
Pitteloud N, Hayes F, Boepple PA, et al. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2002;87:152-160.
Lieblich JM, Rogol AD, White BJ, Rosen SW. Syndrome of anosmia with hypogonadotropic hypogonadism (Kallmann syndrome): clinical and laboratory studies in 23 cases. Am J Med. 1982;73:506-519.
Lee YH, Bak Y, Park CH, et al. Patterns of olfactory functional networks in P'arkinson's disease dementia and A'lzheimer's dementia. Neurobiol Aging. 2020;89:63-70.
Thijssen EH, La Joie R, Wolf A, et al. Diagnostic value of plasma phosphorylated tau181 in A'lzheimer's disease and frontotemporal lobar degeneration. Nat Med. 2020;26:387-397.
Upadhyay UD, Holbrook EH. Olfactory loss as a result of toxic exposure. Otolaryngol Clin North Am. 2004;37:1185-1207.
Kamel UF, Maddison P, Whitaker R. Impact of primary’ Sjogren's syndrome on smell and taste: effect on quality of life. Rheumatology (Oxford). 2009;48:1512-1514.
Sanke H, Mita T, Yoshii H, et al. Relationship between olfactory dysfunction and cognitive impairment in elderly patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2014;106:465-473.
Mueller A, Reuner U, Landis B, Kitzler H, Reichmann H, Hummel T. Extrapyramidal symptoms i'n Wilson's disease are associated with olfactory dysfunction. Mov Disord. 2006;21:1311-1316.
Temmel AF, Pabinger S, Quint C, Munda P, Ferenci P, Hummel T. Dysfunction of the liver affects the sense of smell. Wien Klin Wochenschr. 2005;117:26-30.
Whitcroft KL, Hummel T. Olfactory dysfunction in COVID-19: Diagnosis and management. JAMA. 2020;323:2512-2514.
Walker A, Pottinger G, Scott A, Hopkins C. Anosmia and loss of smell in the era of covid-19. BMJ. 2020;370: m2808.
Malnic B, Glezer I. Olfactory loss of function as a possible symptom of COVID-19. JAMA Otolaryngol Head Neck Surg. 2020;146:872-873.
Makaronidis J, Mok J, Balogun N, et al. Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study. PLoS Med. 2020;17: e1003358.
Venugopal U, Jilani N, Rabah S, et al. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic. Int J Infect Dis. 2020;102:63-69.
Leopold D. Distortion of olfactory perception: Diagnosis and treatment. Chem Senses. 2002;27:611-615.
Leopold D, Meyerrose G. Diagnosis and treatment of distorted olfactory perception. In: Kurihara K, Suzuki N, Ogawa H, eds. Olfaction and Taste XI. Tokyo, Japan: Springer-Verlag; 1994: 618-621.
Sjölund S, Larsson M, Olofsson JK, et al. Phantom smells: Prevalence and correlates in a population-based sample of older adults. Chem Senses. 2017;42:309-318.
Leopold DA, Loehrl TA, Schwob JE. Long-term follow-up of surgically treated phantosmia. Arch Otolaryngol Head Neck Surg. 2002;128:642-647.
Jion YI, Grosberg BM, Evans RW. Phantosmia and migraine with and without headache. Headache. 2016;56:1494-1502.
Landis BN, Reden J, Haehner A. Idiopathic phantosmia: Outcome and clinical significance. ORL J Otorhinolaryngol Relat Spec. 2010;72:252-255.
Frasnelli J, Landis BN, Heilmann S, et al. Clinical presentation of qualitative olfactory dysfunction. Eur Arch Otorhinolaryngol. 2004;261:411-415.
Saltagi MZ, Rabbani CC, Ting JY, et al. Management of long-lasting phantosmia: a systematic review. Int Forum Allergy Rhinol. 2018;8:790-796.
Oey NE and Lo YL. Migraine with multiple sensory auras. Acta Neurol Taiwan. 2016;25:148-151.
Fornazieri MA, Neto AR, Pinna FdR, et al. Olfactory symptoms reported by migraineurs with and without auras. Headache. 2016;56:1608-1616.
Landis BN, Burkhard PR. Phantosmias and Parkinson disease. Arch Neurol. 2008;65:1237-1239.
Croy I, Yarina S, Hummel T. Enhanced parosmia and phantosmia in patients with severe depression. Psychol Med. 2013;43:2460-2464.
Henkin RI, Potolicchio SJ, Levy LM. Olfactory hallucinations without clinical motor activity: A comparison of unirhinal with birhinal phantosmia. Brain Sci. 2003;3:1483-1553.
Morosanu CO, Clamp PJ, Teo MK. Phantosmia as the first presentation of a c-vernous sinus - clinoidal meningioma. Br J Neurosurg. 2020 Oct 14; 1-7. https://doi.org/10.1080/02688697.2020.1834510. Online ahead of print.
Leopold DA, Schwob JE, Youngentob SL, et al. Successful treatment of phantosmia with preservation of olfaction. Arch Otolaryngol Head Neck Surg. 1991;117:1402-1406.
Wrobel BB, Leopold DA. Clinical assessment of patients with smell and taste disorder. Otolaryngol Clin North Am. 2004;37:1127-1142.
Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54:1-30.
Lee DY, Lee WH, Wee JH, Kim JW. Prognosis of postviral olfactory loss: Follow-up study for longer than one year. Am J Rhinol Allergy. 2014;28:419-422.
Sumner D. Post-traumatic anosmia. Brain. 1964;87:107-120.
Zusho H. Posttraumatic anosmia. Arch Otolaryngol. 1982;108:90-92.
Deems DA, Doty RL, Settle RG, et al. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch OtolaryngolHead Neck Surg. 1991;117:519-528.
Doty RL, Yousem DM, Pham LT, Kreshak AA, Geckle R, Lee WW. Olfactory dysfunction in patients with head trauma. Arch Neurol. 1997;54:1131-1140.
Duncan HJ, Seiden AM. Long-term follow-up of olfactory loss secondary to head trauma and upper respiratory tract infection. Arch Otolaryngol Head Neck Surg. 1995;121:1183-1187.
Hummel T, Lötsch J. Prognostic factors of olfactory dysfunction. Arch Otolaryngol Head Neck Surg. 2010;136:347-351.
London B, Nabet B, Fisher AR, White B, Sammel MD, Doty RL. Predictors of prognosis in patients with olfactory disturbance. Ann Neurol. 2008;63:159-166.
Mori J, Aiba T, Sugiura M, et al. Clinical study of olfactory disturbance. Acta Otolaryngol Suppl. 1998;538:197-201.
Ogawa T, Nakamura K, Yamamoto S, Tojima I, Shimizu T. Recovery over time and prognostic factors in treated patients with post-infectious olfactory dysfunction: A retrospective study. Ann Otol Rhinol Laryngol. 2020;129:977-982.
Reden J, Maroldt H, Fritz A, Zahnert T, Hummel T. A study on the prognostic significance of qualitative olfactory dysfunction. Eur Arch Otorhinolaryngol. 2007;264:139-144.
Reden J, Mueller A, Mueller C, et al. Recovery of olfactory function following closed head injury or infections of the upper respiratory tract. Arch Otolaryngol Head Neck Surg. 2006;132:265-269.
Rombaux P, Huart C, Deggouj N, Duprez T, Hummel T. Prognostic value of olfactory bulb volume measurement for recovery in postinfectious and posttraumatic olfactory loss. Otolaryngol Head Neck Surg. 2012;147:1136-1141.
Pellegrino R, Walliczek-Dworschak U, Winter G, Hull D, Hummel T. Investigation of chemosensitivity during and after an acute cold. Int Forum Allergy Rhinol. 2017;7:185-191.
Hummel T, Rothbauer C, Pauli E, Kobal G. Effects of the nasal decongestant oxymetazoline on human olfactory and intranasal trigeminal function in acute rhinitis. Eur J Clin Pharmacol. 1998;54(7):521-528.
Cooper KW, Brann DH, Farruggia MC, et al. COVID-19 and the chemical senses: Supporting players take center stage. Neuron. 2020;107:219-233.
Gorzkowski V, Bevilacqua S, Charmillon A, et al. Evolution of olfactory disorders in COVID-19 patients. Laryngoscope. 2020;130:2667-2673.
Iannuzzi L, Salzo AE, Angarano G, et al. Gaining back what is lost: Recovering the sense of smell in mild to moderate patients after COVID-19. Chem Senses. 2020;45:875-881.
Lee Y, Min P, Lee S, Kim SW. Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 2020;35: e174.
Parente-Arias P, Barreira-Fernandez P, Quintana-Sanjuas A, Patiño-Castiñeira B. Recovery rate and factors associated with smell and taste disruption in patients with coronavirus disease 2019. Am J Otolaryngol. 2020;42: 102648.
Schwob JE, Jang W, Holbrook EH, et al. Stem and progenitor cells of the mammalian olfactory epithelium: Taking poietic license. J Comp Neurol. 2017;525:1034-1054.
Konstantinidis I, Tsakiropoulou E, Constantinidis J. Long term effects of olfactory training in patients with post-infectious olfactory loss. Rhinology. 2016;54:170-175.
Cavazzana A, Larsson M, Münch M, Hähner A, Hummel T. Postinfectious olfactory loss: A retrospective study on 791 patients. Laryngoscope. 2018;128:10-15.
Mueller CA, Hummel T. Recovery of olfactory function after nine years of post-traumatic anosmia: A case report. J Med Case Rep. 2009;3:9283.
Bonfils P, Avan P, Faulcon P, Malinvaud D. Distorted odorant perception: Analysis of a series of 56 patients with parosmia. Arch Otolaryngol Head Neck Surg. 2005;131:107-112.
Frasnelli J, Landis BN, Heilmann S, et al. Clinical presentation of qualitative olfactory dysfunction. Eur Arch Otorhinolaryngol. 2004;261:411-415.
Portier F, Faulcon P, Lamblin B, Bonfils P. [Signs and symptoms, etiologies and clinical course of parosmia + in a series of 84 patients]. Ann Otolaryngol Chir Cervicofac. 2000;117:12-18.
Rombaux P, Martinage S, Huart C, Collet S. Post-infectious olfactory loss: A cohort study and update. B-ENT. 2009;5 suppl 13; 89-95.
Ciurleo R, De Salvo S, Bonanno L, Marino S, Bramanti P, Caminiti F. Parosmia and neurological disorders: A neglected association. Front Neurol. 2020;11: 543275.
Hong SC, Holbrook EH, Leopold DA, Hummel T. Distorted olfactory perception: A systematic review. Acta Otolaryngol. 2012;132(suppl 1): S27-S31.
Fan LY, Kuo CL, Lirng JF, Shu CH. Investigation of prognostic factors for post-traumatic olfactory dysfunction. J Chin Med Assoc. 2015;78:299-303.
Rombaux P, Huart C, Collet S, Eloy P, Negoias S, Hummel T. Presence of olfactory event-related potentials predicts recovery in patients with olfactory loss following upper respiratory tract infection. Laryngoscope. 2010;120:2115-2118.
Mobley AS, Rodriguez-Gil DJ, Imamura F, Greer CA. Aging in the olfactory system. Trends Neurosci. 2014;37:77-84.
Doty RL, Kamath V. The influences of age on olfaction: A review. Front Psychol. 2014;5:20.
Watabe-Rudolph M, Begus-Nahrmann Y, Lechel A, et al. Telomere shortening impairs regeneration of the olfactory epithelium in response to injury but not under homeostatic conditions. PLoS One. 2011;6: e27801.
Brann JH, Firestein SJ. A lifetime of neurogenesis in the olfactory system. Front Neurosci. 2014;8:182.
Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54:1-30.
Mueller CA, Hummel T. Recovery of olfactory function after nine years of post-traumatic anosmia: a case report. J Med Case Rep. 2009;3:9283.
Reden J, Mueller A, Mueller C, et al. Recovery of olfactory function following closed head injury or infections of the upper respiratory tract. Arch Otolaryngol Head Neck Surg. 2006;132:265-269.
Konstantinidis I, Tsakiropoulou E, Bekiaridou P, Kazantzidou C, Constantinidis J. Use of olfactory training in post-traumatic and postinfectious olfactory dysfunction. Laryngoscope. 2013;123:E85-E90.
Miwa T, Tsukatani T, Ikeno S, Furukawa M. The effectiveness of Toki-syakuyaku-san for the olfactory disturbed patients. Jpn Assoc Study Taste Smell. 2005;12:523-524.
Shiga H. Post-traumatic olfactory impairment. J Jpn Assoc Odor Environ. 2014;45:278-281.
Henkin RI, Schecter PJ, Friedewald WT, Demets DL, Raff M. A double blind study of the effects of zinc sulfate on taste and smell dysfunction. Am J Med Sci. 1976;272:285-299.
Jiang RS, Twu CW, Liang KL. Medical treatment of traumatic anosmia. Otolaryngol Head Neck Surg. 2015;152:954-958.
Aiba T, Sugiura M, Mori J, et al. Effect of zinc sulfate on sensoryneural olfactory disorder. Acta Otolaryngol. 1998; suppl 538:202-204.
Kitano M, Kobayashi M, Miyamura T, Takeuchi K. Prognosticators for the olfactory dysfunction by head injury. Jpn Assoc Study Taste Smell. 2013;3:401-404.
Mori J, Aiba T, Sugiura M, et al. Clinical study of olfactory disturbance. Acta Otolaryngol. 1998; suppl 538:197-201.
Ikeda K, Sakurada T, Takasaka T, Okitsu T, Yoshida S. Anosmia following head trauma: Preliminary study of steroid treatment. Tohoku J of Exp Med. 1995;177:343-351.
Jiang RS, Wu SH, Liang KL, Shiao JY, Hsin CH, Su MC. Steroid treatment of posttraumatic anosmia. Eur Arch Otorhinolaryngol. 2010;267:1563-1567.
Reden J, Lill K, Zahnert T, Haehner A, Hummel T. Olfactory function in patients with postinfectious and posttraumatic smell disorders before and after treatment with vitamin A: A double-blind, placebo-controlled, randomized clinical trial. Laryngoscope. 2012;122:1906-1909.
Altundag A, Saatci O, Kandemirli SG, et al. Imaging features to predict response to olfactory training in post-traumatic olfactory dysfunction. Laryngoscope. 202; 131: E2243-E2250
Pellegrino R, Han P, Reither N, Hummel T. Effectiveness of olfactory training on different severities of posttraumatic loss of smell. Laryngoscope. 2019;129:1737-1743.
Miwa T, Furukawa M, Tsukatani T, Costanzo RM, DiNardo LJ, Reiter ER. Impact of olfactory impairment on quality of life and disability. Arch Otolaryngol Head Neck Surg. 2001;127:497-503.
Yang J, Pinto JM. The epidemiology of olfactory disorders. Curr Otorhinolaryngol Rep. 2016;4:130-141.
Bromley SM. Smell and taste disorders: A primary care approach. Am Fam Physician. 2000;61:427-436, 438.
Mullol J, Mariño-Sánchez F, Valls M, Alobid I, Marin C. The sense of smell in chronic rhinosinusitis. J Allergy Clin Immunol. 2020;145:773-776.
Stuck BA, Hummel T. Olfaction in allergic rhinitis: A systematic review. J Allergy Clin Immunol. 2015;136:1460-1470.
Kohli P, Naik AN, Harruff EE, Nguyen SA, Schlosser RJ, Soler ZM. The prevalence of olfactory dysfunction in chronic rhinosinusitis. Laryngoscope. 2017;127:309-320.
Schlosser RJ, Smith TL, Mace JC, et al. Factors driving olfactory loss in patients with chronic rhinosinusitis: a case control study. Int Forum Allergy Rhinol. 2020;10:7-14.
Banglawala SM, Oyer SL, Lohia S, Psaltis AJ, Soler ZM, Schlosser RJ. Olfactory outcomes in chronic rhinosinusitis with nasal polyposis after medical treatments: A systematic review and meta-analysis. Int Forum Allergy Rhinol. 2014;4:986-994.
b. Blomqvist EH, Lundblad L, Anggård A, Haraldsson PO, Stjärne P. A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. J Allergy Clin Immunol. 2001;107(2):224-228.
Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394:1638-1650.
Han JK, Bachert C, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps: results from the randomized phase 3 sinus-24 study. J Allergy Clin Immunol.
Bachert C, Mannent L, Naclerio RM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: A randomized clinical trial. JAMA. 2016;315:469-479.
Gevaert P, Omachi TA, Corren J, et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020;146:595-605.
Bachert C, Sousa AR, Lund VJ, et al. Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial. J Allergy Clin Immunol. 2017;140:1024-1031.e14.
Head K, Chong LY, Hopkins C, Philpott C, Burton MJ, Schilder AG. Short-course oral steroids alone for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4: CD011991.
Haxel BR, Clemens M, Karaiskaki N, Dippold U, Kettern L, Mann WJ. Controlled trial for long-term low-dose erythromycin after sinus surgery for chronic rhinosinusitis. Laryngoscope. 2015;125:1048-1055.
Varvyanskaya A, Lopatin A. Efficacy of long-term low-dose macrolide therapy in preventing early recurrence of nasal polyps after endoscopic sinus surgery. Int Forum Allergy Rhinol. 2014;4:533-541.
Dabirmoghaddam P, Seraj JM, Bastaninejad S, Meighani A, Mokhtari Z. The efficacy of clarithromycin in patients with severe nasal polyposis. Acta Med Iran. 2013 51:359-364.
Videler WJ, Badia L, Harvey RJ, et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy. 2011;66:1457-1468.
Klimek L, Poletti SC, Sperl A, et al. Olfaction in patients with allergic rhinitis: an indicator of successful MP-AzeFlu therapy. Int Forum Allergy Rhinol. 2017;7:287-292.
Dalgic A, Dinc ME, Ulusoy S, Dizdar D, Is A, Topak M. Comparison of the effects of nasal steroids and montelukast on olfactory functions in patients with allergic rhinitis. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134:213-216.
Sivam A, Jeswani S, Reder L, et al. Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. Am J Rhinol Allergy. 2010;24:286-290.
Stuck BA, Blum A, Hagner AE, Hummel T, Klimek L, Hörmann K. Mometasone furoate nasal spray improves olfactory performance in seasonal allergic rhinitis. Allergy. 2003;58:1195.
Meltzer EO. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol. 1998;81:128-134.
Golding-Wood DG, Holmstrom M, Darby Y, Scadding GK, Lund VJ. The treatment of hyposmia with intranasal steroids. J Laryngol Otol. 1996;110:132-135.
Tansuker D, Coşkun BU, Uçal YO, Sözen E, Erdurak C, Sakalli E. Effects of systemic immunotherapy on olfactory function in allergic rhinitis patients. J Craniofac Surg. 2014;25:e339-e343.
Mun SJ, Shin JM, Han DH, et al. Efficacy and safety of a once-daily sublingual immunotherapy without escalation regimen in house dust mite-induced allergic rhinitis. Int Forum Allergy Rhinol. 2013;3:177-183.
Katotomichelakis M, Simopoulos E, Tripsianis G, et al. Improvement of olfactory function for quality of life recovery. Laryngoscope. 2013;123:E10-E16.
Chang H, Han DH, Mo JH, et al. Early compliance and efficacy of sublingual immunotherapy in patients with allergic rhinitis for house dust mites. Clin Exp Otorhinolaryngol. 2009;2:136-140.
Radcliffe MJ, Lampe FC, Brostoff J. Allergen-specific low-dose immunotherapy in perennial allergic rhinitis: A double-blind placebo-controlled crossover study. J Investig Allergol Clin Immunol. 1996;6:242-247.
Ecevit MC, Erdag TK, Dogan E, Sutay S. Effect of steroids for nasal polyposis surgery: A placebo-controlled, randomized, double-blind study. Laryngoscope. 2015;125:2041-2045.
Alobid I, Benítez P, Cardelús S, et al. Oral plus nasal corticosteroids improve smell, nasal congestion, and inflammation in sino-nasal polyposis. Laryngoscope. 2014;124:50-56.
Kirtsreesakul V, Wongsritrang K, Ruttanaphol S. Does oral prednisolone increase the efficacy of subsequent nasal steroids in treating nasal polyposis? Am J Rhinol Allergy. 2012;26:455-462.
Alobid I, Benítez P, Valero A, Muñoz R, Langdon C, Mullol J. Oral and intranasal steroid treatments improve nasal patency and paradoxically increase nasal nitric oxide in patients with severe nasal polyposis. Rhinology. 2012;50:171-177.
Vaidyanathan S, Barnes M, Williamson P, Hopkinson P, Donnan PT, Lipworth B. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: A randomized trial. Ann Intern Med. 2011;154:293-302.
Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: Two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125:1069-1076.e4.
Benítez P, Alobid I, De Haro J, et al. A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope. 2006;116:770-775.
Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: Evaluation with the novel Perioperative Sinus Endoscopy (POSE) scoring system. Laryngoscope. 2007;117(11 pt 2 suppl 115): 1-28.
Alobid I, Benitez P, Pujols L, et al. Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by long-term intranasal steroid treatment. Rhinology 2006;44:8-13.
Kroflic B, Coer A, Baudoin T, Kalogjera L. Topical furosemide versus oral steroid in preoperative management of nasal polyposis. Eur Arch Otorhinolaryngol. 2006;263:767-771.
Hissaria P, Smith W, Wormald PJ, et al. Short course of systemic corticosteroids in sinonasal polyposis: A double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol. 2006;118:128-133.
Xu Z, Luo X, Xu L, et al. Effect of short-course glucocorticoid application on patients with chronic rhinosinusitis with nasal polyps. World Allergy Organ J. 2020;13: 100131.
Zeng M, Wang H, Wang H, et al. Comparison of efficacy of fluticasone propionate versus clarithromycin for postoperative treatment of different phenotypic chronic rhinosinusitis: a randomized controlled trial. Rhinology. 2019;57:101-109.
Khan AR, Arif MA. Mometasone furoate intra nasal spray for the treatment of bilateral nasal polyposis. J Med Sci. 2019;27:203-209.
Zhou B, He G, Liang J, et al. Mometasone furoate nasal spray in the treatment of nasal polyposis in Chinese patients: A double-blind, randomized, placebo-controlled trial. Int Forum Allergy Rhinol. 2016;6:88-94.
Chong LY, Head K, Hopkins C, Philpott C, Schilder AG, Burton MJ. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4: CD011996.
Jankowski R, Klossek JM, Attali V, Coste A, Serrano E. Long-term study of fluticasone propionate aqueous nasal spray in acute and maintenance therapy of nasal polyposis. Allergy. 2009;64:944-950.
Ehnhage A, Olsson P, Kölbeck KG, et al. Functional endoscopic sinus surgery improved asthma symptoms as well as PEFR and olfaction in patients with nasal polyposis. Allergy. 2009;64:762-769.
Small CB, Stryszak P, Danzig M, Damiano A. Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis. J Allergy Clin Immunol. 2008;121:928-932.
Stjärne P, Blomgren K, Cayé-Thomasen P, Salo S, Søderstrøm T. The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: A randomized, double-blind, placebo-controlled study. Acta Otolaryngol. 2006 126:606-612.
Stjärne P, Mösges R, Jorissen M, et al. A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. Arch Otolaryngol Head Neck Surg. 2006;132:179-185.
Aukema AA, Mulder PG, Fokkens WJ. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery. J Allergy Clin Immunol. 2005;115:1017-1023.
Small CB, Hernandez J, Reyes A, et al. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J Allergy Clin Immunol. 2005;116:1275-1281.
Dijkstra MD, Ebbens FA, Poublon RM, Fokkens WJ. Fluticasone propionate aqueous nasal spray does not influence the recurrence rate of chronic rhinosinusitis and nasal polyps 1 year after functional endoscopic sinus surgery. Clin Exp Allergy. 2004;34:1395-1400.
Parikh A, Scadding GK, Darby Y, Baker RC. Topical corticosteroids in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial using fluticasone propionate aqueous nasal spray. Rhinology. 2001;39:75-79.
Jankowski R, Schrewelius C, Bonfils P, et al. Efficacy and tolerability of budesonide aqueous nasal spray treatment in patients with nasal polyps. Arch Otolaryngol Head Neck Surg. 2001;127:447-452.
Keith P, Nieminen J, Hollingworth K, Dolovich J. Efficacy and tolerability of fluticasone propionate nasal drops 400 μg daily compared with placebo for the treatment of bilateral polyposis in adults. Clin Exp Allergy. 2000;30:1460-1468.
Penttilä M, Poulsen P, Hollingworth K, Holmström M. Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 μg once daily and twice daily in the treatment of bilateral nasal polyposis: A placebo-controlled randomized study in adult patients. Clin Exp Allergy. 2000;30:94-102.
Mott AE, Cain WS, Lafreniere D, Leonard G, Gent JF, Frank ME. Topical corticosteroid treatment of anosmia associated with nasal and sinus disease. Arch Otolaryngol Head Neck Surg. 1997;123:367-372.
Mastalerz L, Milewski M, Duplaga M, Nizankowska E, Szczeklik A. Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma. Allergy. 1997;52:895-900.
Lildholdt T, Rundcrantz H, Lindqvist N. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol Allied Sci. 1995;20:26-30.
Huang ZZ, Chen XZ, Huang JC, et al. Budesonide nasal irrigation improved Lund-Kennedy endoscopic score of chronic rhinosinusitis patients after endoscopic sinus surgery. Eur Arch Otorhinolaryngol. 2019;276:1397-1403.
Harvey RJ, Snidvongs K, Kalish LH, Oakley GM, Sacks R. Corticosteroid nasal irrigations are more effective than simple sprays in a randomized double-blinded placebo-controlled trial for chronic rhinosinusitis after sinus surgery. Int Forum Allergy Rhinol. 2018;8:461-470.
Rawal RB, Deal AM, Ebert CS Jr, et al. Post-operative budesonide irrigations for patients with polyposis: a blinded, randomized controlled trial. Rhinology. 2015;53:227-234.
Sindwani R, Han JK, Soteres DF, et al. NAVIGATE I: randomized, placebo-controlled, double-blind trial of the exhalation delivery system with fluticasone for chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2019;33:69-82.
Leopold DA, Elkayam D, Messina JC, Kosik-Gonzalez C, Djupesland PG, Mahmoud RA. NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis. J Allergy Clin Immunol. 2019;143:126-134.e5
Kobayashi Y, Yasuba H, Asako M, et al. HFA-BDP metered-dose inhaler exhaled through the nose improves eosinophilic chronic rhinosinusitis with bronchial asthma: a blinded, placebo-controlled study. Front Immunol. 2018;9:2192.
Soteres DF, Messina J Jr, Carothers J, Mahmoud R, Djupesland PG. Navigate I: A randomized double-blind trial of a fluticasone propionate exhalation delivery system (FLU-EDS) for treatment of chronic rhinosinusitis with nasal polyps (CRSWNP). J Allergy Clin Immunol. 2017;139:AB66
Kern RC, Stolovitzky JP, Silvers SL, et al. A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps. Int Forum Allergy Rhinol. 2018;8:471-481.
Gevaert P, Van Bruaene N, Cattaert T, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011;128: 989-995.e1-8.
Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol. 2013;131:110-116.e1.
Pinto JM, Mehta N, DiTineo M, Wang J, Baroody FM, Naclerio RM. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010;48:318-324.
Stryjewska-Makuch G, Humeniuk-Arasiewicz M, Jura-Szołtys E, Glück J. The effect of antileukotrienes on the results of postoperative treatment of paranasal sinuses in patients with non-steroidal anti-inflammatory drug-exacerbated respiratory disease. Int Arch Allergy Immunol. 2019;179:281-289.
Van Gerven L, Steelant B, Hellings PW. Nasal hyperreactivity in rhinitis: A diagnostic and therapeutic challenge. Allergy. 2018;73:1784-1791.
Dahlén B, Nizankowska E, Szczeklik A, et al. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med. 1998;157(4 pt 1): 1187-1194.
Larivée N, Chin CJ. Aspirin desensitization therapy in aspirin-exacerbated respiratory disease: a systematic review. Int Forum Allergy Rhinol. 2020;10:450-464.
Świerczyńska-Krępa M, Sanak M, Bochenek G, et al. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: A double-blind study. J Allergy Clin Immunol. 2014;134:883-890.
Fruth K, Pogorzelski B, Schmidtmann I, et al. Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease. Allergy. 2013;68:659-665.
Lee JY, Simon RA, Stevenson DD. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2007;119:157-164.
Cho KS, Soudry E, Psaltis AJ, et al. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease. Otolaryngol Head Neck Surg. 2014;151:575-581.
Liu YF, Richardson CM, Bernard SH, Church CA, Seiberling KA. Antibiotics, steroids, and combination therapy in chronic rhinosinusitis without nasal polyps in adults. Ear Nose Throat J. 2018;97:167-172.
Ikeda K, Sakurada T, Suzaki Y, Takasaka T. Efficacy of systemic corticosteroid treatment for anosmia with nasal and paranasal sinus disease. Rhinology. 1995;33:162-165.
Zeng M, Long XB, Cui YH, Liu Z. Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults. Am J Rhinol Allergy. 2011;25:e203-e207.
Hansen FS, Djupesland PG, Fokkens WJ. Preliminary efficacy of fluticasone delivered by a novel device in recalcitrant chronic rhinosinusitis. Rhinology. 2010;48:292-299.
Lund VJ, Black JH, Szabó LZ, Schrewelius C, Åkerlund A. Efficacy and tolerability of budesonide aqueous nasal spray in chronic rhinosinusitis patients. Rhinology. 2004;42:57-62.
Deng J, Chen F, Lai YY, et al. Lack of additional effects of long-term, low-dose clarithromycin combined treatment compared with topical steroids alone for chronic rhinosinusitis in China: a randomized, controlled trial. Int Forum Allergy Rhinol. 2018;8:8-14.
Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope. 2006;116:189-193.
Guilemany JM, García-Piñero A, Alobid I, et al. The loss of smell in persistent allergic rhinitis is improved by levocetirizine due to reduction of nasal inflammation but not nasal congestion (the CIRANO study). Int Arch Allergy Immunol. 2012;158:184-190.
Kalpaklioglu AF, Kavut AB. Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis. Am J Rhinol Allergy. 2010;24:29-33.
Wober W, Crespo CD, Bähre M. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age. Arzneimittelforschung. 1997;47:841-844.
Gambardella R. A comparison of the efficacy of azelastine nasal spray and loratidine tablets in the treatment of seasonal allergic rhinitis. J Int Med Res. 1993;21:268-275.
Higaki T, Okano M, Makihara S, et al. Early interventional treatment with intranasal corticosteroids compared with postonset treatment in pollinosis. Ann Allergy Asthma Immunol. 2012;109:458-464.
Ebbens FA, Scadding GK, Badia L, Hellings PW, Jorissen M, Mullol J, Cardesin A, Bachert C, van Zele TP, Dijkgraaf MG, Lund V, Fokkens WJ. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2006 Nov;118(5):1149-56.
Weschta M., Rimek D., Formanek M., et. al.: Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 2004;113: pp. 1122-1128.
Jiang RS, Twu CW, Liang KL. Efficacy of nasal irrigation with 200 μg/mL amphotericin B after functional endoscopic sinus surgery: a randomized, placebo-controlled, double-blind study. Int Forum Allergy Rhinol. 2018 Jan;8(1):41-48.
Han JK, Bachert C, Fokkens W, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021;9(10):1141-1153.
Mullol J, Mariño-Sánchez F, Valls M, Alobid I, Marin C. The sense of smell in chronic rhinosinusitis. J Allergy Clin Immunol. 2020;145:773-776.
Garzaro M, Pezzoli M, Landolfo V, Defilippi S, Giordano C, Pecorari G. Radiofrequency inferior turbinate reduction: Long-term olfactory and functional outcomes.Otolaryngol Head Neck Surg. 2012;146:146-150.
Ikeda K, Oshima T, Suzuki M, Suzuki H, Shimomura A. Functional inferior turbinosurgery (FITS) for the treatment of resistant chronic rhinitis. Acta Otolaryngol. 2006;126:739-745.
Assanasen P, Choochurn P, Banhiran W, Bunnag C. Radiofrequency inferior turbinate reduction improves smell ability of patients with chronic rhinitis and inferior turbinate hypertrophy. Allergy Rhinol. 2014;5:12-16.
Hamerschmidt R, Hamerschmidt R, Moreira AT, Tenório SB, Timi JR. Comparison of turbinoplasty surgery efficacy in patients with and without allergic rhinitis. Braz J Otorhinolaryngol. 2016;82:131-139.
Parida PK, Santhosh K, Ganesan S, Surianarayanan G, Saxena SK. The efficacy of radiofrequency volumetric tissue reduction of hypertrophied inferior turbinate in allergic rhinitis. Indian J Med Sci. 2011;65:269-277.
Schlosser RJ, Smith TL, Mace JC, et al. Factors driving olfactory loss in patients with chronic rhinosinusitis: a case control study. Int Forum Allergy Rhinol. 2020;10:7-14.
Orlandi RR, Kingdom TT, Hwang PH, et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 2016; 6 suppl 1; S22-S209.
Zhao R, Chen K, Tang Y. Olfactory changes after endoscopic sinus surgery for chronic rhinosinusitis: A meta-analysis. Clin Otolaryngol. 2021;46:41-51.
Kohli P, Naik AN, Farhood Z, et al. Olfactory outcomes after endoscopic sinus surgery for chronic rhinosinusitis: A meta-analysis. Otolaryngol Head Neck Surg. 2016;155:936-948.
Moreno-Luna R, González-García J, Maza-Solano JM, et al. Free nasal floor mucosal grafting after endoscopic total ethmoidectomy for severe nasal polyposis: A pilot study. Rhinology. 2019;57:219-224.
Zhang LC, Sun JW, Li XP, et al. [Effect of endoscopic sinus surgery on olfactory function in patients with chronic rhinosinusitis with nasal polyps.] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019;33:713-717.
Li JY, Chen F, Yu CJ, Ma XF, Li H, Wang HD. [Value discussion of radical sinus surgery for difficult-to-treat rhinosinusitis.] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018;32:749-753.
Mattos JL, Schlosser RJ, Mace JC, Smith TL, Soler ZM. Establishing the minimal clinically important difference for the Questionnaire of Olfactory Disorders. Int Forum Allergy Rhinol. 2018;8:1041-1046.
Walliczek-Dworschak U, Pellegrino R, Taube F, et al. Chemosensory function before and after multimodal treatment in chronic rhinosinusitis patients. Laryngoscope. 2018;128:E86-E90.
Haxel BR, Boessert P, Weyer-Elberich V, Fruth K. Course of olfaction after sinus surgery for chronic rhinosinusitis. Laryngoscope Investig Otolaryngol. 2017;2:269-275.
a. Andrews PJ, Poirrier AL, Lund VJ, Choi D. Outcomes in endoscopic sinus surgery: olfaction, nose scale and quality of life in a prospective cohort study. Clin Otolaryngol. 2016;41(6):798-803.
Dahlén B, Nizankowska E, Szczeklik A, et al. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med. 1998;157(4 pt 1): 1187-1194.
Chen FH, Deng J, Hong HY, et al. Extensive versus functional endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps and asthma: A 1-year study. Am J Rhinol Allergy. 2016;30:143-148.
Lind H, Joergensen G, Lange B, Svendstrup F, Kjeldsen AD. Efficacy of ESS in chronic rhinosinusitis with and without nasal polyposis: a Danish cohort study. Eur Arch Otorhinolaryngol. 2016;273:911-919.
Levy JM, Mace JC, Sansoni ER, Soler ZM, Smith TL. Longitudinal improvement and stability of olfactory function in the evaluation of surgical management for chronic rhinosinusitis. Int Forum Allergy Rhinol. 2016;6:1188-1195.
Soler ZM, Smith TL, Alt JA, Ramakrishnan VR, Mace JC, Schlosser RJ. Olfactory-specific quality of life outcomes after endoscopic sinus surgery. Int Forum Allergy Rhinol. 2016;6:407-413.
Nguyen DT, Guillemin F, Arous F, Jankowski R. Assessment of quality-of-life outcomes after surgery for nasal polyposis with the DyNaChron questionnaire. Eur Arch Otorhinolaryngol. 2015;272:367-375.
Nguyen DT, Bey A, Arous F, Nguyen-Thi PL, Felix-Ravelo M, Jankowski R. Can surgeons predict the olfactory outcomes after endoscopic surgery for nasal polyposis? Laryngoscope. 2015;125:1535-1540.
DeConde AS, Mace JC, Alt JA, Soler ZM, Orlandi RR, Smith TL. Investigation of change in cardinal symptoms of chronic rhinosinusitis after surgical or ongoing medical management. Int Forum Allergy Rhinol. 2015;5:36-45.
Kim BG, Oh JH, Choi HN, Park SY. Simple assessment of olfaction in patients with chronic rhinosinusitis. Acta Otolaryngol. 2015;135:258-263.
Kuperan AB, Lieberman SM, Jourdy DN, Al-Bar MH, Goldstein BJ, Casiano RR. The effect of endoscopic olfactory cleft polyp removal on olfaction. Am J Rhinol Allergy. 2015;29:309-313.
Hajjij A, Mace JC, Soler ZM, Smith TL, Hwang PH. The impact of diabetes mellitus on outcomes of endoscopic sinus surgery: A nested case-control study. Int Forum Allergy Rhinol. 2015;5:533-540.
Deconde AS, Mace JC, Alt JA, Schlosser RJ, Smith TL, Soler ZM. Comparative effectiveness of medical and surgical therapy on olfaction in chronic rhinosinusitis: A prospective, multi-institutional study. Int Forum Allergy Rhinol. 2014;4:725-733.
Jiang RS, Liang KL, Wu SH, Su MC, Chen WK, Lu FJ. Electrolyzed acid water nasal irrigation after functional endoscopic sinus surgery. Am J Rhinol Allergy. 2014;28:176-181.
Katotomichelakis M, Simopoulos E, Tripsianis G, et al. Improvement of olfactory function for quality of life recovery. Laryngoscope. 2013;123:E10-E16.
Minwegen F, Thomas JP, Bernal-Sprekelsen M, Dazert S, Minovi A. Predictive value of disease severity on self-reported rating and quantitative measures of olfactory function outcomes after primary endoscopic sinus surgery. A prospective study. Rhinology. 2014;52:437-443.
Baradaranfar MH, Ahmadi ZS, Dadgarnia MH, et al. Comparison of the effect of endoscopic sinus surgery versus medical therapy on olfaction in nasal polyposis. Eur Arch Otorhinolaryngol. 2014;271:311-316.
Murthy P, Banerjee S. Predictive factors for a good outcome following endoscopic sinus surgery. Indian J Otolaryngol Head Neck Surg. 2013;65(suppl 2): 276-282.
Saedi B, Sadeghi M, Yazdani N, Afshari A. Effectiveness of FESS in smell improvement of sinusitis patients. Indian J Otolaryngol Head Neck Surg. 2013;65(suppl 2): 283-287.
Schriever VA, Gupta N, Pade J, Szewczynska M, Hummel T. Olfactory function following nasal surgery: A 1-year follow-up. Eur Arch Otorhinolaryngol. 2013;270:1074-111.
Hsu CY, Wang YP, Shen PH, Weitzel EK, Lai JT, Wormald PJ. Objective olfactory outcomes after revision endoscopic sinus surgery. Am J Rhinol Allergy. 2013;27:e96-e100.
Saafan ME, Ragab SM, Albirmawy OA, Elsherif HS. Powered versus conventional endoscopic sinus surgery instruments in management of sinonasal polyposis. Eur Arch Otorhinolaryngol. 2013;270:149-155.
Bhandarkar ND, Mace JC, Smith TL. The impact of osteitis on disease severity measures and quality of life outcomes in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2011;1:372-378.
Soler ZM, Sauer DA, Mace JC, Smith TL. Ethmoid histopathology does not predict olfactory outcomes after endoscopic sinus surgery. Am J Rhinol Allergy. 2010;24:281-285.
Katotomichelakis M, Gouveris H, Tripsianis G, Simopoulou M, Papathanassiou J, Danielides V. Biometric predictive models for the evaluation of olfactory recovery after endoscopic sinus surgery in patients with nasal polyposis. Am J Rhinol Allergy. 2010;24:281-285.
Konstantinidis I, Witt M, Kaidoglou K, Constantinidis J, Gudziol V. Olfactory mucosa in nasal polyposis: Implications for fess outcome. Rhinology. 2010;48:47-53.
Litvack JR, Mace J, Smith TL. Does olfactory function improve after endoscopic sinus surgery? Otolaryngol Head Neck Surg. 2009;140:312-319.
Salama N, Oakley RJ, Skilbeck CJ, Choudhury N, Jacob A. Benefit from the minimally invasive sinus technique. J Laryngol Otol. 2009;123:186-190.
Bugten V, Nordgård S, Romundstad P, Steinsvåg S. Chronic rhinosinusitis and nasal polyposis: Indicia of heterogeneity. Rhinology. 2008;46:40-44.
Konstantinidis I, Triaridis S, Printza A, Vital V, Ferekidis E, Constantinidis J. Olfactory dysfunction in nasal polyposis: Correlation with computed tomography findings. ORL J Otorhinolaryngol Relat Spec. 2007;69:226-232.
Lee JY, Simon RA, Stevenson DD. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2007;119:157-164.
Alobid I, Benítez P, Bernal-Sprekelsen M, et al. Nasal polyposis and its impact on quality of life: Comparison between the effects of medical and surgical treatments. Allergy. 2005;60:452-458.
Brann DH, Datta SR. Finding the brain in the nose. Annu Rev Neurosci. 2020;43:277-295.
Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54:1-30.
Lu VM, Goyal A, Rovin RA. Olfactory groove and tuberculum sellae meningioma resection by endoscopic endonasal approach versus transcranial approach: A systematic review and meta-analysis of comparative studies. Clin Neurol Neurosurg. 2018;174:13-20.
Albers AD, Amato I, Albers MW. Olanzapine improved symptoms and olfactory function in an olfactory reference syndrome patient. J Neuropsychiatry Clin Neurosci. 2018;30:164-167.
Rosenfeldt AB, Dey T, Alberts JL. Aerobic exercise preserves olfaction function in individuals with Parkinson's disease. Parkinsons Dis. 2016;2016: 9725089.
Knudsen K, Damholdt MF, Mouridsen K, Borghammer P. Olfactory function in Parkinson's Disease - effects of training. Acta Neurol Scand. 2015;132:395-400
Sorokowska A, Drechsler E, Karwowski M, Hummel T. Effects of olfactory training: a meta-analysis. Rhinology. 2017;55:17-26.
Al Aïn S, Poupon D, Hétu S, Mercier N, Steffener J, Frasnelli J. Smell training improves olfactory function and alters brain structure. Neuroimage. 2019;189:45-54.
Haehner A, Tosch C, Wolz M, et al. Olfactory training in patients with Parkinson's disease. PLoS One. 2013;8: e61680.
Hauser RA, Silver D, Choudhry A, Eyal E, Isaacson S; ANDANTE study investigators. Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease. Mov Disord. 2014;29:1028-1034.
Haehner A, Hummel T, Wolz M, et al. Effects of rasagiline on olfactory function in patients with Parkinson's disease. Mov Disord. 2013;28:2023-2027.
Haehner A, Habersack A, Wienecke M, Storch A, Reichmann H, Hummel T. Early Parkinson's disease patients on rasagiline present with better odor discrimination. J Neural Transm (Vienna). 2015;122:1541-1546.
Weinstock RS, Wright HN, Smith DU. Olfactory dysfunction in diabetes mellitus. Physiol Behav. 1993;53:17-21.
Brady S, Lalli P, Midha N, et al. Presence of neuropathic pain may explain poor performances on olfactory testing in diabetes mellitus patients. Chem Senses. 2013;38:497-507.
Sanke H, Mita T, Yoshii H, et al. Relationship between olfactory dysfunction and cognitive impairment in elderly patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2014;106:465-473.
Yulug B, Saatci O, Işıklar A, et al. The association between HbA1c levels, olfactory memory and cognition in normal, pre-diabetic and diabetic persons. Endocr Metab Immune Disord Drug Targets. 2020;20:198-212.
Altundag A, Ay SA, Hira S, et al. Olfactory and gustatory functions in patients with non-complicated type 1 diabetes mellitus. Eur Arch Otorhinolaryngol. 2017;274:2621-2627.
Gouveri E, Katotomichelakis M, Gouveris H, Danielides V, Maltezos E, Papanas N. Olfactory dysfunction in type 2 diabetes mellitus: an additional manifestation of microvascular disease? Angiology. 2014;65:869-876.
Veyseller B, Dogan R, Yenigun A, et al. Hyperbaric oxygen therapy of olfactory dysfunction in diabetic neuropathy with type 2 diabetes mellitus and a new definition diabetic olfactopathy. Rhinology. 2016;54:273-277.
McConnell RJ, Menendez CE, Smith FR, Henkin RI, Rivlin RS. Defects of taste and smell in patients with hypothyroidism. Am J Med. 1975;59:354-364.
Günbey E, Karlı R, Gökosmanoğlu F, et al. Evaluation of olfactory function in adults with primary hypothyroidism. Int Forum Allergy Rhinol. 2015;5:919-922.
Paternostro MA, Meisami E. Essential role of thyroid hormones in maturation of olfactory receptor neurons: an immunocytochemical study of number and cytoarchitecture of OMP-positive cells in developing rats. Int J Dev Neurosci. 1996;14:867-880.
Baskoy K, Ay SA, Altundag A, et al. Is there any effect on smell and taste functions with levothyroxine treatment in subclinical hypothyroidism? PLoS One. 2016;11: e0149979.
Peng M, Coutts D, Wang T, Cakmak YO. Systematic review of olfactory shifts related to obesity. Obes Rev. 2019;20:325-338.
Richardson BE, Vanderwoude EA, Sudan R, Leopold DA, Thompson JS. Gastric bypass does not influence olfactory function in obese patients. Obes Surg. 2012;22:283-286.
Holinski F, Menenakos C, Haber G, Olze H, Ordemann J. Olfactory and gustatory function after bariatric surgery. Obes Surg. 2015;25:2314-2320.
Perricone C, Shoenfeld N, Agmon-Levin N, de Carolis C, Perricone R, Shoenfeld Y. Smell and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol. 2013;45:87-96.
Strous RD, Shoenfeld Y. To smell the immune system: olfaction, autoimmunity and brain involvement. Autoimmun Rev. 2006;6:54-60.
Shoenfeld N, Agmon-Levin N, Flitman-Katzevman I, et al. The sense of smell in systemic lupus erythematosus. Arthritis Rheum. 2009;60:1484-1487.
Bombini MF, Peres FA, Lapa AT, et al. Olfactory function in systemic lupus erythematosus and systemic sclerosis. A longitudinal study and review of the literature. Autoimmun Rev. 2018;17:405-412.
Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539-551.
Yagi-Nakanishi S, Kondo S, Kaneda M, et al. Olfactory dysfunction in IgG4-related disease. Chem Senses. 2016;41:721-725.
Takano K, Yamamoto M, Kondo A, Takahashi H, Himi T. A clinical study of olfactory dysfunction in patients with Mikulicz's disease. Auris Nasus Larynx. 2011;38:347-351.
Henkin RI, Patten BM, Re PK, Bronzert DA. A syndrome of acute zinc loss. Cerebellar dysfunction, mental changes, anorexia, and taste and smell dysfunction. Arch Neurol. 1975;32:745-751.
Tomita H. [Zinc-deficient disorders of sense organs-dark adaptation, taste and smell disorders]. Nihon Rinsho. 1996;54:141-147.
a. Aiba T, Sugiura M, Mori J, et al. Effect of zinc sulfate on sensorineural olfactory disorder. Acta Otolaryngol Suppl. 1998;538:202-204.
Cancalon P. Degeneration and regeneration of olfactory cells induced by ZNSO4, and other chemicals. Tissue Cell. 1982;14:717-733.
Schultz EW, Gebhardt LP. Zinc Sulphaye prophylaxis in poliomyelitis. JAMA. 1937;108:2184-2187.
Tisdale FF, Brown A, Defries RD. Persistent anosmia following zinc sulphate spraying. J Pediatrics. 1938;13:277-314.
Jafek BW, Linschoten MR, Murrow BW. Anosmia after intranasal zinc gluconate use. Am J Rhinol. 2004;18:137-141.
Alexander TH, Davidson TM. Intranasal zinc and anosmia: the zinc-induced anosmia syndrome. Laryngoscope. 2006;116:217-220.
Seidman M. Letter to the Editor RE: Alexander TH, Davidson TM. Intranasal zinc and anosmia: the zinc-induced anosmia syndrome. Laryngoscope 2006;116:217-220. Laryngoscope 2006; 116: 1720-1721; discussion 1722-1723.
a. Garrett-Laster M, Russell RM, Jacques PF. Impairment of taste and olfaction in patients with cirrhosis: the role of vitamin A. Hum Nutr Clin Nutr. 1984;38:203-214.
Reden J, Lill K, Zahnert T, Haehner A, Hummel T. Olfactory function in patients with postinfectious and posttraumatic smell disorders before and after treatment with vitamin A: a double-blind, placebo-controlled, randomized clinical trial. Laryngoscope. 2012;122:1906-1909.
Hummel T, Whitcroft KL, Rueter G, Haehner A. Intranasal vitamin A is beneficial in post-infectious olfactory loss. Eur Arch Otorhinolaryngol. 2017;274:2819-2825.
Kopala LC, Good K, Goldner EM, Birmingham CL. Olfactory identification ability in anorexia nervosa. J Psychiatry Neurosci. 1995;20:283-286.
Dinc ME, Dalgic A, Ulusoy S, Dizdar D, Develioglu O, Topak M. Does iron deficiency anemia affect olfactory function? Acta Otolaryngol. 2016;136:754-757.
Hansen BR, Bottner WA, Ravindran A, DeJesus R, Go RS. A follow-up on desiderosmia (olfactory craving), a novel symptom associated with iron deficiency anemia. Am J Hematol. 2017;92:E546.
Derin S, Koseoglu S, Sahin C, Sahan M. Effect of vitamin B12 deficiency on olfactory function. Int Forum Allergy Rhinol. 2016;6:1051-1055
Eibenstein A, Fioretti AB, Simaskou MN, et al. Olfactory screening test in mild cognitive impairment. Neurol Sci. 2005;26:156-160.
Håglin L, Johansson I, Forsgren L, Bäckman L. Intake of vitamin B before onset of Parkinson's disease and atypical parkinsonism and olfactory function at the time of diagnosis. Eur J Clin Nutr. 2017;71:97-102.
Heilmann S, Just T, Göktas O, Hauswald B, Hüttenbrink KB, Hummel T. [Effects of systemic or topical administration of corticosteroids and vitamin B in patients with olfactory loss]. Laryngorhinootologie. 2004;83:729-734.
Selhub J, Bagley LC, Miller J, Rosenberg IH. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr. 2000;71:614S-620S.
Moll S, Varga EA. Homocysteine and MTHFR mutations. Circulation. 2015;132:e6-e9.
Yan CH, Overdevest JB, Patel ZM. Therapeutic use of steroids in non-chronic rhinosinusitis olfactory dysfunction: a systematic evidence-based review with recommendations. Int Forum Allergy Rhinol. 2019;9:165-176.
Stenner M, Vent J, Huttenbrink K-B, Hummel T, Damm M. Topical therapy in anosmia: relevance of steroid-responsiveness. Laryngoscope. 2008;118:1681-1686.
Fleiner F, Goktas O. Topical beclomethasone in the therapy of smelling disorders-a new application technique. Indian J Otolaryngol Head Neck Surg. 2011;63:5-9.
Fleiner F, Lau L, Goktas O. Active olfactory training for the treatment of smelling disorders. Ear Nose Throat J. 2012;91:198-203, 215.
Blomqvist EH, Lundblad L, Bergstedt H, Stjärne P. Placebo-controlled, randomized, double-blind study evaluating the efficacy of fluticasone propionate nasal spray for the treatment of patients with hyposmia/anosmia. Acta Otolaryngol (Stockh). 2003;123:862-868.
Nguyen TP, Patel ZM. Budesonide irrigation with olfactory training improves outcomes compared with olfactory training alone in patients with olfactory loss. Int Forum Allergy Rhinol. 2018;8:977-981.
Lam K, Tan BK, Lavin JM, Meen E, Conley DB. Comparison of nasal sprays and irrigations in the delivery of topical agents to the olfactory mucosa. Laryngoscope. 2013;123:2950-2957.
Beule A, Athanasiadis T, Athanasiadis E, Field J, Wormald PJ. Efficacy of different techniques of sinonasal irrigation after modified Lothrop procedure. Am J Rhinol Allergy. 2009;23:85-90.
Scheibe M, Bethge C, Witt M, Hummel T. Intranasal administration of drugs. Arch Otolaryngol Head Neck Surg. 2008;134:643-646.
Herranz Gonzalez-Botas J, Padin Seara A. Nasal gel and olfactory cleft. Acta Otorrinolaringol Esp. 2012;63:370-375.
Cannady SB, Batra PS, Citardi MJ, Lanza DC. Comparison of delivery of topical medications to the paranasal sinuses via “vertex-to-floor” position and atomizer spray after FESS. Otolaryngol Head Neck Surg. 2005;133:735-740.
Rudman KL, O'Brien EK, Leopold DA. Radiographic distribution of drops and sprays within the sinonasal cavities. Am J Rhinol Allergy. 2011;25:94-97.
Manes RP, Tong L, Batra PS. Prospective evaluation of aerosol delivery by a powered nasal nebulizer in the cadaver model. Int Forum Allergy Rhinol. 2011;1:366-371.
Raghavan U, Logan BM. New method for the effective instillation of nasal drops. J Laryngol Otol. 2000;114:456-459.
Mori E, Merkonidis C, Cuevas M, Gudziol V, Matsuwaki Y, Hummel T. The administration of nasal drops in the “Kaiteki” position allows for delivery of the drug to the olfactory cleft: a pilot study in healthy subjects. Eur Arch Otorhinolaryngol. 2016;273:939-943.
Kidwai SM, Parasher AK, Khan MN, et al. Improved delivery of sinus irrigations after middle turbinate resection during endoscopic sinus surgery. Int Forum Allergy Rhinol. 2017;7:338-342.
Fujii M, Fukazawa K, Takayasu S, Sakagami M. Olfactory dysfunction in patients with head trauma. Auris Nasus Larynx. 2002;29:35-40.
Fukazawa K. A local steroid injection method for olfactory loss due to upper respiratory infection. Chem Senses. 2005;30 suppl 1: i212-i213.
Jiang RS, Wu SH, Liang KL, Shiao JY, Hsin CH, Su MC. Steroid treatment of posttraumatic anosmia. Eur Arch Otorhinolaryngol. 2010;267:1563-1567.
Schriever VA, Merkonidis C, Gupta N, Hummel C, Hummel T. Treatment of smell loss with systemic methylprednisolone. Rhinology. 2012;50:284-289.
Ikeda K, Sakurada T, Suzaki Y, Takasaka T. Efficacy of systemic corticosteroid treatment for anosmia with nasal and paranasal sinus disease. Rhinology. 1995;33:162-165.
Jiang RS, Twu CW, Liang KL. Medical treatment of traumatic anosmia. Otolaryngol Head Neck Surg. 2015;152:954-958.
Seo BS, Lee HJ, Mo JH, Lee CH, Rhee CS, Kim JW. Treatment of postviral olfactory loss with glucocorticoids, Ginkgo biloba, and mometasone nasal spray. Arch Otolaryngol Head Neck Surg. 2009;135:1000-1004.
Kim DH, Kim SW, Hwang SH, et al. Prognosis of olfactory dysfunction according to etiology and timing of treatment. Otolaryngol Head Neck Surg. 2017;156:371-377.
Ikeda K, Sakurada T, Takasaka T, Okitsu T, Yoshida S. Anosmia following head trauma: preliminary study of steroid treatment. Tohoku J Exp Med. 1995;177:343-351.
Heilmann S, Huettenbrink KB, Hummel T. Local and systemic administration of corticosteroids in the treatment of olfactory loss. Am J Rhinol. 2004;18:29-33.
Yao TC, Huang YW, Chang SM, Tsai SY, Wu AC, Tsai HJ. Association between oral corticosteroid bursts and severe adverse events: a nationwide population-based cohort study. Ann Intern Med. 2020;173:325-330.
Hummel T, Rissom K, Reden J, Hahner A, Weidenbecher M, Huttenbrink KB. Effects of olfactory training in patients with olfactory loss. Laryngoscope. 2009;119:496-499.
Liu DT, Pellegrino R, Sabha M, et al. Factors associated with relevant olfactory recovery after olfactory training: a retrospective study including 601 participants. Rhinology. 2020 Sep 9. https://doi.org/10.4193/Rhin20.262. Online ahead of print.
Kattar N, Do TM, Unis GD, Migneron MR, Thomas AJ, McCoul ED. Olfactory training for postviral olfactory dysfunction: Systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2021;164:244-254.
Konstantinidis I, Tsakiropoulou E, Bekiaridou P, Kazantzidou C, Constantinidis J. Use of olfactory training in post-traumatic and postinfectious olfactory dysfunction. Laryngoscope. 2013;123:E85-E90.
Hura N, Xie DX, Choby GW, et al. Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2020;10:1065-1086.
Damm M, Pikart L, Reimann H. Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study. Laryngoscope. 2014;124:826-831.
Haehner A, Tosch C, Wolz M. Olfactory training in patients with Parkinson's disease. PLoS One. 2013;8: e61680.
Lamira JM, Soler ZM, Schlosser RJ. A pilot study of olfactory training in older hyposmic adults. Am J Rhinol Allergy. 2019;33:650-656.
Sorokowska A, Drechsler E, Karwowski M, Hummel T. Effects of olfactory training: a meta-analysis. Rhinology. 2017;55:17-26.
Pekala K, Chandra RK, Turner JH. Efficacy of olfactory training in patients with olfactory loss: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2016;6:299-307.
Patel ZM, Wise SK, DelGaudio JM. Randomized controlled trial demonstrating cost-effective method of olfactory training in clinical practice: essential oils at uncontrolled concentration. Laryngoscope Investig Otolaryngol. 2017;2:53-56.
Altundag A, Cayonu M, Kayabasoglu G, et al. Modified olfactory training in patients with postinfectious olfactory loss. Laryngoscope. 2015;125:1763-1766.
Saatci O, Altundag A, Duz OA, Hummel T. Olfactory training ball improves adherence and olfactory outcomes in post-infectious olfactory dysfunction. Eur Arch Otorhinolaryngol. 2020;277:2125-2132.
Oleszkiewicz A, Hanf S, Whitcroft KL, Haehner A, Hummel T. Examination of olfactory training effectiveness in relation to its complexity and the cause of olfactory loss. Laryngoscope. 2018;128:1518-1522.
Jiang RS, Twu CW, Liang KL. The effect of olfactory training on odor identification in patients with traumatic anosmia. Int Forum Allergy Rhinol. 2019;9:1244-1251.
Poletti SC, Michel E, Hummel T. Olfactory training using heavy and light weight molecule odors. Perception. 2017;46:343-351.
Langdon C, Lehrer E, Berenguer J, et al. Olfactory training in post-traumatic smell impairment: mild improvement in threshold performances: results from a randomized controlled trial. J Neurotrauma. 2018;35:2641-2652.
Qiao XF; Bai YH; Wang GP; Li X; Zheng W. Clinical effects of two combinations of olfactory agents on olfactory dysfunction after upper respiratory tract infection during olfactory training. Rev Assoc Med Bras (1992). 2020: 66:18-24.
Konstantinidis I, Tsakiropoulou E, Constantinidis J. Long term effects of olfactory training in patients with post-infectious olfactory loss. Rhinology. 2016;54:170-175.
Fornazieri MA, Garcia EC, Lopes NM, et al. Adherence and efficacy of olfactory training as a treatment for persistent olfactory loss. Am J Rhinol Allergy. 2020;34:238-248.
Addison AB, Philpott CM. A systematic review of therapeutic options for non-conductive olfactory dysfunction. Otorhinolaryngologist. 2018;11:61-71.
Jiang RS, Twu CW, Liang KL. The effect of olfactory training on the odor threshold in patients with traumatic anosmia. Am J Rhinol Allergy. 2017;31:317-322.
Choi BY, Jeong H, Noh H, Park JY, Cho JH, Kim JK. Effects of olfactory training in patients with postinfectious olfactory dysfunction. Clin Exp Otorhinolaryngol. 2021;14:88-92.
Gellrich J, Han P, Manesse C, Betz A, Junghanns A, Raue C, Schriever VA, Hummel T. Brain volume changes in hyposmic patients before and after olfactory training. Laryngoscope. 2018;128:1531-1536.
Hummel T, Stupka G, Haehner A, Poletti SC. Olfactory training changes electrophysiological responses at the level of the olfactory epithelium. Rhinology. 2018;56:330-335.
Hura N, Xie DX, Choby GW, et al. Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2020;10:1065-1086.
Addison AB, Philpott CM. A systematic review of therapeutic options for non-conductive olfactory dysfunction. Otorhinolaryngologist. 2018;11:61-71.
Whitcroft KL, Merkonidis C, Cuevas M, et al. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia. Rhinology. 2016;54:368-374.
Philpott CM, Erskine SE, Clark A, et al. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders. Clin Otolaryngol. 2017;42:1295-1302.
Whitcroft KL, Ezzat M, Cuevas M, et al. The effect of intranasal sodium citrate on olfaction in post-infectious loss: results from a prospective, placebo-controlled trial in 49 patients. Clin Otolaryngol. 2017;42:557-563.
Whitcroft KL, Gunder N, Cuevas M, et al. Intranasal sodium citrate in quantitative and qualitative olfactory dysfunction: results from a prospective, controlled trial of prolonged use in 60 patients. Eur Arch Otorhinolaryngol. 2021;278:2891-2897.
Panagiotopoulos G, Naxakis S, Papavasiliou A, Filipakis K, Papatheodorou G, Goumas P. Decreasing nasal mucus Ca++ improves hyposmia. Rhinology. 2005;43:130-134.
Hichami A, Datiche F, Ullah S, et al. Olfactory discrimination ability and brain expression of c-fos, Gir and Glut1 mRNA are altered in n-3 fatty acid-depleted rats. Behav Brain Res. 2007;184(1):1-10.
Canhada S, Castro K, Perry IS, Luft VC. Omega-3 fatty acids’ supplementation in Alzheimer's disease: A systematic review. Nutr Neurosci. 2018;21:529-538.
Lewis EJ, Perkins BA, Lovblom LE, Bazinet RP, Wolever TM, Bril V. Effect of omega-3 supplementation on neuropathy in type 1 diabetes. Neurology. 2017;88:2294-2301.
Gladman SJ, Huang W, Lim SN, et al. Improved outcome after peripheral nerve injury in mice with increased levels of endogenous ω-3 polyunsaturated fatty acids. J Neurosci. 2012;32:563-571.
Yan CH, Rathor A, Krook K, et al. Effect of omega-3 supplementation in patients with smell dysfunction following endoscopic sellar and parasellar tumor resection: a multicenter prospective randomized controlled trial. Neurosurgery. 2020;87:E91-E98.
Gopinath B, Sue CM, Flood VM, Burlutsky G, Mitchell P. Dietary intakes of fats, fish and nuts and olfactory impairment in older adults. Br J Nutr. 2015;114:240-247.
Mazahery H, Conlon CA, Beck KL, et al. A randomised-controlled trial of vitamin d and omega-3 long chain polyunsaturated fatty acids in the treatment of core symptoms of autism spectrum disorder in children. J Autism Dev Disord. 2019;49:1778-1794.
Lyckholm L, Heddinger SP, Parker G, Coyne PJ, Ramakrishnan V, Smith TJ, Henkin RI. A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders. J Pain Palliat Care Pharmacother. 2012;26:111-114.
Aiba T, Sugiura M, Mori J, Matsumoto K, Tomiyama K, Okuda F, et al. Effect of zinc sulfate on sensoryneural olfactory disorder. Acta Otolaryngol. 1998; suppl 538:202-204.
Quint C, Temmel AF, Hummel T, Ehrenberger K. The quinoxaline derivative caroverine in the treatment of sensorineural smell disorders: A proof-of-concept study. Acta Otolaryngol. 2002;122:877-881.
Harless L, Liang J. Pharmacologic treatment for postviral olfactory dysfunction: A systematic review. Int Forum Allergy Rhinol. 2016;6:760-767.
Henkin RI, Schecter PJ, Friedewald WT, Demets DL, Raff M. A double blind study of the effects of zinc sulfate on taste and smell dysfunction. Am J Med Sci. 1976;272:285-299.
Jiang RS, Twu CW, Liang KL. Medical treatment of traumatic anosmia. Otolaryngol Head Neck Surg. 2015;152:954-958.
Fosmire GJ. Zinc toxicity. Am J Clin Nutr. 1990;51:225-227.
Eby GA, Halcomb WW. Ineffectiveness of zinc gluconate nasal spray and zinc orotate lozenges in common-cold treatment: A double-blind, placebo-controlled clinical trial. Altern Ther Health Med. 2006;12:34-38.
Hummel T, Heilmann S, Hüttenbriuk KB. Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract. Laryngoscope. 2002;112:2076-2080.
Duncan R, Briggs M. Treatment of uncomplicated anosmia by vitamin A. Arch Otolaryngol. 1962;75:116-124.
Garrett-Laster M, Russell RM, Jacques PF. Impairment of taste and olfaction in patients with cirrhosis: the role of vitamin A. Hum Nutr Clin Nutr. 1984;38:203-214.
Reden J, Lill K, Zahnert T, Haehner A, Hummel T. Olfactory function in patients with postinfectious and posttraumatic smell disorders before and after treatment with vitamin A: A double-blind, placebo-controlled, randomized clinical trial. Laryngoscope. 2012;122:1906-1909.
Kartal D, Yaşar M, Kartal L, Özcan I, Borlu M. Effects of isotretinoin on the olfactory function in patients with acne. An Bras Dermatol. 2017;92:191-195.
Hummel T, Whitcroft K, Rueter G, Haehner A. Intranasal vitamin A is beneficial in post-infectious olfactory loss. Eur Arch Otorhinolaryngol. 2017;274:2819-2825.
Intranasal retinoic acid treatment for patients with olfactory loss: a randomized controlled trial. ClinicalTrials.gov identifier: NCT03574701. Accessed June 22, 2021. https://clinicaltrials.gov/ct2/show/NCT03574701
Miwa T, Ikeda K, Ishibashi T, et al. Clinical practice guidelines for the management of olfactory dysfunction - secondary publication. Auris Nasus Larynx. 2019;46:653-662.
Miwa T, Tsukatani T, Ikeno S, Furukawa M. The effectiveness of Toki-syakuyaku-san for the olfactory disturbed patients. Jpn Assoc Study Taste Smell. 2005;12:523-524.
Uchida J, Furuta A, Suzaki H. Kampo treatment on the cases of olfactory dysfunction. Otorhinolaryngol Neurosci. 2009;23:20-21.
Ogawa T, Kato T, Tojima I, Shibayama M, Shimizu T. Clinical study of olfactory dysfunction after upper respiratory infection. Jpn J Taste Smell Res. 2010;17:511-514.
Ogawa T, Nakamura K, Yamamoto S, Tojima I, Shimizu T. Recovery over time and prognostic factors in treated patients with post-infectious olfactory dysfunction: A retrospective study. Ann Otol Rhinol Laryngol. 2020;129:977-982.
Jonas M, Cunha BA. Minocycline. Ther Drug Monit. 1982;4:137-145.
Garrido-Mesa N, Zarzuelo A, Gálvez J. Minocycline: far beyond an antibiotic. Br J Pharmacol. 2013;169:337-352.
Lees KA, Orlandi RR, Oakley G, Alt JA. The role of macrolides and doxycycline in chronic rhinosinusitis. Immunol Allergy Clin North Am. 2020;40:303-315.
Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review. Clin Ther. 2005;27:1329-1342.
Plane JM, Shen Y, Pleasure DE, Deng W. Prospects for minocycline neuroprotection. Arch Neurol. 2010;67:1442-1448.
Kern RC, Conley DB, Haines GK 3rd, Robinson AM. Treatment of olfactory dysfunction, II: Studies with minocycline. Laryngoscope. 2004;114:2200-2204.
Conley DB, Robinson AM, Shinners MJ, Kern RC. Age-related olfactory dysfunction: cellular and molecular characterization in the rat. Am J Rhinol. 2003;17:169-75.
Vent J, Robinson AM, Gentry-Nielsen MJ, Conley DB, Hallworth R, Leopold DA, Kern RC. Pathology of the olfactory epithelium: smoking and ethanol exposure. Laryngoscope. 2004;114:1383-1388.
Kern RC, Conley DB, Haines GK 3rd, Robinson AM. Pathology of the olfactory mucosa: implications for the treatment of olfactory dysfunction. Laryngoscope. 2004;114:279-285.
Reden J, Herting B, Lill K, Kern R, Hummel T. Treatment of postinfectious olfactory disorders with minocycline: a double-blind, placebo-controlled study. Laryngoscope. 2011;121:679-682.
Henkin RI, Velicu I, Schmidt L. An open-label controlled trial of theophylline for treatment of patients with hyposmia. Am J Med Sci. 2009;337:396-406.
Henkin RI, Schultz M, Minnick-Poppe L. Intranasal theophylline treatment of hyposmia and hypogeusia: A pilot study. Arch Otolaryngol Head Neck Surg. 2012;138:1064-1070.
Nigwekar SU, Weiser JM, Kalim S, et al. Characterization and correction of olfactory deficits in kidney disease. J Am Soc Nephrol. 2017;28:3395-3403.
Meusel T, Albinus J, Welge-Luessen A, Hähner A, Hummel T. Short-term effect of caffeine on olfactory function in hyposmic patients. Eur Arch Otorhinolaryngol. 2016;273:2091-2095.
Gudziol V, Mück-Weymann M, Seizinger O, Rauh R, Siffert W, Hummel T. Sildenafil affects olfactory function. J Urol. 2007;177:258-261; discussion 261.
Gudziol V, Hummel T. Effects of pentoxifylline on olfactory sensitivity: a postmarketing surveillance study. Arch Otolaryngol Head Neck Surg. 2009;135:291-295.
Whitcroft KL, Gudziol V, Hummel T. Short-course pentoxifylline is not effective in post-traumatic smell loss: A pilot study. Ear Nose Throat J. 2020;99:58-61.
Levy LM, Henkin RI, Lin CS, Hutter A, Schellinger D. Increased brain activation in response to odors in patients with hyposmia after theophylline treatment demonstrated by fMRI. J Comput Assist Tomogr. 1998;22:760-770.
Henkin RI, Velicu I, Schmidt L. Relative resistance to oral theophylline treatment in patients with hyposmia manifested by decreased secretion of nasal mucus cyclic nucleotides. Am J Med Sci. 2011;341:17-22.
Henkin RI, Hosein S, Stateman WA, Knöppel AB, Abdelmeguid M. Improved smell function with increased nasal mucus sonic hedgehog in hyposmic patients after treatment with oral theophylline. Am J Otolaryngol. 2017;38:143-147.
Stafford LD, Damant K, Ashurst S, Parker MO. Higher olfactory sensitivity to coffee odour in habitual caffeine users. Exp Clin Psychopharmacol. 2020;28:245-250.
Renner DB, Svitak AL, Gallus NJ, Ericson ME, Frey WH, Hanson LR. Intranasal delivery of insulin via the olfactory nerve pathway. J Pharm Pharmacol. 2012;64:1709-1714.
Ketterer C, Heni M, Thamer C, Herzberg-Schäfer SA, Häring HU, Fritsche A. Acute, short-term hyperinsulinemia increases olfactory threshold in healthy subjects. Int J Obes (Lond). 2011;35:1135-1138.
Brünner YF, Benedict C, Freiherr J. Intranasal insulin reduces olfactory sensitivity in normosmic humans. J Clin Endocrinol Metab. 2013;98:1626-1630.
Thanarajah SE, Hoffstall V, Rigoux L, Hanssen R, Brüning JC, Tittgemeyer M. The role of insulin sensitivity and intranasally applied insulin on olfactory perception. Sci Rep. 2019;10; 9: 7222.
Hallschmid M, Higgs S, Thienel M, Ott V, Lehnert H. Postprandial administration of intranasal insulin intensifies satiety and reduces intake of palatable snacks in women. Diabetes. 2012;61:782-789
Rezaeian A. Effect of intranasal insulin on olfactory recovery in patients with hyposmia: A randomized clinical trial. Otolaryngol Head Neck Surg. 2018;158:1134-1139.
Schöpf V, Kollndorfer K, Pollak M, Mueller CA, Freiherr J. Intranasal insulin influences the olfactory performance of patients with smell loss, dependent on the body mass index: A pilot study. Rhinology. 2015;53:371-378.
Degerman, E, Rauch, U, Lindberg, S, Caye-Thomasen, P, Hultgårdh, A, Magnusson, M. Expression of insulin signalling components in the sensory epithelium of the human saccule. Cell Tissue Res. 2013;352:469-478.
Yan CH, Mundy DC, Patel ZM. The use of platelet-rich plasma in treatment of olfactory dysfunction: A pilot study. Laryngoscope Investig Otolaryngol. 2020;5:187-193.
Mavrogeni P, Kanakopoulos A, Maihoub S, Maihoub S, Krasznai M, Szirmai A. Anosmia treatment by platelet rich plasma injection. Int Tinnitus J. 2016;20:102-105.
Tutar B, Ekincioglu E, Karaketir S, et al. The impact of platelet-rich fibrin (PRF) on olfactory function and pain after septoplasty operations. Eur Arch Otorhinolaryngol. 2020;277:1115-1120.
Ikumi A, Hara Y, Yoshioka T, Kanamori A, Yamazaki M. Effect of local administration of platelet-rich plasma (PRP) on peripheral nerve regeneration: An experimental study in the rabbit model. Microsurg. 2018;38:300-309.
Farrag TY, Lehar M, Verhaegen P, Carson KA, Byrne PJ. Effect of Platelet Rich Plasma and Fibrin Sealant on Facial Nerve Regeneration in a Rat Model. Laryngoscope. 2007;117:157-165.
Sariguney Y, Yavuzer R, Elmas C, Yenicesu I, Bolay H, Atabay K. Effect of platelet-rich plasma on peripheral nerve regeneration. J Reconstr Microsurg. 2008;24:159-167.
Zheng C, Zhu Q, Liu X, et al. Effect of platelet-rich plasma (PRP) concentration on proliferation, neurotrophic function and migration of Schwann cells in vitro. J Tissue Eng Regen M. 2016;10:428-436.
Trull-Ahuir C, Sala D, Chismol-Abad J, Vila-Caballer M, Lisón JF. Efficacy of platelet-rich plasma as an adjuvant to surgical carpal ligament release: a prospective, randomized controlled clinical trial. Sci Rep. 2020;10:2085.
Sánchez M, Garate A, Delgado D, Padilla S. Platelet-rich plasma, an adjuvant biological therapy to assist peripheral nerve repair. Neural Regen Res. 2017;12:47-52.
Yasak AG, Yigit O, Server EA, Dastan SD, Gul M. The effectiveness of platelet-rich plasma in an anosmia-induced mice model. Laryngoscope. 2018;128:E157-E162.
Intranasal Injection of PRP Versus Saline for Treatment of olfactory loss: a randomized controlled trial. ClinicalTrials.gov identifier: NCT04406584. https://clinicaltrials.gov/ct2/show/NCT04406584, Accessed 8/18/2021
Saltagi MZ, Rabbani CC, Ting JY, Higgins TS. Management of long-lasting phantosmia: a systematic review. Int Forum Allergy Rhinol. 2018;8:790-796.
Landis BN, Reden J, Haehner A. Idiopathic phantosmia: outcome and clinical significance. ORL J Otorhinolaryngol Relat Spec. 2010;72:252-255.
Morrissey DK, Pratap U, Brown C, Wormald PJ. The role of surgery in the management of phantosmia. Laryngoscope. 2016;126:575-578.
Majumdar S, Jones NS, McKerrow WS, Scadding G. The management of idiopathic olfactory hallucinations: A study of two patients. Laryngoscope. 2003;113:879-881.
Leopold DA, Hornung DE. Olfactory cocainization is not an effective long-term treatment for phantosmia. Chem Senses. 2013;38:803-806.
Coleman ER, Grosberg BM, Robbins MS. Olfactory hallucinations in primary headache disorders: case series and literature review. Cephalalgia. 2011;31:1477-1489.
Leopold D. Distortion of olfactory perception: Diagnosis and treatment. Chem Senses. 2002;27:611-615.
Sarnat HB, Flores-Sarnat L. Might the olfactory bulb be an origin of olfactory auras in focal epilepsy? Epileptic Disord. 2016;18:344-355.
Pekala K, Chandra RK, Turner JH. Efficacy of olfactory training in patients with olfactory loss: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2016;6:299-307.
Konstantinidis I, Tsakiropoulou E, Bekiaridou P, Kazantzidou C, Constantinidis J. Use of olfactory training in posttraumatic and postinfectious olfactory dysfunction. Laryngoscope. 2013;123:E85-E90.
Patel ZM, Wise SK, DelGaudio JM. Randomized controlled trial demonstrating cost-effective method of olfactory training in clinical practice: essential oils at uncontrolled concentration. Laryngoscope Investig Otolaryngol. 2017;2:53-56.
Liu DT, Sabha M, Damm M, et al. Parosmia is associated with relevant olfactory recovery after olfactory training. Laryngoscope. 2021;131:618-623.
Frasnelli J, Landis BN, Heilmann S, et al. Clinical presentation of qualitative olfactory dysfunction. Eur Arch Otorhinolaryngol. 2004;261:411-415.
Leopold D. Distortion of olfactory perception: Diagnosis and treatment. Chem Senses. 2002;27:611-615.
Landis BN, Reden J, Haehner A. Idiopathic phantosmia: Outcome and clinical significance. ORL J Otorhinolaryngol Relat Spec. 2010;72:252-255.
Kaufman MD, Lassiter KR, Shenoy BV. Paroxysmal unilateral dysosmia: A cured patient. Ann Neurol. 1988;24:450-451.
Markert JM, Hartshorn DO, Farhat SM. Paroxysmal bilateral dysosmia treated by resection of the olfactory bulbs. Surg Neurol. 1993;40:160-163.
Sarangi P, Aziz TZ. Post-traumatic parosmia treated by olfactory nerve section. Br J Neurosurg. 1990;4:358-358.
Leopold DA, Schwob JE, Youngentob SL, Hornung DE, Wright HN, Mozell MM. Successful treatment of phantosmia with preservation of olfaction. Arch Otolaryngol Head Neck Surg. 1991;117:1402-1406.
Saltagi MZ, Rabbani CC, Ting JY, Higgins TS. Management of long-lasting phantosmia: A systematic review. Int Forum Allergy Rhinol. 2018;8:790-796.
Leopold DA, Loehrl TA, Schwob JE. Long-term follow-up of surgically treated phantosmia. Arch Otolaryngol Head Neck Surg. 2002;128:642-647.
Morrissey DK, Pratap U, Brown C, Wormald PJ. The role of surgery in the management of phantosmia. Laryngoscope. 2016;126:575-578.
Liu J, Pinheiro-Neto CD, Zhao J, Chen Z, Wang Y. A novel surgical treatment for long lasting unilateral peripheral parosmia: Olfactory cleft blocking technique. Auris Nasus Larynx. 2020; S0385-8146(20)30195-4.
Young J, Xu C, Papadakis GE, Acierno JS, et al. Clinical management of congenital hypogonadotropic hypogonadism. Endocr Rev. 2019;40:669-710.
Patel ZM, Wise SK, DelGaudio JM. Randomized controlled trial demonstrating cost-effective method of olfactory training in clinical practice: Essential oils at uncontrolled concentration. Laryngoscope Investig Otolaryngol. 2017;2 :53-56.
Nguyen TP, Patel ZM. Budesonide irrigation with olfactory training improves outcomes compared with olfactory training alone in patients with olfactory loss. Int Forum Allergy Rhinol. 2018;8:977-981.
Damm M, Pikart LK, Reimann H, et al. Olfactory training is helpful in postinfectious olfactory loss: A randomized, controlled, multicenter study. Laryngoscope. 2014;124:826-831.
Kollndorfer K, Jakab A, Mueller CA, et al. Effects of chronic peripheral olfactory loss on functional brain networks. Neuroscience. 2015;310:589-599.
Reichert JL, Postma EM, Smeets PAM, et al. Severity of olfactory deficits is reflected in functional brain networks-An fMRI study. Hum Brain Mapp. 2018;39:3166-3177.
Schlosser RJ, Smith TL, Mace JC, et al. Factors driving olfactory loss in patients with chronic rhinosinusitis: a case control study. Int Forum Allergy Rhinol. 2020;10:7-14.
Doty RL. Epidemiology of smell and taste dysfunction. Handb Clin Neurol. 2019;164:3-13.
Liu G, Zong G, Doty RL, Sun Q. Prevalence and risk factors of taste and smell impairment in a nationwide representative sample of the US population: A cross-sectional study. BMJ Open. 2016;6: e013246.
Yao L, Yi X, Pinto JM, et al. Olfactory cortex and olfactory bulb volume alterations in patients with post-infectious olfactory loss. Brain Imaging Behav. 2018;12:1355-1362.
Ren Y, Yang L, Guo Y, Xutao M, Li K, Wei Y. Intranasal trigeminal chemosensitivity in patients with postviral and post-traumatic olfactory dysfunction. Acta Otolaryngol. 2012;132:974-980.
Tian J, Pinto JM, Cui X, et al. Sendai virus induces persistent olfactory dysfunction in a murine model of pvod via effects on apoptosis, cell proliferation, and response to odorants. PLoS One. 2016;11: e0159033.
van Riel D, Verdijk R, Kuiken T. The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol. 2015;235:277-287.
Gellrich J, Han P, Manesse C, et al. Brain volume changes in hyposmic patients before and after olfactory training. Laryngoscope. 2018;128:1531-1536.
Jitaroon K, Wangworawut Y, Ma Y, Patel ZM. Evaluation of the incidence of other cranial neuropathies in patients with postviral olfactory loss. JAMA Otolaryngology Head Neck Surg. 2020;146:465-470.
Santos DV, Reiter ER, DiNardo LJ, Costanzo RM. Hazardous events associated with impaired olfactory function. Arch Otolaryngol Head Neck Surg. 2004;130:317-319.
Pence TS, Reiter ER, DiNardo LJ, Costanzo RM. Risk factors for hazardous events in olfactory-impaired patients. JAMA Otolaryngol Head Neck Surg. 2014;140:951-955.
Miwa T, Furukawa M, Tsukatani T, Costanzo RM, DiNardo LJ, Reiter ER. Impact of olfactory impairment on quality of life and disability. Arch Otolaryngol Head Neck Surg. 2001;127:497-503.
Hoffman HJ, Rawal S, Li CM, Duffy VB. New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunction. Rev Endocr Metab Disord. 2016;17:221-240.
Berner LA, Winter SR, Matheson BE, Benson L, Lowe MR. Behind binge eating: A review of food-specific adaptations of neurocognitive and neuroimaging tasks. Physiol Behav. 2017;176:59-70.
McCrickerd K, Forde CG. Sensory influences on food intake control: Moving beyond palatability. Obes Rev. 2016;17:18-29.
Boesveldt S, de Graaf K. The differential role of smell and taste for eating behavior. Perception. 2017;46:307-319.
Rapps N, Giel KE, Söhngen E, et al. Olfactory deficits in patients with anorexia nervosa. Eur Eat Disord Rev. 2010;18:385-389.
Islam MA, Fagundo AB, Arcelus J, et al. Olfaction in eating disorders and abnormal eating behavior: A systematic review. Front Psychol. 2015;6:1431.
Mattes RD, Cowart BJ, Schiavo MA, et al. Dietary evaluation of patients with smell and/or taste disorders. Am J Clin Nutr. 1990;51:233-240.
Aschenbrenner K, Hummel C, Teszmer K, et al. The influence of olfactory loss on dietary behaviors. Laryngoscope. 2008;118:135-144.
Zang Y, Han P, Burghardt S, Knaapila A, Schriever V, Hummel T. Influence of olfactory dysfunction on the perception of food. Eur Arch Otorhinolaryngol. 2019;276:2811-2817.
Bryant-Waugh R. Avoidant restrictive food intake disorder: An illustrative case example. Int J Eat Disord. 2013;46:420-423.
Havermans RC, Hermanns J, Jansen A. Eating without a nose: Olfactory dysfunction and sensory-specific satiety. Chem Senses. 2010;35:735-741.
Manesse C, Ferdenzi C, Sabri M, et al. Dysosmia-associated changes in eating behavior. Chem Percept. 2017;10:104-113.
Henkin RI. Effects of smell loss (hyposmia) on salt usage. Nutrition. 2014;30:690-695.
Mattes RD, Cowart BJ. Dietary assessment of patients with chemosensory disorders. J Am Diet Assoc. 1994;94:50-56.
Besser G, Oswald MM, Liu DT, Renner B, Mueller CA. Flavor education and training in olfactory dysfunction: A pilot study. Eur Arch Otorhinolaryngol. 2020;277:1987-1994.
Shannon J, Kristal AR, Curry SJ, Beresford SA. Application of a behavioral approach to measuring dietary change: The fat-and fiber-related diet behavior questionnaire. Cancer Epidemiol Biomarkers Prev. 1997;6:355-361.
Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364:2392-2404.
Auinger AB, Besser G, Liu DT, Renner B, Mueller CA. Long-term impact of olfactory dysfunction on daily life. Wien Klin Wochenschr. 2020 Oct 21. https://doi.org/10.1007/s00508-020-01751-5. [Online ahead of print].
Schiffman SS, Graham BG. Taste and smell perception affect appetite and immunity in the elderly. Eur J Clin Nutr. 2000;54 suppl 3: S54-S63.
Boesveldt S, Postma EM, Boak D, et al. Anosmia-a clinical review. Chem Senses. 2017;42:513-523.
Wittchen HU, Zaudig M, Fydrich T. SKID Strukturiertes klinisches Interview für DSM-IV. Achse I und II. Göttingen: Handanweisung. 1997.
Schaub A, Roth E, Goldmann U. Kognitiv-psychoedukative therapie zur bewältigung von Depressionen: ein therapiemanual. Hogrefe Verlag. 2013; 39.
Murr J, Hummel T, Ritschel G, Croy I. Individual significance of olfaction: a comparison between normosmic and dysosmic people. Psychosomatics. 2018;59:283-292.
Blomqvist EH, Brämerson A, Stjärne P, Nordin S. Consequences of olfactory loss and adopted coping strategies. Rhinology. 2004;42:189-194.
Schäfer L, Schriever V, Croy I. Human olfactory dysfunction: Causes and consequences. Cell Tissue Res. 2021;383:569-579.
Nordin S, Blomqvist EH, Olsson P, Stjärne P, Ehnhage A; NAF2S2 Study Group. Effects of smell loss on daily life and adopted coping strategies in patients with nasal polyposis with asthma. Acta Otolaryngologica. 2011;131:826-832.
Croy I, Landis BN, Meusel T, Seo HS, Krone F, Hummel T. Patient adjustment to reduced olfactory function. Arch Otolaryngol Head Neck Surg. 2011;137:377-382.
Modinos G, Ormel J, Aleman A. Individual differences in dispositional mindfulness and brain activity involved in reappraisal of emotion. Soc Cogn Affect Neurosci. 2010;5:369-377.
Kabat-Zinn J. Mindfulness-based interventions in context: Past, present, and future. Clin Psychol Sci Pract. 2003;10:144-156.
Prazak M, Critelli J, Martin L, Miranda V, Purdum M, Powers C. Mindfulness and its role in physical and psychological health. Appl Psychol Health Well Being. 2012;4:91-105.
Fitzgerald RG, Parkes CM. Blindness and loss of other sensory and cognitive functions. BMJ. 1998;316:1160-1163.
Lehane CM, Hofsöe SM, Wittich W, Dammeyer J. Mental health and spouse support among older couples living with sensory loss. J Aging Health. 2018;30:1205-1223.
Olze H, Szczepek AJ, Haupt H, Förster U, Zirke N, Gräbel S, Mazurek B. Cochlear implantation has a positive influence on quality of life, tinnitus, and psychological comorbidity. Laryngoscope. 2011;121:2220-2227.
Hofsöe SM, Lehane CM, Wittich W, Hilpert P, Dammeyer J. Interpersonal communication and psychological well-being among couples coping with sensory loss: The mediating role of perceived spouse support. J Soc Pers Relat. 2018;8:2323-2344.
Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54:1-30.
Mueller C, Temmel AF, Toth J, et al. Computed tomography scans in the evaluation of patients with olfactory dysfunction. Am J Rhinol. 2006;20:109-12.
Harju T, Rautiainen M, Kivekäs I. Significance of imaging in the diagnosis of olfactory disorder. Ear Nose Throat J. 2017;96:E13-E17.
Birkenbeuel JL, Cheung DC, Sahyouni R, et al. The use of imaging to detect intracranial tumors in idiopathic olfactory dysfunction: A systematic review. Am J Rhinol Allergy. 2020;34:297-305.
Yildirim D, Altundag A, Tekcan Sanli DE, et al. A new perspective on imaging of olfactory dysfunction: Does size matter? Eur J Radiol. 2020;132: 109290.
Seiden AM, Duncan HJ. The diagnosis of a conductive olfactory loss. Laryngoscope. 2001;111:9-14.
Shiga H, Taki J, Okuda K, et al. Prognostic value of olfactory nerve damage measured with thallium-based olfactory imaging in patients with idiopathic olfactory dysfunction. Sci Rep. 2017;7:3581.
Yoshikawa K, Wang H, Jaen C, et al. The human olfactory cleft mucus proteome and its age-related changes. Sci Rep. 2018;8: 17170.
Soler ZM, Yoo F, Schlosser RJ, et al. Correlation of mucus inflammatory proteins and olfaction in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2020;10:343-355.
Doty RL. A review of olfactory dysfunctions in man. Am J Otolaryngol. 1979;1:57-79.
Paik SI, Lehman MN, Seiden AM, Duncan HJ, Smith DV. Human olfactory biopsy. The influence of age and receptor distribution. Arch Otolaryngol Head Neck Surg. 1992;118:731-738.
Kern RC, Conley DB, Haines GK 3rd, Robinson AM. Pathology of the olfactory mucosa: Implications for the treatment of olfactory dysfunction. Laryngoscope. 2004;114:279-285.
Mainland JD, Barlow LA, Munger SD, et al. Identifying treatments for taste and smell disorders: Gaps and opportunities. Chem Senses. 2020;45:493-502.
Brann DH, Tsukahara T, Weinreb C, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020;6: eabc5801.
Schwob JE, Youngentob SL, Mezza RC. Reconstitution of the rat olfactory epithelium after methyl bromide-induced lesion. J Comp Neurol. 1995;359:15-37.
Bergman U, Ostergren A, Gustafson AL, Brittebo B. Differential effects of olfactory toxicants on olfactory regeneration. Arch Toxicol. 2002;76:104-112.
Xiong Y, Mahmood A, Chopp M. Animal models of traumatic brain injury. Nat Rev Neurosci. 2013;14:128-142.
McIntyre JC, Davis EE, Joiner A, et al. Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model. Nat Med. 2012;18:1423-1428.
Dumm RE, Wellford SA, Moseman EA, Heaton NS. Heterogeneity of antiviral responses in the upper respiratory tract mediates differential non-lytic clearance of influenza viruses. Cell Rep. 2020;32: 108103.
Fornazieri MA, Doty RL, Santos CA, et al. A new cultural adaptation of the University of Pennsylvania Smell Identification Test. Clinics (Sao Paulo). 2013;68:65-68.
Balungwe P, Huart C, Matanda R, et al. Adaptation of the Sniffin' Sticks test in South-Kivu. Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137:467-471.
Fenólio GH, Anselmo-Lima WT, Tomazini GC, et al. Validation of the Connecticut olfactory test (CCCRC) adapted to Brazil. Braz J Otorhinolaryngol. 2020;6: S1808-8694(20)30189-0.
Sorokowska A, Sorokowski P, Hummel T. Cross-Cultural administration of an odor discrimination test. Chemosens Percept. 2014;7:85-90.
Rodríguez-Violante M, Gonzalez-Latapi P, Camacho-Ordoñez A, Martínez-Ramírez D, Morales-Briceño H, Cervantes-Arriaga A. Comparing the accuracy of different smell identification tests in Parkinson's disease: Relevance of cultural aspects. Clin Neurol Neurosurg. 2014;123:9-14.
van Beusekom M, Bos M, Wolterbeek R, Guchelaar HJ, van den Broek J. Patients' preferences for visuals: Differences in the preferred level of detail, type of background and type of frame of icons depicting organs between literate and low-literate people. Patient Educ Couns. 2015;98:226-233.
Knecht M, Hummel T. Recording of the human electro-olfactogram. Physiol Behav. 2004;83:13-19.
http://techfinder.stanford.edu/technologies/S15-465_electrical-neurostimulation-of-the. Accessed 8/18/2021.
Schriever VA, Merkonidis C, Gupta N, et al. Treatment of smell loss with systemic methylprednisolone. Rhinology. 2012;50:284-289.
Seiden AM, Duncan HJ. The diagnosis of a conductive olfactory loss. Laryngoscope. 2001;111:9-14.
Stenner M, Vent J, Hüttenbrink KB, et al. Topical therapy in anosmia: Relevance of steroid-responsiveness. Laryngoscope. 2008;118:1681-1686.
Zhang W, Meng Y, Wang C, et al. Self-reported course of olfactory impairment determines outcome for successful surgical intervention in nasal polyps with anosmia. Acta Otolaryngol. 2020;140:1021-1027.
Akiyama K, Samukawa Y, Hoshikawa H. Short-term outcomes of olfaction in patients with eosinophilic chronic rhinosinusitis after endoscopic sinus surgery and an assessment of prognostic factors. Int Forum Allergy Rhinol. 2020;10:208-216.
Liu DT, Pellegrino R, Sabha M, et al. Factors associated with relevant olfactory recovery after olfactory training: a retrospective study including 601 participants. Rhinology. 2020 Sep 9. https://doi.org/10.4193/Rhin20.262. Online ahead of print.
Horikiri K, Kikuta S, Kanaya K, et al. Intravenous olfactory test latency correlates with improvement in post-infectious olfactory dysfunction. Acta Otolaryngol. 2017;137:1083-1089.
Ogawa T, Nakamura K, Yamamoto S, et al. Recovery over time and prognostic factors in treated patients with post-infectious olfactory dysfunction: A retrospective study. Ann Otol Rhinol Laryngol. 2020;129:977-982.
Rombaux P, Huart C, Deggouj N, et al. Prognostic value of olfactory bulb volume measurement for recovery in postinfectious and posttraumatic olfactory loss. Otolaryngol Head Neck Surg. 2012;147:1136-1141.
Shiga H, Taki J, Okuda K, et al. Prognostic value of olfactory nerve damage measured with thallium-based olfactory imaging in patients with idiopathic olfactory dysfunction. Sci Rep. 2017;7:3581.
Whitcroft KL, Hummel T. Clinical diagnosis and current management strategies for olfactory dysfunction: A review. JAMA Otolaryngol Head Neck Surg. 2019;145:846-853.
Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58:1-464.
Mainland JD, Barlow LA, Munger SD, et al. Identifying treatments for taste and smell disorders: Gaps and opportunities. Chem Senses. 2020;45:493-502.
Kurtenbach S, Goss GM, Goncalves S, et al. Cell-based therapy restores olfactory function in an inducible model of hyposmia. Stem Cell Reports. 2019;12:1354-1365.
Holbrook EH, Coelho DH. Cranial nerve stimulation for olfaction (cranial nerve 1). Otolaryngol Clin North Am. 2020;53:73-85.
Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinol Suppl. 2017;54:1-30.
Fifth Sense weB-SIT®e. Accessed July 16, 2021. https://www.fifthsense.org.uk/
AbScent weB-SIT®e. Accessed July 16, 2021. https://abscent.org/
STANA weB-SIT®e. Accessed July 16, 2021. https://thestana.org/
Reuksmaakstoornis weB-SIT®e. Accessed July 16, 2021. https://reuksmaakstoornis.nl/